返回首页 在线留言 联系我们
首页 > 产品展示 > > 所有 > LKT T3040 Thienylpentyl Isothiocyanate

产品中心

LKT T3040 Thienylpentyl Isothiocyanate

  • 型   号:
  • 价   格:

LKT Labs 是一家专注于防癌抗癌特殊化学品研究和开发的公司。主要提供:癌症药物、药物发现试剂盒、天然产物、广泛的生命科学研究试剂、定制合成。
美国LKT Labs 是1988年在美国成立的,为全球提供先端的药物研发试剂、试剂盒、委托合成,并为药物生产企业提供原料,最近几年在农药、水产养殖业有很大程度的开发。LKT T3040 Thienylpentyl Isothiocyanate

分享到:

LKT Labs 是一家专注于防癌抗癌特殊化学品研究和开发的公司。主要提供:癌症药物、药物发现试剂盒、天然产物、广泛的生命科学研究试剂、定制合成。
美国LKT Labs 是1988年在美国成立的,为全球提供先端的药物研发试剂、试剂盒、委托合成,并为药物生产企业提供原料,最近几年在农药、水产养殖业有很大程度的开发。在LKT Labs 可以找到在其他地方找不到的产品。

LKT  T3040 Thienylpentyl Isothiocyanate

LKT  T3040 Thienylpentyl Isothiocyanate

 

LKT G3456 Ginsenoside Rd 1 mg 47.6 Triterpene saponin found in species of Panax; 26S proteasome inhibitor, TRPM7 antagonist. Gypenoside VIII 52705-93-8 ≥98% 947.16 C48H82O18 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C Ambient 4°C "Zhu D, Liu M, Yang Y, et al. Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice. J Neurosci Res. 2014 Sep;92(9):1217-26. PMID: 24798871.

 

Zhang YX, Wang L, Xiao EL, et al. Ginsenoside-Rd exhibits anti-inflammatory activities through elevation of antioxidant enzyme activities and inhibition of JNK and ERK activation in vivo. Int Immunopharmacol. 2013 Dec;17(4):1094-100. PMID: 24455777.

 

Wang Y, Li X, Wang X, et al. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway. PLoS One. 2013 Aug 16;8(8):e70956. PMID: 23976968.

 

Li L, Liu Z, Liu J, et al. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A. Neurobiol Dis. 2013 Jun;54:320-8. PMID: 23321003.

 

Kim BJ. Involvement of melastatin type transient receptor potential 7 channels in ginsenoside Rd-induced apoptosis in gastric and breast cancer cells. J Ginseng Res. 2013 Apr;37(2):201-9. PMID: 23717173.

 

Yoon JH, Choi YJ, Cha SW, et al. Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation. Phytomedicine. 2012 Feb 15;19(3-4):284-92. PMID: 21982435.

 

Chang TL, Ding HY, Kao YW. Role of ginsenoside Rd in inhibiting 26S proteasome activity. J Agric Food Chem. 2008 Dec 24;56(24):12011-5. PMID: 19053398.

" Xn Not dangerous goods.

LKT G3456 Ginsenoside Rd 5 mg 203.8 Triterpene saponin found in species of Panax; 26S proteasome inhibitor, TRPM7 antagonist. Gypenoside VIII 52705-93-8 ≥98% 947.16 C48H82O18 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C Ambient 4°C "Zhu D, Liu M, Yang Y, et al. Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice. J Neurosci Res. 2014 Sep;92(9):1217-26. PMID: 24798871.

 

Zhang YX, Wang L, Xiao EL, et al. Ginsenoside-Rd exhibits anti-inflammatory activities through elevation of antioxidant enzyme activities and inhibition of JNK and ERK activation in vivo. Int Immunopharmacol. 2013 Dec;17(4):1094-100. PMID: 24455777.

 

Wang Y, Li X, Wang X, et al. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway. PLoS One. 2013 Aug 16;8(8):e70956. PMID: 23976968.

 

Li L, Liu Z, Liu J, et al. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A. Neurobiol Dis. 2013 Jun;54:320-8. PMID: 23321003.

 

Kim BJ. Involvement of melastatin type transient receptor potential 7 channels in ginsenoside Rd-induced apoptosis in gastric and breast cancer cells. J Ginseng Res. 2013 Apr;37(2):201-9. PMID: 23717173.

 

Yoon JH, Choi YJ, Cha SW, et al. Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation. Phytomedicine. 2012 Feb 15;19(3-4):284-92. PMID: 21982435.

 

Chang TL, Ding HY, Kao YW. Role of ginsenoside Rd in inhibiting 26S proteasome activity. J Agric Food Chem. 2008 Dec 24;56(24):12011-5. PMID: 19053398.

" Xn Not dangerous goods.

LKT G3456 Ginsenoside Rd 10 mg 298.9 Triterpene saponin found in species of Panax; 26S proteasome inhibitor, TRPM7 antagonist. Gypenoside VIII 52705-93-8 ≥98% 947.16 C48H82O18 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C Ambient 4°C "Zhu D, Liu M, Yang Y, et al. Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice. J Neurosci Res. 2014 Sep;92(9):1217-26. PMID: 24798871.

 

Zhang YX, Wang L, Xiao EL, et al. Ginsenoside-Rd exhibits anti-inflammatory activities through elevation of antioxidant enzyme activities and inhibition of JNK and ERK activation in vivo. Int Immunopharmacol. 2013 Dec;17(4):1094-100. PMID: 24455777.

 

Wang Y, Li X, Wang X, et al. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway. PLoS One. 2013 Aug 16;8(8):e70956. PMID: 23976968.

 

Li L, Liu Z, Liu J, et al. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A. Neurobiol Dis. 2013 Jun;54:320-8. PMID: 23321003.

 

Kim BJ. Involvement of melastatin type transient receptor potential 7 channels in ginsenoside Rd-induced apoptosis in gastric and breast cancer cells. J Ginseng Res. 2013 Apr;37(2):201-9. PMID: 23717173.

 

Yoon JH, Choi YJ, Cha SW, et al. Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation. Phytomedicine. 2012 Feb 15;19(3-4):284-92. PMID: 21982435.

 

Chang TL, Ding HY, Kao YW. Role of ginsenoside Rd in inhibiting 26S proteasome activity. J Agric Food Chem. 2008 Dec 24;56(24):12011-5. PMID: 19053398.

" Xn Not dangerous goods.

LKT G3457 Ginsenoside Re 1 mg 101.7 Triterpene saponin found in species of Panax; PPARγ agonist. Panaxoside RE; Ginsenoside B2 52286-59-6 ≥98% 947.18 C49H84O17 CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)O)C7(C3C(C(CC7)O)(C)C)C)C)CO)O)O)O)O)O Ambient 4°C Soluble in ethanol (5 mg/ml), DMSO (15 mg/ml), and DMF (20 mg/ml). Insoluble in water. "Su X, Pei Z, Hu S. Ginsenoside Re as an adjuvant to enhance the immune response to the inactivated rabies virus vaccine in mice. Int Immunopharmacol. 2014 Jun;20(2):283-9. PMID: 24680943.

 

Lee S, Kim MG, Ko SK, et al. Protective effect of ginsenoside Re on acute gastric mucosal lesion induced by compound 48/80. J Ginseng Res. 2014 Apr;38(2):89-96. PMID: 24748832.

 

Lim KH, Lim DJ, Kim JH. Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approach. J Ginseng Res. 2013 Jul;37(3):283-92. PMID: 24198653.

 

Gao Y, Yang MF, Su YP, et al. Ginsenoside Re reduces insulin resistance through activation of PPAR-γ pathway and inhibition of TNF-α production. J Ethnopharmacol. 2013 May 20;147(2):509-16. PMID: 23545455.

 

Bae HM, Cho OS, Kim SJ, et al. Inhibitory effects of ginsenoside re isolated from ginseng berry on histamine and cytokine release in human mast cells and human alveolar epithelial cells. J Ginseng Res. 2012 Oct;36(4):369-74. PMID: 23717138.

 

Lee KW, Jung SY, Choi SM, et al. Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cells. BMC Complement Altern Med. 2012 Oct 26;12:196. PMID: 23102375.

 

Lee B, Shim I, Lee H, et al. Effect of ginsenoside Re on depression- and anxiety-like behaviors and cognition memory deficit induced by repeated immobilization in rats. J Microbiol Biotechnol. 2012 May;22(5):708-20. PMID: 22561867.

" Xn Not dangerous goods.

LKT G3457 Ginsenoside Re 5 mg 254.3 Triterpene saponin found in species of Panax; PPARγ agonist. Panaxoside RE; Ginsenoside B2 52286-59-6 ≥98% 947.18 C49H84O17 CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)O)C7(C3C(C(CC7)O)(C)C)C)C)CO)O)O)O)O)O Ambient 4°C Soluble in ethanol (5 mg/ml), DMSO (15 mg/ml), and DMF (20 mg/ml). Insoluble in water. "Su X, Pei Z, Hu S. Ginsenoside Re as an adjuvant to enhance the immune response to the inactivated rabies virus vaccine in mice. Int Immunopharmacol. 2014 Jun;20(2):283-9. PMID: 24680943.

 

Lee S, Kim MG, Ko SK, et al. Protective effect of ginsenoside Re on acute gastric mucosal lesion induced by compound 48/80. J Ginseng Res. 2014 Apr;38(2):89-96. PMID: 24748832.

 

Lim KH, Lim DJ, Kim JH. Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approach. J Ginseng Res. 2013 Jul;37(3):283-92. PMID: 24198653.

 

Gao Y, Yang MF, Su YP, et al. Ginsenoside Re reduces insulin resistance through activation of PPAR-γ pathway and inhibition of TNF-α production. J Ethnopharmacol. 2013 May 20;147(2):509-16. PMID: 23545455.

 

Bae HM, Cho OS, Kim SJ, et al. Inhibitory effects of ginsenoside re isolated from ginseng berry on histamine and cytokine release in human mast cells and human alveolar epithelial cells. J Ginseng Res. 2012 Oct;36(4):369-74. PMID: 23717138.

 

Lee KW, Jung SY, Choi SM, et al. Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cells. BMC Complement Altern Med. 2012 Oct 26;12:196. PMID: 23102375.

 

Lee B, Shim I, Lee H, et al. Effect of ginsenoside Re on depression- and anxiety-like behaviors and cognition memory deficit induced by repeated immobilization in rats. J Microbiol Biotechnol. 2012 May;22(5):708-20. PMID: 22561867.

" Xn Not dangerous goods.

LKT G3457 Ginsenoside Re 10 mg 445 Triterpene saponin found in species of Panax; PPARγ agonist. Panaxoside RE; Ginsenoside B2 52286-59-6 ≥98% 947.18 C49H84O17 CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)O)C7(C3C(C(CC7)O)(C)C)C)C)CO)O)O)O)O)O Ambient 4°C Soluble in ethanol (5 mg/ml), DMSO (15 mg/ml), and DMF (20 mg/ml). Insoluble in water. "Su X, Pei Z, Hu S. Ginsenoside Re as an adjuvant to enhance the immune response to the inactivated rabies virus vaccine in mice. Int Immunopharmacol. 2014 Jun;20(2):283-9. PMID: 24680943.

 

Lee S, Kim MG, Ko SK, et al. Protective effect of ginsenoside Re on acute gastric mucosal lesion induced by compound 48/80. J Ginseng Res. 2014 Apr;38(2):89-96. PMID: 24748832.

 

Lim KH, Lim DJ, Kim JH. Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approach. J Ginseng Res. 2013 Jul;37(3):283-92. PMID: 24198653.

 

Gao Y, Yang MF, Su YP, et al. Ginsenoside Re reduces insulin resistance through activation of PPAR-γ pathway and inhibition of TNF-α production. J Ethnopharmacol. 2013 May 20;147(2):509-16. PMID: 23545455.

 

Bae HM, Cho OS, Kim SJ, et al. Inhibitory effects of ginsenoside re isolated from ginseng berry on histamine and cytokine release in human mast cells and human alveolar epithelial cells. J Ginseng Res. 2012 Oct;36(4):369-74. PMID: 23717138.

 

Lee KW, Jung SY, Choi SM, et al. Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cells. BMC Complement Altern Med. 2012 Oct 26;12:196. PMID: 23102375.

 

Lee B, Shim I, Lee H, et al. Effect of ginsenoside Re on depression- and anxiety-like behaviors and cognition memory deficit induced by repeated immobilization in rats. J Microbiol Biotechnol. 2012 May;22(5):708-20. PMID: 22561867.

" Xn Not dangerous goods.

LKT G3458 Ginsenoside Rg1 5 mg 173 Triterpene saponin found in species of Panax. Sanchinoside Rg1; Panaxoside A 22427-39-0 ≥98% 801.01 C42H72O14 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C Ambient 4°C "Zhu J, Mu X, Zeng J, et al. Ginsenoside rg1 prevents cognitive impairment and hippocampus senescence in a rat model of d-galactose-induced aging. PLoS One. 2014 Jun 30;9(6):e101291. PMID: 24979747.

 

Li JP, Gao Y, Chu SF, et al. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis. Acta Pharmacol Sin. 2014 Jun 30. [Epub ahead of print]. PMID: 24976156.

 

Li J, Wei Q, Zuo GW, et al. Ginsenoside Rg1 induces apoptosis through inhibition of the EpoR-mediated JAK2/STAT5 signalling pathway in the TF-1/ Epo human leukemia cell line. Asian Pac J Cancer Prev. 2014;15(6):2453-9. PMID: 24761846.

 

Zhou Y, Li HQ, Lu L, et al. Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression. Phytomedicine. 2014 Jun 15;21(7):998-1003. PMID: 24462216.

 

He Y, Zhao H, Su G. Ginsenoside Rg1 decreases neurofibrillary tangles accumulation in retina by regulating activities of neprilysin and PKA in retinal cells of AD mice model. J Mol Neurosci. 2014 Jan;52(1):101-6. PMID: 24287922.

 

Zhou Q, Jiang L, Xu C, et al. Ginsenoside Rg1 inhibits platelet activation and arterial thrombosis. Thromb Res. 2014 Jan;133(1):57-65. PMID: 24196231.

 

Oh HA, Seo JY, Jeong HJ, et al. Ginsenoside Rg1 inhibits the TSLP production in allergic rhinitis mice. Immunopharmacol Immunotoxicol. 2013 Dec;35(6):678-86. PMID: 24053327.

 

Zhang YJ, Zhang XL, Li MH, et al. The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis. J Cardiovasc Pharmacol. 2013 Jul;62(1):50-7. PMID: 23846802.

" Xn Not dangerous goods.

LKT G3458 Ginsenoside Rg1 10 mg 292.5 Triterpene saponin found in species of Panax. Sanchinoside Rg1; Panaxoside A 22427-39-0 ≥98% 801.01 C42H72O14 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C Ambient 4°C "Zhu J, Mu X, Zeng J, et al. Ginsenoside rg1 prevents cognitive impairment and hippocampus senescence in a rat model of d-galactose-induced aging. PLoS One. 2014 Jun 30;9(6):e101291. PMID: 24979747.

 

Li JP, Gao Y, Chu SF, et al. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis. Acta Pharmacol Sin. 2014 Jun 30. [Epub ahead of print]. PMID: 24976156.

 

Li J, Wei Q, Zuo GW, et al. Ginsenoside Rg1 induces apoptosis through inhibition of the EpoR-mediated JAK2/STAT5 signalling pathway in the TF-1/ Epo human leukemia cell line. Asian Pac J Cancer Prev. 2014;15(6):2453-9. PMID: 24761846.

 

Zhou Y, Li HQ, Lu L, et al. Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression. Phytomedicine. 2014 Jun 15;21(7):998-1003. PMID: 24462216.

 

He Y, Zhao H, Su G. Ginsenoside Rg1 decreases neurofibrillary tangles accumulation in retina by regulating activities of neprilysin and PKA in retinal cells of AD mice model. J Mol Neurosci. 2014 Jan;52(1):101-6. PMID: 24287922.

 

Zhou Q, Jiang L, Xu C, et al. Ginsenoside Rg1 inhibits platelet activation and arterial thrombosis. Thromb Res. 2014 Jan;133(1):57-65. PMID: 24196231.

 

Oh HA, Seo JY, Jeong HJ, et al. Ginsenoside Rg1 inhibits the TSLP production in allergic rhinitis mice. Immunopharmacol Immunotoxicol. 2013 Dec;35(6):678-86. PMID: 24053327.

 

Zhang YJ, Zhang XL, Li MH, et al. The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis. J Cardiovasc Pharmacol. 2013 Jul;62(1):50-7. PMID: 23846802.

" Xn Not dangerous goods.

LKT G3458 Ginsenoside Rg1 25 mg 571.9 Triterpene saponin found in species of Panax. Sanchinoside Rg1; Panaxoside A 22427-39-0 ≥98% 801.01 C42H72O14 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C Ambient 4°C "Zhu J, Mu X, Zeng J, et al. Ginsenoside rg1 prevents cognitive impairment and hippocampus senescence in a rat model of d-galactose-induced aging. PLoS One. 2014 Jun 30;9(6):e101291. PMID: 24979747.

 

Li JP, Gao Y, Chu SF, et al. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis. Acta Pharmacol Sin. 2014 Jun 30. [Epub ahead of print]. PMID: 24976156.

 

Li J, Wei Q, Zuo GW, et al. Ginsenoside Rg1 induces apoptosis through inhibition of the EpoR-mediated JAK2/STAT5 signalling pathway in the TF-1/ Epo human leukemia cell line. Asian Pac J Cancer Prev. 2014;15(6):2453-9. PMID: 24761846.

 

Zhou Y, Li HQ, Lu L, et al. Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression. Phytomedicine. 2014 Jun 15;21(7):998-1003. PMID: 24462216.

 

He Y, Zhao H, Su G. Ginsenoside Rg1 decreases neurofibrillary tangles accumulation in retina by regulating activities of neprilysin and PKA in retinal cells of AD mice model. J Mol Neurosci. 2014 Jan;52(1):101-6. PMID: 24287922.

 

Zhou Q, Jiang L, Xu C, et al. Ginsenoside Rg1 inhibits platelet activation and arterial thrombosis. Thromb Res. 2014 Jan;133(1):57-65. PMID: 24196231.

 

Oh HA, Seo JY, Jeong HJ, et al. Ginsenoside Rg1 inhibits the TSLP production in allergic rhinitis mice. Immunopharmacol Immunotoxicol. 2013 Dec;35(6):678-86. PMID: 24053327.

 

Zhang YJ, Zhang XL, Li MH, et al. The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis. J Cardiovasc Pharmacol. 2013 Jul;62(1):50-7. PMID: 23846802.

" Xn Not dangerous goods.

LKT G3459 Ginsenoside Rg2 1 mg 61.1 Triterpene saponin found in species of Panax. 52286-74-5 ≥98% 785.01 C42H72O13 CCC(=CCCC(C)(C1CCC2(C1C(CC3C2CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)C)O)O)O)O)C)O)C Ambient 4°C "Cho YS, Kim CH, Ha TS, et al. Ginsenoside rg2 inhibits lipopolysaccharide-induced adhesion molecule expression in human umbilical vein endothelial cell. Korean J Physiol Pharmacol. 2013 Apr;17(2):133-7. PMID: 23626475.

 

Yuan HD, Kim do Y, Quan HY, et al. Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3β via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells. Chem Biol Interact. 2012 Jan 5;195(1):35-42. PMID: 22062806.

 

Zhang G, Liu A, Zhou Y, et al. Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. J Ethnopharmacol. 2008 Feb 12;115(3):441-8. PMID: 18083315.

" Xn Not dangerous goods.

LKT G3459 Ginsenoside Rg2 5 mg 203.8 Triterpene saponin found in species of Panax. 52286-74-5 ≥98% 785.01 C42H72O13 CCC(=CCCC(C)(C1CCC2(C1C(CC3C2CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)C)O)O)O)O)C)O)C Ambient 4°C "Cho YS, Kim CH, Ha TS, et al. Ginsenoside rg2 inhibits lipopolysaccharide-induced adhesion molecule expression in human umbilical vein endothelial cell. Korean J Physiol Pharmacol. 2013 Apr;17(2):133-7. PMID: 23626475.

 

Yuan HD, Kim do Y, Quan HY, et al. Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3β via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells. Chem Biol Interact. 2012 Jan 5;195(1):35-42. PMID: 22062806.

 

Zhang G, Liu A, Zhou Y, et al. Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. J Ethnopharmacol. 2008 Feb 12;115(3):441-8. PMID: 18083315.

" Xn Not dangerous goods.

LKT G3459 Ginsenoside Rg2 10 mg 271.7 Triterpene saponin found in species of Panax. 52286-74-5 ≥98% 785.01 C42H72O13 CCC(=CCCC(C)(C1CCC2(C1C(CC3C2CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)C)O)O)O)O)C)O)C Ambient 4°C "Cho YS, Kim CH, Ha TS, et al. Ginsenoside rg2 inhibits lipopolysaccharide-induced adhesion molecule expression in human umbilical vein endothelial cell. Korean J Physiol Pharmacol. 2013 Apr;17(2):133-7. PMID: 23626475.

 

Yuan HD, Kim do Y, Quan HY, et al. Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3β via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells. Chem Biol Interact. 2012 Jan 5;195(1):35-42. PMID: 22062806.

 

Zhang G, Liu A, Zhou Y, et al. Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. J Ethnopharmacol. 2008 Feb 12;115(3):441-8. PMID: 18083315.

" Xn Not dangerous goods.

LKT G3460 Ginsenoside F1 1 mg 101.7 Triterpene saponin found in species of Panax. 53963-43-2 ≥98% 638.87 C36H62O9 CC(=CCCC(C)(C1(CCC2(C1C(CC3C2CC(C4C3(CCC(C4(C)C)O)C)O)O)C)C)OC5C(C(C(C(O5)CO)O)O)O)C Ambient 4°C "Lee EH, Cho SY, Kim SJ, et al. Ginsenoside F1 protects human HaCaT keratinocytes from ultraviolet-B-induced apoptosis by maintaining constant levels of Bcl-2. J Invest Dermatol. 2003 Sep;121(3):607-13. PMID: 12925222.

 

Zhang YW, Dou DQ, Zhang L, et al. Effects of ginsenosides from Panax ginseng on cell-to-cell communication function mediated by gap junctions. Planta Med. 2001 Jul;67(5):417-22. PMID: 11488454.

" Not dangerous goods.

LKT G3460 Ginsenoside F1 5 mg 254.3 Triterpene saponin found in species of Panax. 53963-43-2 ≥98% 638.87 C36H62O9 CC(=CCCC(C)(C1(CCC2(C1C(CC3C2CC(C4C3(CCC(C4(C)C)O)C)O)O)C)C)OC5C(C(C(C(O5)CO)O)O)O)C Ambient 4°C "Lee EH, Cho SY, Kim SJ, et al. Ginsenoside F1 protects human HaCaT keratinocytes from ultraviolet-B-induced apoptosis by maintaining constant levels of Bcl-2. J Invest Dermatol. 2003 Sep;121(3):607-13. PMID: 12925222.

 

Zhang YW, Dou DQ, Zhang L, et al. Effects of ginsenosides from Panax ginseng on cell-to-cell communication function mediated by gap junctions. Planta Med. 2001 Jul;67(5):417-22. PMID: 11488454.

" Not dangerous goods.

LKT G3460 Ginsenoside F1 10 mg 445 Triterpene saponin found in species of Panax. 53963-43-2 ≥98% 638.87 C36H62O9 CC(=CCCC(C)(C1(CCC2(C1C(CC3C2CC(C4C3(CCC(C4(C)C)O)C)O)O)C)C)OC5C(C(C(C(O5)CO)O)O)O)C Ambient 4°C "Lee EH, Cho SY, Kim SJ, et al. Ginsenoside F1 protects human HaCaT keratinocytes from ultraviolet-B-induced apoptosis by maintaining constant levels of Bcl-2. J Invest Dermatol. 2003 Sep;121(3):607-13. PMID: 12925222.

 

Zhang YW, Dou DQ, Zhang L, et al. Effects of ginsenosides from Panax ginseng on cell-to-cell communication function mediated by gap junctions. Planta Med. 2001 Jul;67(5):417-22. PMID: 11488454.

" Not dangerous goods.

LKT T7197 Tryprostatin A 0.5 mg 461.1 Diketopiperazine produced by Aspergillus; microtubule polymerization inhibitor. TPS-A ≥92% 383.48 C22H29N3O3 CC(=CCC1=C(C2=C(N1)C=C(C=C2)OC)CC3C(=O)N4CCCC4C(=O)N3)C Blue Ice -20°C Soluble in methanol, ethanol, or DMSO. "Jain HD, Zhang C, Zhou S, et al. Synthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance protein. Bioorg Med Chem. 2008 Apr 15;16(8):4626-51. PMID: 18321710.

 

Usui T, Kondoh M, Cui CB, et al. Tryprostatin A, a specific and novel inhibitor of microtubule assembly. Biochem J. 1998 Aug 1;333 ( Pt 3):543-8. PMID: 9677311.

 

Cui CB, Kakeya H, Osada H. Novel mammalian cell cycle inhibitors, tryprostatins A, B and other diketopiperazines produced by Aspergillus fumigatus. II. Physico-chemical properties and structures. J Antibiot (Tokyo). 1996 Jun;49(6):534-40. PMID: 8698635.

" Not dangerous goods.

LKT T7158 Tropicamide 100 mg 40.7 mAChR antaonist. N-Ethyl-α-(hydroxymethyl)-N-(4-pyridinyl methyl)- benzeneacetamide Mydriacyl; Mydriaticum 1508-75-4 ≥98% 284.35 C17H20N2O2 CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2 Ambient 4°C Soluble in water or ethanol "Kim JM, Park KH, Han SY, et al. Changes in intraocular pressure after pharmacologic pupil dilation. BMC Ophthalmol. 2012 Sep 27;12:53. PMID: 23017184.

 

Park JH, Lee YC, Lee SY. The comparison of mydriatic effect between two drugs of different mechanism. Korean J Ophthalmol. 2009 Mar;23(1):40-2. PMID: 19337478.

 

Manny RE, Hussein M, Scheiman M, et al. Tropicamide (1%): an effective cycloplegic agent for myopic children. Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1728-35. PMID: 11431435.

" Xn, Xi Not dangerous goods.

LKT T7158 Tropicamide 500 mg 136 mAChR antaonist. N-Ethyl-α-(hydroxymethyl)-N-(4-pyridinyl methyl)- benzeneacetamide Mydriacyl; Mydriaticum 1508-75-4 ≥98% 284.35 C17H20N2O2 CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2 Ambient 4°C Soluble in water or ethanol "Kim JM, Park KH, Han SY, et al. Changes in intraocular pressure after pharmacologic pupil dilation. BMC Ophthalmol. 2012 Sep 27;12:53. PMID: 23017184.

 

Park JH, Lee YC, Lee SY. The comparison of mydriatic effect between two drugs of different mechanism. Korean J Ophthalmol. 2009 Mar;23(1):40-2. PMID: 19337478.

 

Manny RE, Hussein M, Scheiman M, et al. Tropicamide (1%): an effective cycloplegic agent for myopic children. Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1728-35. PMID: 11431435.

" Xn, Xi Not dangerous goods.

LKT T7158 Tropicamide 1 g 197.1 mAChR antaonist. N-Ethyl-α-(hydroxymethyl)-N-(4-pyridinyl methyl)- benzeneacetamide Mydriacyl; Mydriaticum 1508-75-4 ≥98% 284.35 C17H20N2O2 CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2 Ambient 4°C Soluble in water or ethanol "Kim JM, Park KH, Han SY, et al. Changes in intraocular pressure after pharmacologic pupil dilation. BMC Ophthalmol. 2012 Sep 27;12:53. PMID: 23017184.

 

Park JH, Lee YC, Lee SY. The comparison of mydriatic effect between two drugs of different mechanism. Korean J Ophthalmol. 2009 Mar;23(1):40-2. PMID: 19337478.

 

Manny RE, Hussein M, Scheiman M, et al. Tropicamide (1%): an effective cycloplegic agent for myopic children. Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1728-35. PMID: 11431435.

" Xn, Xi Not dangerous goods.

LKT T7156 Tropisetron Hydrochloride 10 mg 69.3 α7 nAChR partial agonist, 5-HT3 antagonist. 1H-Indole-3-carboxylic acid (3-endo)-8-methyl- 8-azabicyclo[3.2.1]oct-3-yl ester monohydrochloride Navoban; Novaban 105826-92-4 ≥98% 320.82 C17H20N2O2 HCl CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43.Cl Ambient 4°C Soluble in water. "Zirak MR, Rahimian R, Ghazi-Khansari M, et al. Tropisetron attenuates cisplatin-induced nephrotoxicity in mice. Eur J Pharmacol. 2014 Jun 4. [Epub ahead of print]. PMID: 24905858.

 

Swartz MM, Linn DM, Linn CL. Tropisetron as a neuroprotective agent against glutamate-induced excitotoxicity and mechanisms of action. Neuropharmacology. 2013 Oct;73:111-21. PMID: 23727438.

 

Stegemann A, Sindrilaru A, Eckes B, et al. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model. Arthritis Rheum. 2013 Mar;65(3):792-804. PMID: 23440693.

 

Bandschapp O, Filitz J, Urwyler A, et al. Tropisetron blocks analgesic action of acetaminophen: a human pain model study. Pain. 2011 Jun;152(6):1304-10. PMID: 21420788.

 

Hsu ES. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Am J Ther. 2010 Sep-Oct;17(5):476-86. PMID: 20844345.

" None Not dangerous goods.

LKT T7156 Tropisetron Hydrochloride 50 mg 196.8 α7 nAChR partial agonist, 5-HT3 antagonist. 1H-Indole-3-carboxylic acid (3-endo)-8-methyl- 8-azabicyclo[3.2.1]oct-3-yl ester monohydrochloride Navoban; Novaban 105826-92-4 ≥98% 320.82 C17H20N2O2 HCl CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43.Cl Ambient 4°C Soluble in water. "Zirak MR, Rahimian R, Ghazi-Khansari M, et al. Tropisetron attenuates cisplatin-induced nephrotoxicity in mice. Eur J Pharmacol. 2014 Jun 4. [Epub ahead of print]. PMID: 24905858.

 

Swartz MM, Linn DM, Linn CL. Tropisetron as a neuroprotective agent against glutamate-induced excitotoxicity and mechanisms of action. Neuropharmacology. 2013 Oct;73:111-21. PMID: 23727438.

 

Stegemann A, Sindrilaru A, Eckes B, et al. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model. Arthritis Rheum. 2013 Mar;65(3):792-804. PMID: 23440693.

 

Bandschapp O, Filitz J, Urwyler A, et al. Tropisetron blocks analgesic action of acetaminophen: a human pain model study. Pain. 2011 Jun;152(6):1304-10. PMID: 21420788.

 

Hsu ES. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Am J Ther. 2010 Sep-Oct;17(5):476-86. PMID: 20844345.

" None Not dangerous goods.

LKT T7156 Tropisetron Hydrochloride 100 mg 288.8 α7 nAChR partial agonist, 5-HT3 antagonist. 1H-Indole-3-carboxylic acid (3-endo)-8-methyl- 8-azabicyclo[3.2.1]oct-3-yl ester monohydrochloride Navoban; Novaban 105826-92-4 ≥98% 320.82 C17H20N2O2 HCl CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43.Cl Ambient 4°C Soluble in water. "Zirak MR, Rahimian R, Ghazi-Khansari M, et al. Tropisetron attenuates cisplatin-induced nephrotoxicity in mice. Eur J Pharmacol. 2014 Jun 4. [Epub ahead of print]. PMID: 24905858.

 

Swartz MM, Linn DM, Linn CL. Tropisetron as a neuroprotective agent against glutamate-induced excitotoxicity and mechanisms of action. Neuropharmacology. 2013 Oct;73:111-21. PMID: 23727438.

 

Stegemann A, Sindrilaru A, Eckes B, et al. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model. Arthritis Rheum. 2013 Mar;65(3):792-804. PMID: 23440693.

 

Bandschapp O, Filitz J, Urwyler A, et al. Tropisetron blocks analgesic action of acetaminophen: a human pain model study. Pain. 2011 Jun;152(6):1304-10. PMID: 21420788.

 

Hsu ES. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Am J Ther. 2010 Sep-Oct;17(5):476-86. PMID: 20844345.

" None Not dangerous goods.

LKT T7135 Triticonazole 5 g 65.6 Triazole; 14-α demethylase inhibitor, potential aromatase inhibitor. (5E)-5-[(4-chlorophenyl)methylene]-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol 131983-72-7 ≥95% 317.81 C17H20ClN3O CC1(CCC(=CC2=CC=C(C=C2)Cl)C1(CN3C=NC=N3)O)C Ambient Ambient "Kjærstad MB, Taxvig C, Nellemann C, et al. Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. Reprod Toxicol. 2010 Dec;30(4):573-82. PMID: 20708073.

 

Raveton M, Ravanel P, Royer F, et al. Triticonazole distribution in dressed corn caryopsis and seedlings. J Agric Food Chem. 1999 Apr;47(4):1740-4. PMID: 10564047.

" N "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Triticonazole)"

LKT T7135 Triticonazole 10 g 93.8 Triazole; 14-α demethylase inhibitor, potential aromatase inhibitor. (5E)-5-[(4-chlorophenyl)methylene]-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol 131983-72-7 ≥95% 317.81 C17H20ClN3O CC1(CCC(=CC2=CC=C(C=C2)Cl)C1(CN3C=NC=N3)O)C Ambient Ambient "Kjærstad MB, Taxvig C, Nellemann C, et al. Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. Reprod Toxicol. 2010 Dec;30(4):573-82. PMID: 20708073.

 

Raveton M, Ravanel P, Royer F, et al. Triticonazole distribution in dressed corn caryopsis and seedlings. J Agric Food Chem. 1999 Apr;47(4):1740-4. PMID: 10564047.

" N "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Triticonazole)"

LKT T7135 Triticonazole 100 g 515.7 Triazole; 14-α demethylase inhibitor, potential aromatase inhibitor. (5E)-5-[(4-chlorophenyl)methylene]-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol 131983-72-7 ≥95% 317.81 C17H20ClN3O CC1(CCC(=CC2=CC=C(C=C2)Cl)C1(CN3C=NC=N3)O)C Ambient Ambient "Kjærstad MB, Taxvig C, Nellemann C, et al. Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. Reprod Toxicol. 2010 Dec;30(4):573-82. PMID: 20708073.

 

Raveton M, Ravanel P, Royer F, et al. Triticonazole distribution in dressed corn caryopsis and seedlings. J Agric Food Chem. 1999 Apr;47(4):1740-4. PMID: 10564047.

" N "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Triticonazole)"

LKT T7133 Trimetazidine 250 mg 71.3 Long-chain 3-ketoacyl-CoA thiolase inhibitor, potential kainate and AMPA antagonist. 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine 5011-34-7 ≥98% 266.34 C14H22N2O3 COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC Ambient Ambient "Ferraro E, Giammarioli AM, Caldarola S, et al. The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes. FEBS J. 2013 Oct;280(20):5094-108. PMID: 23953053.

 

Khan M, Meduru S, Mostafa M, et al. Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling. J Pharmacol Exp Ther. 2010 May;333(2):421-9. PMID: 20167841.

 

Tuunanen H, Engblom E, Naum A, et al. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation. 2008 Sep 16;118(12):1250-8. PMID: 18765391.

 

Dayanithi G, Desmadryl G, Travo C, et al. Trimetazidine modulates AMPA/kainate receptors in rat vestibular ganglion neurons. Eur J Pharmacol. 2007 Nov 21;574(1):8-14. PMID: 17658512.

 

Demaison L, Fantini E, Sentex E, et al. Trimetazidine: in vitro influence on heart mitochondrial function. Am J Cardiol. 1995 Aug 24;76(6):31B-37B. PMID: 7645525.

" Not dangerous goods.

LKT T7133 Trimetazidine 1 g 112.5 Long-chain 3-ketoacyl-CoA thiolase inhibitor, potential kainate and AMPA antagonist. 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine 5011-34-7 ≥98% 266.34 C14H22N2O3 COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC Ambient Ambient "Ferraro E, Giammarioli AM, Caldarola S, et al. The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes. FEBS J. 2013 Oct;280(20):5094-108. PMID: 23953053.

 

Khan M, Meduru S, Mostafa M, et al. Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling. J Pharmacol Exp Ther. 2010 May;333(2):421-9. PMID: 20167841.

 

Tuunanen H, Engblom E, Naum A, et al. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation. 2008 Sep 16;118(12):1250-8. PMID: 18765391.

 

Dayanithi G, Desmadryl G, Travo C, et al. Trimetazidine modulates AMPA/kainate receptors in rat vestibular ganglion neurons. Eur J Pharmacol. 2007 Nov 21;574(1):8-14. PMID: 17658512.

 

Demaison L, Fantini E, Sentex E, et al. Trimetazidine: in vitro influence on heart mitochondrial function. Am J Cardiol. 1995 Aug 24;76(6):31B-37B. PMID: 7645525.

" Not dangerous goods.

LKT T7133 Trimetazidine 5 g 421.8 Long-chain 3-ketoacyl-CoA thiolase inhibitor, potential kainate and AMPA antagonist. 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine 5011-34-7 ≥98% 266.34 C14H22N2O3 COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC Ambient Ambient "Ferraro E, Giammarioli AM, Caldarola S, et al. The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes. FEBS J. 2013 Oct;280(20):5094-108. PMID: 23953053.

 

Khan M, Meduru S, Mostafa M, et al. Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling. J Pharmacol Exp Ther. 2010 May;333(2):421-9. PMID: 20167841.

 

Tuunanen H, Engblom E, Naum A, et al. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation. 2008 Sep 16;118(12):1250-8. PMID: 18765391.

 

Dayanithi G, Desmadryl G, Travo C, et al. Trimetazidine modulates AMPA/kainate receptors in rat vestibular ganglion neurons. Eur J Pharmacol. 2007 Nov 21;574(1):8-14. PMID: 17658512.

 

Demaison L, Fantini E, Sentex E, et al. Trimetazidine: in vitro influence on heart mitochondrial function. Am J Cardiol. 1995 Aug 24;76(6):31B-37B. PMID: 7645525.

" Not dangerous goods.

LKT T7044 Triamcinolone Acetonide Acetate 50 mg 30.2 Steroid; glucocorticoid agonist. (11β,16α)-9-Fluoro-11,12-dihydroxy-16,17-[1- methylethylidenebis-(oxy)]pregna-1,4-diene-3,20-dione 21-acetate. Triamcinolone acetonide 21-acetate ≥97% 476.53 C26H33FO7 CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CCC5=CC(=O)C=CC54C)F)O)C)OC(O2)(C)C Ambient Ambient Sparingly soluble in ethanol, acetone. "Zhou H, Yang L, Li H, et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine. 2012;7:4649-60. PMID: 22942646.

 

McAllister IL, Vijayasekaran S, Chen SD, et al. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. PMID: 19211093.

 

Mizuno D, Matsubara A, Ogura Y. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 2008 May;49(5):2127-33. PMID: 18436845.

" Not dangerous goods.

LKT T7044 Triamcinolone Acetonide Acetate 250 mg 81 Steroid; glucocorticoid agonist. (11β,16α)-9-Fluoro-11,12-dihydroxy-16,17-[1- methylethylidenebis-(oxy)]pregna-1,4-diene-3,20-dione 21-acetate. Triamcinolone acetonide 21-acetate ≥97% 476.53 C26H33FO7 CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CCC5=CC(=O)C=CC54C)F)O)C)OC(O2)(C)C Ambient Ambient Sparingly soluble in ethanol, acetone. "Zhou H, Yang L, Li H, et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine. 2012;7:4649-60. PMID: 22942646.

 

McAllister IL, Vijayasekaran S, Chen SD, et al. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. PMID: 19211093.

 

Mizuno D, Matsubara A, Ogura Y. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 2008 May;49(5):2127-33. PMID: 18436845.

" Not dangerous goods.

LKT T7044 Triamcinolone Acetonide Acetate 1 g 219.7 Steroid; glucocorticoid agonist. (11β,16α)-9-Fluoro-11,12-dihydroxy-16,17-[1- methylethylidenebis-(oxy)]pregna-1,4-diene-3,20-dione 21-acetate. Triamcinolone acetonide 21-acetate ≥97% 476.53 C26H33FO7 CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CCC5=CC(=O)C=CC54C)F)O)C)OC(O2)(C)C Ambient Ambient Sparingly soluble in ethanol, acetone. "Zhou H, Yang L, Li H, et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine. 2012;7:4649-60. PMID: 22942646.

 

McAllister IL, Vijayasekaran S, Chen SD, et al. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. PMID: 19211093.

 

Mizuno D, Matsubara A, Ogura Y. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 2008 May;49(5):2127-33. PMID: 18436845.

" Not dangerous goods.

LKT T7044 Triamcinolone Acetonide Acetate 5 g 611.5 Steroid; glucocorticoid agonist. (11β,16α)-9-Fluoro-11,12-dihydroxy-16,17-[1- methylethylidenebis-(oxy)]pregna-1,4-diene-3,20-dione 21-acetate. Triamcinolone acetonide 21-acetate ≥97% 476.53 C26H33FO7 CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CCC5=CC(=O)C=CC54C)F)O)C)OC(O2)(C)C Ambient Ambient Sparingly soluble in ethanol, acetone. "Zhou H, Yang L, Li H, et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine. 2012;7:4649-60. PMID: 22942646.

 

McAllister IL, Vijayasekaran S, Chen SD, et al. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. PMID: 19211093.

 

Mizuno D, Matsubara A, Ogura Y. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 2008 May;49(5):2127-33. PMID: 18436845.

" Not dangerous goods.

LKT G3461 Ginsenoside F2    1 mg 101.7 Triterpene saponin found in species of Panax. 62025-49-4 ≥98% 785.03 C42H72O14 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C Ambient 4°C "Shin HS, Park SY, Hwang ES, et al. Ginsenoside F2 reduces hair loss by controlling apoptosis through the sterol regulatory element-binding protein cleavage activating protein and transforming growth factor-β pathways in a dihydrotestosterone-induced mouse model. Biol Pharm Bull. 2014;37(5):755-63. PMID: 24789999.

 

Siraj FM, Sathishkumar N, Kim YJ, et al. Ginsenoside F2 possesses anti-obesity activity via binding with PPARγ and inhibiting adipocyte differentiation in the 3T3-L1 cell line. J Enzyme Inhib Med Chem. 2014 Mar 25. [Epub ahead of print]. PMID: 24666293.

 

Mai TT, Moon J, Song Y, et al. Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells. Cancer Lett. 2012 Aug 28;321(2):144-53. PMID: 22326284.

 

Quan LH, Piao JY, Min JW, et al. Biotransformation of Ginsenoside Rb1 to Prosapogenins, Gypenoside XVII, Ginsenoside Rd, Ginsenoside F2, and Compound K by Leuconostoc mesenteroides DC102. J Ginseng Res. 2011 Sep;35(3):344-51. PMID: 23717079.

" Not dangerous goods.

LKT G3461 Ginsenoside F2    5 mg 254.3 Triterpene saponin found in species of Panax. 62025-49-4 ≥98% 785.03 C42H72O14 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C Ambient 4°C "Shin HS, Park SY, Hwang ES, et al. Ginsenoside F2 reduces hair loss by controlling apoptosis through the sterol regulatory element-binding protein cleavage activating protein and transforming growth factor-β pathways in a dihydrotestosterone-induced mouse model. Biol Pharm Bull. 2014;37(5):755-63. PMID: 24789999.

 

Siraj FM, Sathishkumar N, Kim YJ, et al. Ginsenoside F2 possesses anti-obesity activity via binding with PPARγ and inhibiting adipocyte differentiation in the 3T3-L1 cell line. J Enzyme Inhib Med Chem. 2014 Mar 25. [Epub ahead of print]. PMID: 24666293.

 

Mai TT, Moon J, Song Y, et al. Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells. Cancer Lett. 2012 Aug 28;321(2):144-53. PMID: 22326284.

 

Quan LH, Piao JY, Min JW, et al. Biotransformation of Ginsenoside Rb1 to Prosapogenins, Gypenoside XVII, Ginsenoside Rd, Ginsenoside F2, and Compound K by Leuconostoc mesenteroides DC102. J Ginseng Res. 2011 Sep;35(3):344-51. PMID: 23717079.

" Not dangerous goods.

LKT G3461 Ginsenoside F2    10 mg 445 Triterpene saponin found in species of Panax. 62025-49-4 ≥98% 785.03 C42H72O14 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C Ambient 4°C "Shin HS, Park SY, Hwang ES, et al. Ginsenoside F2 reduces hair loss by controlling apoptosis through the sterol regulatory element-binding protein cleavage activating protein and transforming growth factor-β pathways in a dihydrotestosterone-induced mouse model. Biol Pharm Bull. 2014;37(5):755-63. PMID: 24789999.

 

Siraj FM, Sathishkumar N, Kim YJ, et al. Ginsenoside F2 possesses anti-obesity activity via binding with PPARγ and inhibiting adipocyte differentiation in the 3T3-L1 cell line. J Enzyme Inhib Med Chem. 2014 Mar 25. [Epub ahead of print]. PMID: 24666293.

 

Mai TT, Moon J, Song Y, et al. Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells. Cancer Lett. 2012 Aug 28;321(2):144-53. PMID: 22326284.

 

Quan LH, Piao JY, Min JW, et al. Biotransformation of Ginsenoside Rb1 to Prosapogenins, Gypenoside XVII, Ginsenoside Rd, Ginsenoside F2, and Compound K by Leuconostoc mesenteroides DC102. J Ginseng Res. 2011 Sep;35(3):344-51. PMID: 23717079.

" Not dangerous goods.

LKT T7037 Triptorelin Acetate 10 mg 197 Peptide, GnRH analog. 140194-24-7 ≥95% 1371.52 C64H82N18O13 C2H4O2 CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8.CC(=O)O Ambient -20°C "Saleh-Abady MM, Alizadeh A, Shamsipour F, et al. The anticancer activity compared between triptorelin and a new gonadotropin releasing hormone analogue. Avicenna J Med Biotechnol. 2009 Jul;1(2):105-10. PMID: 23407883.

 

Larivière S, Garrel-Lazayres G, Simon V, et al. Gonadotropin-releasing hormone inhibits pituitary adenylyl cyclase-activating polypeptide coupling to 3',5'-cyclic adenosine-5'-monophosphate pathway in LbetaT2 gonadotrope cells through novel protein kinase C isoforms and phosphorylation of pituitary adenylyl cyclase-activating polypeptide type I receptor. Endocrinology. 2008 Dec;149(12):6389-98. PMID: 18755795.

 

Umathe SN, Bhutada PS, Jain NS, et al. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats. Behav Pharmacol. 2008 Jul;19(4):308-16. PMID: 18622178.

 

Kim JW, Lee YS, Kim BK, et al. Cell cycle arrest in endometrial carcinoma cells exposed to gonadotropin-releasing hormone analog. Gynecol Oncol. 1999 Jun;73(3):368-71. PMID: 10366462.

" Not dangerous goods.

LKT T7037 Triptorelin Acetate 25 mg 421.8 Peptide, GnRH analog. 140194-24-7 ≥95% 1371.52 C64H82N18O13 C2H4O2 CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8.CC(=O)O Ambient -20°C "Saleh-Abady MM, Alizadeh A, Shamsipour F, et al. The anticancer activity compared between triptorelin and a new gonadotropin releasing hormone analogue. Avicenna J Med Biotechnol. 2009 Jul;1(2):105-10. PMID: 23407883.

 

Larivière S, Garrel-Lazayres G, Simon V, et al. Gonadotropin-releasing hormone inhibits pituitary adenylyl cyclase-activating polypeptide coupling to 3',5'-cyclic adenosine-5'-monophosphate pathway in LbetaT2 gonadotrope cells through novel protein kinase C isoforms and phosphorylation of pituitary adenylyl cyclase-activating polypeptide type I receptor. Endocrinology. 2008 Dec;149(12):6389-98. PMID: 18755795.

 

Umathe SN, Bhutada PS, Jain NS, et al. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats. Behav Pharmacol. 2008 Jul;19(4):308-16. PMID: 18622178.

 

Kim JW, Lee YS, Kim BK, et al. Cell cycle arrest in endometrial carcinoma cells exposed to gonadotropin-releasing hormone analog. Gynecol Oncol. 1999 Jun;73(3):368-71. PMID: 10366462.

" Not dangerous goods.

LKT G3462 Ginsenoside F3              1 mg 152.7 Triterpene saponin found in species of Panax. ≥98% 770.99 C41H70O13 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)O)C)O)C)OC5C(C(C(C(O5)COC6C(C(C(CO6)O)O) Ambient Yu JL, Dou DQ, Chen XH, et al. Immunoenhancing activity of protopanaxatriol-type ginsenoside-F3 in murine spleen cells. Acta Pharmacol Sin. 2004 Dec;25(12):1671-6. PMID: 15569414. Not dangerous goods.

LKT G3462 Ginsenoside F3              5 mg 381.4 Triterpene saponin found in species of Panax. ≥98% 770.99 C41H70O13 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)O)C)O)C)OC5C(C(C(C(O5)COC6C(C(C(CO6)O)O) Ambient Yu JL, Dou DQ, Chen XH, et al. Immunoenhancing activity of protopanaxatriol-type ginsenoside-F3 in murine spleen cells. Acta Pharmacol Sin. 2004 Dec;25(12):1671-6. PMID: 15569414. Not dangerous goods.

LKT T7037 Triptorelin Acetate 100 mg 1312.6 Peptide, GnRH analog. 140194-24-7 ≥95% 1371.52 C64H82N18O13 C2H4O2 CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8.CC(=O)O Ambient -20°C "Saleh-Abady MM, Alizadeh A, Shamsipour F, et al. The anticancer activity compared between triptorelin and a new gonadotropin releasing hormone analogue. Avicenna J Med Biotechnol. 2009 Jul;1(2):105-10. PMID: 23407883.

 

Larivière S, Garrel-Lazayres G, Simon V, et al. Gonadotropin-releasing hormone inhibits pituitary adenylyl cyclase-activating polypeptide coupling to 3',5'-cyclic adenosine-5'-monophosphate pathway in LbetaT2 gonadotrope cells through novel protein kinase C isoforms and phosphorylation of pituitary adenylyl cyclase-activating polypeptide type I receptor. Endocrinology. 2008 Dec;149(12):6389-98. PMID: 18755795.

 

Umathe SN, Bhutada PS, Jain NS, et al. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats. Behav Pharmacol. 2008 Jul;19(4):308-16. PMID: 18622178.

 

Kim JW, Lee YS, Kim BK, et al. Cell cycle arrest in endometrial carcinoma cells exposed to gonadotropin-releasing hormone analog. Gynecol Oncol. 1999 Jun;73(3):368-71. PMID: 10366462.

" Not dangerous goods.

LKT G3462 Ginsenoside F3              10 mg 667.7 Triterpene saponin found in species of Panax. ≥98% 770.99 C41H70O13 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)O)C)O)C)OC5C(C(C(C(O5)COC6C(C(C(CO6)O)O) Ambient Yu JL, Dou DQ, Chen XH, et al. Immunoenhancing activity of protopanaxatriol-type ginsenoside-F3 in murine spleen cells. Acta Pharmacol Sin. 2004 Dec;25(12):1671-6. PMID: 15569414. Not dangerous goods.

LKT G3552 20S-Ginsenoside Rg3 5 mg 113.9 Triterpene saponin found in Panax; Kv7.1 K+ channel activator, γ2 GABA-A agonist, α10 nAChR antagonist. Ginsenoside Rg3 14197-60-5 ≥98% 785.01 C42H72O13 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)O)C Ambient 4°C "Zhang YH, Li HD, Li B, et al. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells. Oncol Rep. 2014 Feb;31(2):919-25. PMID: 24337872.

 

Lee B, Sur B, Park J, et al. Ginsenoside rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in rats. Biomol Ther (Seoul). 2013 Sep 30;21(5):381-90. PMID: 24244826.

 

Lee BH, Choi SH, Hwang SH, et al. Effects of ginsenoside Rg3 on α9α10 nicotinic acetylcholine receptor-mediated ion currents. Biol Pharm Bull. 2013;36(5):812-8. PMID: 23649337.

 

Lee BH, Kim HJ, Chung L, et al. Ginsenoside Rg₃ regulates GABAA receptor channel activity: involvement of interaction with the γ₂ subunit. Eur J Pharmacol. 2013 Apr 5;705(1-3):119-25. PMID: 23499684.

 

Park SM, Choi MS, Sohn NW, et al. Ginsenoside Rg3 attenuates microglia activation following systemic lipopolysaccharide treatment in mice. Biol Pharm Bull. 2012;35(9):1546-52. PMID: 22975507.

 

Wei X, Su F, Su X, et al. Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice. Fitoterapia. 2012 Jun;83(4):636-42. PMID: 22310172.

 

Kim JW, Jung SY, Kwon YH, et al. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol Ther. 2012 May;13(7):504-15. PMID: 22406998.

" Xn Not dangerous goods.

LKT G3552 20S-Ginsenoside Rg3 10 mg 197 Triterpene saponin found in Panax; Kv7.1 K+ channel activator, γ2 GABA-A agonist, α10 nAChR antagonist. Ginsenoside Rg3 14197-60-5 ≥98% 785.01 C42H72O13 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)O)C Ambient 4°C "Zhang YH, Li HD, Li B, et al. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells. Oncol Rep. 2014 Feb;31(2):919-25. PMID: 24337872.

 

Lee B, Sur B, Park J, et al. Ginsenoside rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in rats. Biomol Ther (Seoul). 2013 Sep 30;21(5):381-90. PMID: 24244826.

 

Lee BH, Choi SH, Hwang SH, et al. Effects of ginsenoside Rg3 on α9α10 nicotinic acetylcholine receptor-mediated ion currents. Biol Pharm Bull. 2013;36(5):812-8. PMID: 23649337.

 

Lee BH, Kim HJ, Chung L, et al. Ginsenoside Rg₃ regulates GABAA receptor channel activity: involvement of interaction with the γ₂ subunit. Eur J Pharmacol. 2013 Apr 5;705(1-3):119-25. PMID: 23499684.

 

Park SM, Choi MS, Sohn NW, et al. Ginsenoside Rg3 attenuates microglia activation following systemic lipopolysaccharide treatment in mice. Biol Pharm Bull. 2012;35(9):1546-52. PMID: 22975507.

 

Wei X, Su F, Su X, et al. Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice. Fitoterapia. 2012 Jun;83(4):636-42. PMID: 22310172.

 

Kim JW, Jung SY, Kwon YH, et al. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol Ther. 2012 May;13(7):504-15. PMID: 22406998.

" Xn Not dangerous goods.

LKT G3552 20S-Ginsenoside Rg3 25 mg 393.8 Triterpene saponin found in Panax; Kv7.1 K+ channel activator, γ2 GABA-A agonist, α10 nAChR antagonist. Ginsenoside Rg3 14197-60-5 ≥98% 785.01 C42H72O13 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)O)C Ambient 4°C "Zhang YH, Li HD, Li B, et al. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells. Oncol Rep. 2014 Feb;31(2):919-25. PMID: 24337872.

 

Lee B, Sur B, Park J, et al. Ginsenoside rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in rats. Biomol Ther (Seoul). 2013 Sep 30;21(5):381-90. PMID: 24244826.

 

Lee BH, Choi SH, Hwang SH, et al. Effects of ginsenoside Rg3 on α9α10 nicotinic acetylcholine receptor-mediated ion currents. Biol Pharm Bull. 2013;36(5):812-8. PMID: 23649337.

 

Lee BH, Kim HJ, Chung L, et al. Ginsenoside Rg₃ regulates GABAA receptor channel activity: involvement of interaction with the γ₂ subunit. Eur J Pharmacol. 2013 Apr 5;705(1-3):119-25. PMID: 23499684.

 

Park SM, Choi MS, Sohn NW, et al. Ginsenoside Rg3 attenuates microglia activation following systemic lipopolysaccharide treatment in mice. Biol Pharm Bull. 2012;35(9):1546-52. PMID: 22975507.

 

Wei X, Su F, Su X, et al. Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice. Fitoterapia. 2012 Jun;83(4):636-42. PMID: 22310172.

 

Kim JW, Jung SY, Kwon YH, et al. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol Ther. 2012 May;13(7):504-15. PMID: 22406998.

" Xn Not dangerous goods.

LKT T7036 Triptorelin 10 mg 134.5 Peptide, GnRH analog; GnRH agonist. "5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-

tryptophyl-L-leucyl-L-arginyl-L-prolylglycinamide" Decapeptyl; [DTrp6]-LH-RH, Amide 57773-63-4 ≥98% 1311.5 C64H83N18O13 CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8 Ambient -20°C "Saleh-Abady MM, Alizadeh A, Shamsipour F, et al. The anticancer activity compared between triptorelin and a new gonadotropin releasing hormone analogue. Avicenna J Med Biotechnol. 2009 Jul;1(2):105-10. PMID: 23407883.

 

Umathe SN, Bhutada PS, Jain NS, et al. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats. Behav Pharmacol. 2008 Jul;19(4):308-16. PMID: 18622178.

" Repr. Cat. 1, Repr. Cat. 2, Not dangerous goods.

LKT T7036 Triptorelin 25 mg 336.1 Peptide, GnRH analog; GnRH agonist. "5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-

tryptophyl-L-leucyl-L-arginyl-L-prolylglycinamide" Decapeptyl; [DTrp6]-LH-RH, Amide 57773-63-4 ≥98% 1311.5 C64H83N18O13 CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8 Ambient -20°C "Saleh-Abady MM, Alizadeh A, Shamsipour F, et al. The anticancer activity compared between triptorelin and a new gonadotropin releasing hormone analogue. Avicenna J Med Biotechnol. 2009 Jul;1(2):105-10. PMID: 23407883.

 

Umathe SN, Bhutada PS, Jain NS, et al. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats. Behav Pharmacol. 2008 Jul;19(4):308-16. PMID: 18622178.

" Repr. Cat. 1, Repr. Cat. 2, Not dangerous goods.

LKT T7035 Triptolide 1 mg 88.3 Diterpenoid epoxide found in Tripterygium. PG490 38748-32-2 ≥98% 360.4 C20H24O6 CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2O)O7)COC6=O)C Protect from light. Ambient 4°C Soluble in DMSO. "Liu M, Chen J, Huang Y, et al. Triptolide alleviates isoprenaline-induced cardiac remodeling in rats via TGF-β1/Smad3 and p38 MAPK signaling pathway. Pharmazie. 2015 Apr;70(4):244-50.PMID: 26012254.

 

Shao H, Ma J, Guo T, et al. Triptolide induces apoptosis of breast cancer cells via a mechanism associated with the Wnt/β-catenin signaling pathway. Exp Ther Med. 2014 Aug;8(2):505-508. PMID: 25009609.

 

Ma JX, Sun YL, Wang YQ, et al. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF. Oncol Res. 2013;20(8):359-68. PMID: 23924856.

 

Wang W, Mei XP, Chen L, et al. Triptolide prevents and attenuates neuropathic pain via inhibiting central immune response. Pain Physician. 2012 Nov-Dec;15(6):E995-1006. PMID: 23159984.

 

Wu C, Xia Y, Wang P, et al. Triptolide protects mice from ischemia/reperfusion injury by inhibition of IL-17 production. Int Immunopharmacol. 2011 Oct;11(10):1564-72. PMID: 21621648.

" None Not dangerous goods.

LKT T7035 Triptolide 5 mg 305.9 Diterpenoid epoxide found in Tripterygium. PG490 38748-32-2 ≥98% 360.4 C20H24O6 CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2O)O7)COC6=O)C Protect from light. Ambient 4°C Soluble in DMSO. "Liu M, Chen J, Huang Y, et al. Triptolide alleviates isoprenaline-induced cardiac remodeling in rats via TGF-β1/Smad3 and p38 MAPK signaling pathway. Pharmazie. 2015 Apr;70(4):244-50.PMID: 26012254.

 

Shao H, Ma J, Guo T, et al. Triptolide induces apoptosis of breast cancer cells via a mechanism associated with the Wnt/β-catenin signaling pathway. Exp Ther Med. 2014 Aug;8(2):505-508. PMID: 25009609.

 

Ma JX, Sun YL, Wang YQ, et al. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF. Oncol Res. 2013;20(8):359-68. PMID: 23924856.

 

Wang W, Mei XP, Chen L, et al. Triptolide prevents and attenuates neuropathic pain via inhibiting central immune response. Pain Physician. 2012 Nov-Dec;15(6):E995-1006. PMID: 23159984.

 

Wu C, Xia Y, Wang P, et al. Triptolide protects mice from ischemia/reperfusion injury by inhibition of IL-17 production. Int Immunopharmacol. 2011 Oct;11(10):1564-72. PMID: 21621648.

" None Not dangerous goods.

LKT G3553 Ginsenoside Rb2 5 mg 271.7 Triterpene saponin found in species of Panax. Ginsenoside C 11021-13-9 ≥84% 1079.27 C53H90O22 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C Ambient 4°C Soluble in water. "Huang Q, Gao B, Jie Q, et al. Ginsenoside-Rb2 displays anti-osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis. Bone. 2014 Jun 13. [Epub ahead of print]. PMID: 24933344.

 

Yoo YC, Lee J, Park SR, et al. Protective effect of ginsenoside-Rb2 from Korean red ginseng on the lethal infection of haemagglutinating virus of Japan in mice. J Ginseng Res. 2013 Mar;37(1):80-6. PMID: 23717160.

 

Kim EJ, Lee HI, Chung KJ, et al. The ginsenoside-Rb2 lowers cholesterol and triacylglycerol levels in 3T3-L1 adipocytes cultured under high cholesterol or fatty acids conditions. BMB Rep. 2009 Apr 30;42(4):194-9. PMID: 19403041.

 

Fujimoto J, Sakaguchi H, Aoki I, et al. Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane. Eur J Gynaecol Oncol. 2001;22(5):339-41. PMID: 11766734.

 

Sato K, Mochizuki M, Saiki I, et al. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull. 1994 May;17(5):635-9. PMID: 7522731.

" None Not dangerous goods.

LKT G3553 Ginsenoside Rb2 10 mg 407.7 Triterpene saponin found in species of Panax. Ginsenoside C 11021-13-9 ≥84% 1079.27 C53H90O22 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C Ambient 4°C Soluble in water. "Huang Q, Gao B, Jie Q, et al. Ginsenoside-Rb2 displays anti-osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis. Bone. 2014 Jun 13. [Epub ahead of print]. PMID: 24933344.

 

Yoo YC, Lee J, Park SR, et al. Protective effect of ginsenoside-Rb2 from Korean red ginseng on the lethal infection of haemagglutinating virus of Japan in mice. J Ginseng Res. 2013 Mar;37(1):80-6. PMID: 23717160.

 

Kim EJ, Lee HI, Chung KJ, et al. The ginsenoside-Rb2 lowers cholesterol and triacylglycerol levels in 3T3-L1 adipocytes cultured under high cholesterol or fatty acids conditions. BMB Rep. 2009 Apr 30;42(4):194-9. PMID: 19403041.

 

Fujimoto J, Sakaguchi H, Aoki I, et al. Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane. Eur J Gynaecol Oncol. 2001;22(5):339-41. PMID: 11766734.

 

Sato K, Mochizuki M, Saiki I, et al. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull. 1994 May;17(5):635-9. PMID: 7522731.

" None Not dangerous goods.

LKT G3553 Ginsenoside Rb2 25 mg 815.4 Triterpene saponin found in species of Panax. Ginsenoside C 11021-13-9 ≥84% 1079.27 C53H90O22 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C Ambient 4°C Soluble in water. "Huang Q, Gao B, Jie Q, et al. Ginsenoside-Rb2 displays anti-osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis. Bone. 2014 Jun 13. [Epub ahead of print]. PMID: 24933344.

 

Yoo YC, Lee J, Park SR, et al. Protective effect of ginsenoside-Rb2 from Korean red ginseng on the lethal infection of haemagglutinating virus of Japan in mice. J Ginseng Res. 2013 Mar;37(1):80-6. PMID: 23717160.

 

Kim EJ, Lee HI, Chung KJ, et al. The ginsenoside-Rb2 lowers cholesterol and triacylglycerol levels in 3T3-L1 adipocytes cultured under high cholesterol or fatty acids conditions. BMB Rep. 2009 Apr 30;42(4):194-9. PMID: 19403041.

 

Fujimoto J, Sakaguchi H, Aoki I, et al. Inhibitory effect of ginsenoside-Rb2 on invasiveness of uterine endometrial cancer cells to the basement membrane. Eur J Gynaecol Oncol. 2001;22(5):339-41. PMID: 11766734.

 

Sato K, Mochizuki M, Saiki I, et al. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull. 1994 May;17(5):635-9. PMID: 7522731.

" None Not dangerous goods.

LKT T7034 Trimethoprim 5 g 54.4 Dihydrofolate reductase inhibitor. 5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4- pyrimidinediamine Instalac; Monotrim; Proloprim; Trimopan; Trimpex; Wellcoprim 738-70-5 ≥98% 290.32 C14H18N4O3 COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N Ambient Ambient Soluble in DMAC, or benzyl alcohol. Slightly soluble in propylene glycol, chloroform, methanol and water. "Singh P, Kaur M, Sachdeva S. Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents. J Med Chem. 2012 Jul 26;55(14):6381-90. PMID: 22734697.

 

Sangurdekar DP, Zhang Z, Khodursky AB. The association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug trimethoprim. BMC Genomics. 2011 Nov 28;12:583. PMID: 22122981.

 

Brogden RN, Carmine AA, Heel RC, et al. Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections. Drugs. 1982 Jun;23(6):405-30. PMID: 7049657.

 

Ho YB, Zakaria MP, Latif PA, Saari N. Occurrence of veterinary antibiotics and progesterone in broiler manure and agricultural soil in Malaysia. Sci Total Environ. 2014 Aug 1;488-489:261-267. PMID: 24836135.

" None Not dangerous goods.

LKT T7034 Trimethoprim 25 g 169.9 Dihydrofolate reductase inhibitor. 5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4- pyrimidinediamine Instalac; Monotrim; Proloprim; Trimopan; Trimpex; Wellcoprim 738-70-5 ≥98% 290.32 C14H18N4O3 COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N Ambient Ambient Soluble in DMAC, or benzyl alcohol. Slightly soluble in propylene glycol, chloroform, methanol and water. "Singh P, Kaur M, Sachdeva S. Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents. J Med Chem. 2012 Jul 26;55(14):6381-90. PMID: 22734697.

 

Sangurdekar DP, Zhang Z, Khodursky AB. The association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug trimethoprim. BMC Genomics. 2011 Nov 28;12:583. PMID: 22122981.

 

Brogden RN, Carmine AA, Heel RC, et al. Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections. Drugs. 1982 Jun;23(6):405-30. PMID: 7049657.

 

Ho YB, Zakaria MP, Latif PA, Saari N. Occurrence of veterinary antibiotics and progesterone in broiler manure and agricultural soil in Malaysia. Sci Total Environ. 2014 Aug 1;488-489:261-267. PMID: 24836135.

" None Not dangerous goods.

LKT T7034 Trimethoprim 100 g 475.7 Dihydrofolate reductase inhibitor. 5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4- pyrimidinediamine Instalac; Monotrim; Proloprim; Trimopan; Trimpex; Wellcoprim 738-70-5 ≥98% 290.32 C14H18N4O3 COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N Ambient Ambient Soluble in DMAC, or benzyl alcohol. Slightly soluble in propylene glycol, chloroform, methanol and water. "Singh P, Kaur M, Sachdeva S. Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents. J Med Chem. 2012 Jul 26;55(14):6381-90. PMID: 22734697.

 

Sangurdekar DP, Zhang Z, Khodursky AB. The association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug trimethoprim. BMC Genomics. 2011 Nov 28;12:583. PMID: 22122981.

 

Brogden RN, Carmine AA, Heel RC, et al. Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections. Drugs. 1982 Jun;23(6):405-30. PMID: 7049657.

 

Ho YB, Zakaria MP, Latif PA, Saari N. Occurrence of veterinary antibiotics and progesterone in broiler manure and agricultural soil in Malaysia. Sci Total Environ. 2014 Aug 1;488-489:261-267. PMID: 24836135.

" None Not dangerous goods.

LKT G3554 Ginsenoside Rb3 5 mg 163.2 Triterpene saponin found in species of Panax. 68406-26-8 ≥98% 1079.27 C53H90O22 CCC(=CCCC(C)(C1CCC2(C1C(CC3C2CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C Ambient 4°C "Wang Y, Dong J, Liu P, et al. Ginsenoside Rb3 attenuates oxidative stress and preserves endothelial function in renal arteries from hypertensive rats. Br J Pharmacol. 2014 Jul;171(13):3171-81. PMID: 24571453.

 

Bu QT, Zhang WY, Chen QC, et al. Anti-diabetic effect of ginsenoside Rb(3) in alloxan-induced diabetic mice. Med Chem. 2012 Sep;8(5):934-41. PMID: 22741793.

 

Cui J, Jiang L, Xiang H. Ginsenoside Rb3 exerts antidepressant-like effects in several animal models. J Psychopharmacol. 2012 May;26(5):697-713. PMID: 21948936.

 

Shi Y, Han B, Yu X, et al. Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats. Pharm Biol. 2011 Sep;49(9):900-6. PMID: 21591990.

" None Not dangerous goods.

LKT G3554 Ginsenoside Rb3 10 mg 298.9 Triterpene saponin found in species of Panax. 68406-26-8 ≥98% 1079.27 C53H90O22 CCC(=CCCC(C)(C1CCC2(C1C(CC3C2CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C Ambient 4°C "Wang Y, Dong J, Liu P, et al. Ginsenoside Rb3 attenuates oxidative stress and preserves endothelial function in renal arteries from hypertensive rats. Br J Pharmacol. 2014 Jul;171(13):3171-81. PMID: 24571453.

 

Bu QT, Zhang WY, Chen QC, et al. Anti-diabetic effect of ginsenoside Rb(3) in alloxan-induced diabetic mice. Med Chem. 2012 Sep;8(5):934-41. PMID: 22741793.

 

Cui J, Jiang L, Xiang H. Ginsenoside Rb3 exerts antidepressant-like effects in several animal models. J Psychopharmacol. 2012 May;26(5):697-713. PMID: 21948936.

 

Shi Y, Han B, Yu X, et al. Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats. Pharm Biol. 2011 Sep;49(9):900-6. PMID: 21591990.

" None Not dangerous goods.

LKT G3554 Ginsenoside Rb3 25 mg 543.6 Triterpene saponin found in species of Panax. 68406-26-8 ≥98% 1079.27 C53H90O22 CCC(=CCCC(C)(C1CCC2(C1C(CC3C2CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C Ambient 4°C "Wang Y, Dong J, Liu P, et al. Ginsenoside Rb3 attenuates oxidative stress and preserves endothelial function in renal arteries from hypertensive rats. Br J Pharmacol. 2014 Jul;171(13):3171-81. PMID: 24571453.

 

Bu QT, Zhang WY, Chen QC, et al. Anti-diabetic effect of ginsenoside Rb(3) in alloxan-induced diabetic mice. Med Chem. 2012 Sep;8(5):934-41. PMID: 22741793.

 

Cui J, Jiang L, Xiang H. Ginsenoside Rb3 exerts antidepressant-like effects in several animal models. J Psychopharmacol. 2012 May;26(5):697-713. PMID: 21948936.

 

Shi Y, Han B, Yu X, et al. Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats. Pharm Biol. 2011 Sep;49(9):900-6. PMID: 21591990.

" None Not dangerous goods.

LKT T7033 Trifluoperazine Dihydrochloride 5 g 81 Phenothiazine; D1/2 and α1-adrenergic antagonist, calmodulin and CDPK4 inhibitor, Nav1.4 and Nav1.7 Na+ channel blocker. "10-[3-(4-Methyl-1-piperazinyl)propyl]-2-

(trifluoromethyl)phenothiazine dihydrochloride" Trifluoperazine dihydrochloride; Triftazin; Eskazinyl; Eskazine; Jatroneural; Modalina; Stelazine; Terfluzine 440-17-5 ≥98% 480.43 C21H24F3N3S 2HCl CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl Hygroscopic. Ambient 4°C Soluble in water (>280 mg/mL), ethanol (90 mg/mL).. "Cavagnino A, Rossi F, Rizzi M. The potent antiplasmodial calmodulin-antagonist trifluoperazine inhibits plasmodium falciparum calcium-dependent protein kinase 4. Protein Pept Lett. 2011 Dec;18(12):1273-9. PMID: 21787279.

 

Chen QY, Wu LJ, Wu YQ, et al. Molecular mechanism of trifluoperazine induces apoptosis in human A549 lung adenocarcinoma cell lines. Mol Med Rep. 2009 Sep-Oct;2(5):811-7. PMID: 21475906.

 

Sheets PL, Gerner P, Wang CF, et al. Inhibition of Nav1.7 and Nav1.4 sodium channels by trifluoperazine involves the local anesthetic receptor. J Neurophysiol. 2006 Oct;96(4):1848-59. PMID: 16807347.

 

Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. J Neuropsychiatry Clin Neurosci. 1996 Spring;8(2):223-6. PMID: 9081563.

 

Huerta-Bahena J, Villalobos-Molina R, García-Sáinz JA. Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects. Mol Pharmacol. 1983 Jan;23(1):67-70. PMID: 6135146.

 

Yano T, Kassovska-Bratinova S, Teh JS, et al. Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species. J Biol Chem. 2011 Mar 25;286(12):10276-10287. PMID: 21193400.

" Xn Not dangerous goods.

LKT T7033 Trifluoperazine Dihydrochloride 10 g 130 Phenothiazine; D1/2 and α1-adrenergic antagonist, calmodulin and CDPK4 inhibitor, Nav1.4 and Nav1.7 Na+ channel blocker. "10-[3-(4-Methyl-1-piperazinyl)propyl]-2-

(trifluoromethyl)phenothiazine dihydrochloride" Trifluoperazine dihydrochloride; Triftazin; Eskazinyl; Eskazine; Jatroneural; Modalina; Stelazine; Terfluzine 440-17-5 ≥98% 480.43 C21H24F3N3S 2HCl CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl Hygroscopic. Ambient 4°C Soluble in water (>280 mg/mL), ethanol (90 mg/mL).. "Cavagnino A, Rossi F, Rizzi M. The potent antiplasmodial calmodulin-antagonist trifluoperazine inhibits plasmodium falciparum calcium-dependent protein kinase 4. Protein Pept Lett. 2011 Dec;18(12):1273-9. PMID: 21787279.

 

Chen QY, Wu LJ, Wu YQ, et al. Molecular mechanism of trifluoperazine induces apoptosis in human A549 lung adenocarcinoma cell lines. Mol Med Rep. 2009 Sep-Oct;2(5):811-7. PMID: 21475906.

 

Sheets PL, Gerner P, Wang CF, et al. Inhibition of Nav1.7 and Nav1.4 sodium channels by trifluoperazine involves the local anesthetic receptor. J Neurophysiol. 2006 Oct;96(4):1848-59. PMID: 16807347.

 

Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. J Neuropsychiatry Clin Neurosci. 1996 Spring;8(2):223-6. PMID: 9081563.

 

Huerta-Bahena J, Villalobos-Molina R, García-Sáinz JA. Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects. Mol Pharmacol. 1983 Jan;23(1):67-70. PMID: 6135146.

 

Yano T, Kassovska-Bratinova S, Teh JS, et al. Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species. J Biol Chem. 2011 Mar 25;286(12):10276-10287. PMID: 21193400.

" Xn Not dangerous goods.

LKT T7033 Trifluoperazine Dihydrochloride 25 g 245.1 Phenothiazine; D1/2 and α1-adrenergic antagonist, calmodulin and CDPK4 inhibitor, Nav1.4 and Nav1.7 Na+ channel blocker. "10-[3-(4-Methyl-1-piperazinyl)propyl]-2-

(trifluoromethyl)phenothiazine dihydrochloride" Trifluoperazine dihydrochloride; Triftazin; Eskazinyl; Eskazine; Jatroneural; Modalina; Stelazine; Terfluzine 440-17-5 ≥98% 480.43 C21H24F3N3S 2HCl CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl Hygroscopic. Ambient 4°C Soluble in water (>280 mg/mL), ethanol (90 mg/mL).. "Cavagnino A, Rossi F, Rizzi M. The potent antiplasmodial calmodulin-antagonist trifluoperazine inhibits plasmodium falciparum calcium-dependent protein kinase 4. Protein Pept Lett. 2011 Dec;18(12):1273-9. PMID: 21787279.

 

Chen QY, Wu LJ, Wu YQ, et al. Molecular mechanism of trifluoperazine induces apoptosis in human A549 lung adenocarcinoma cell lines. Mol Med Rep. 2009 Sep-Oct;2(5):811-7. PMID: 21475906.

 

Sheets PL, Gerner P, Wang CF, et al. Inhibition of Nav1.7 and Nav1.4 sodium channels by trifluoperazine involves the local anesthetic receptor. J Neurophysiol. 2006 Oct;96(4):1848-59. PMID: 16807347.

 

Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. J Neuropsychiatry Clin Neurosci. 1996 Spring;8(2):223-6. PMID: 9081563.

 

Huerta-Bahena J, Villalobos-Molina R, García-Sáinz JA. Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects. Mol Pharmacol. 1983 Jan;23(1):67-70. PMID: 6135146.

 

Yano T, Kassovska-Bratinova S, Teh JS, et al. Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species. J Biol Chem. 2011 Mar 25;286(12):10276-10287. PMID: 21193400.

" Xn Not dangerous goods.

LKT G3557 Ginsenoside Rh1 5 mg 169.9 Triterpene saponin found in species of Panax. Sanchinoside Rh 63223-86-9 ≥77% 638.87 C36H62O9 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)O)C Ambient 4°C "Hou J, Xue J, Lee M, et al. Long-term administration of ginsenoside Rh1 enhances learning and memory by promoting cell survival in the mouse hippocampus. Int J Mol Med. 2014 Jan;33(1):234-40. PMID: 24212564.

 

Gu W, Kim KA, Kim DH. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation. Biol Pharm Bull. 2013;36(1):102-7. PMID: 23302642.

 

Yoon JH, Choi YJ, Lee SG. Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells. Eur J Pharmacol. 2012 Mar 15;679(1-3):24-33. PMID: 22314224.

 

Jung JS, Shin JA, Park EM, et al. Anti-inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide-stimulated microglia: critical role of the protein kinase A pathway and hemeoxygenase-1 expression. J Neurochem. 2010 Dec;115(6):1668-80. PMID: 20969575.

 

Park EK, Choo MK, Han MJ, et al. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol. 2004 Feb;133(2):113-20. PMID: 14739579.

" Xn Not dangerous goods.

LKT G3557 Ginsenoside Rh1 10 mg 285.4 Triterpene saponin found in species of Panax. Sanchinoside Rh 63223-86-9 ≥77% 638.87 C36H62O9 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)O)C Ambient 4°C "Hou J, Xue J, Lee M, et al. Long-term administration of ginsenoside Rh1 enhances learning and memory by promoting cell survival in the mouse hippocampus. Int J Mol Med. 2014 Jan;33(1):234-40. PMID: 24212564.

 

Gu W, Kim KA, Kim DH. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation. Biol Pharm Bull. 2013;36(1):102-7. PMID: 23302642.

 

Yoon JH, Choi YJ, Lee SG. Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells. Eur J Pharmacol. 2012 Mar 15;679(1-3):24-33. PMID: 22314224.

 

Jung JS, Shin JA, Park EM, et al. Anti-inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide-stimulated microglia: critical role of the protein kinase A pathway and hemeoxygenase-1 expression. J Neurochem. 2010 Dec;115(6):1668-80. PMID: 20969575.

 

Park EK, Choo MK, Han MJ, et al. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol. 2004 Feb;133(2):113-20. PMID: 14739579.

" Xn Not dangerous goods.

LKT G3557 Ginsenoside Rh1 25 mg 543.6 Triterpene saponin found in species of Panax. Sanchinoside Rh 63223-86-9 ≥77% 638.87 C36H62O9 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)O)C Ambient 4°C "Hou J, Xue J, Lee M, et al. Long-term administration of ginsenoside Rh1 enhances learning and memory by promoting cell survival in the mouse hippocampus. Int J Mol Med. 2014 Jan;33(1):234-40. PMID: 24212564.

 

Gu W, Kim KA, Kim DH. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation. Biol Pharm Bull. 2013;36(1):102-7. PMID: 23302642.

 

Yoon JH, Choi YJ, Lee SG. Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells. Eur J Pharmacol. 2012 Mar 15;679(1-3):24-33. PMID: 22314224.

 

Jung JS, Shin JA, Park EM, et al. Anti-inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide-stimulated microglia: critical role of the protein kinase A pathway and hemeoxygenase-1 expression. J Neurochem. 2010 Dec;115(6):1668-80. PMID: 20969575.

 

Park EK, Choo MK, Han MJ, et al. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol. 2004 Feb;133(2):113-20. PMID: 14739579.

" Xn Not dangerous goods.

LKT G3558 20R-Ginsenoside Rh2 1 mg 89.3 Triterpene saponin found in Panax. Ginsenoside Rh2 112246-15-8 ≥98% 622.87 C36H62O8 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C Ambient 4°C "Lv S, Yi PF, Shen HQ, et al. Ginsenoside Rh2-B1 stimulates cell proliferation and IFN-γ production by activating the p38 MAPK and ERK-dependent signaling pathways in CTLL-2 cells. Immunopharmacol Immunotoxicol. 2013 Dec 3. [Epub ahead of print]. PMID: 24294901.

 

Hou J, Xue J, Lee M, et al. Ginsenoside Rh2 improves learning and memory in mice. J Med Food. 2013 Aug;16(8):772-6. PMID: 23957360.

 

Tang XP, Tang GD, Fang CY, et al. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol. 2013 Mar 14;19(10):1582-92. PMID: 23538603.

 

Lian LH, Jin Q, Song SZ, et al. Ginsenoside Rh2 Downregulates LPS-Induced NF-κB Activation through Inhibition of TAK1 Phosphorylation in RAW 264.7 Murine Macrophage. Evid Based Complement Alternat Med. 2013;2013:646728. PMID: 23483870.

 

Choi WY, Lim HW, Lim CJ. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes. J Pharm Pharmacol. 2013 Feb;65(2):310-6. PMID: 23278699.

" Xn Not dangerous goods.

LKT G3558 20R-Ginsenoside Rh2 5 mg 216.3 Triterpene saponin found in Panax. Ginsenoside Rh2 112246-15-8 ≥98% 622.87 C36H62O8 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C Ambient 4°C "Lv S, Yi PF, Shen HQ, et al. Ginsenoside Rh2-B1 stimulates cell proliferation and IFN-γ production by activating the p38 MAPK and ERK-dependent signaling pathways in CTLL-2 cells. Immunopharmacol Immunotoxicol. 2013 Dec 3. [Epub ahead of print]. PMID: 24294901.

 

Hou J, Xue J, Lee M, et al. Ginsenoside Rh2 improves learning and memory in mice. J Med Food. 2013 Aug;16(8):772-6. PMID: 23957360.

 

Tang XP, Tang GD, Fang CY, et al. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol. 2013 Mar 14;19(10):1582-92. PMID: 23538603.

 

Lian LH, Jin Q, Song SZ, et al. Ginsenoside Rh2 Downregulates LPS-Induced NF-κB Activation through Inhibition of TAK1 Phosphorylation in RAW 264.7 Murine Macrophage. Evid Based Complement Alternat Med. 2013;2013:646728. PMID: 23483870.

 

Choi WY, Lim HW, Lim CJ. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes. J Pharm Pharmacol. 2013 Feb;65(2):310-6. PMID: 23278699.

" Xn Not dangerous goods.

LKT G3558 20R-Ginsenoside Rh2 10 mg 368.8 Triterpene saponin found in Panax. Ginsenoside Rh2 112246-15-8 ≥98% 622.87 C36H62O8 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C Ambient 4°C "Lv S, Yi PF, Shen HQ, et al. Ginsenoside Rh2-B1 stimulates cell proliferation and IFN-γ production by activating the p38 MAPK and ERK-dependent signaling pathways in CTLL-2 cells. Immunopharmacol Immunotoxicol. 2013 Dec 3. [Epub ahead of print]. PMID: 24294901.

 

Hou J, Xue J, Lee M, et al. Ginsenoside Rh2 improves learning and memory in mice. J Med Food. 2013 Aug;16(8):772-6. PMID: 23957360.

 

Tang XP, Tang GD, Fang CY, et al. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol. 2013 Mar 14;19(10):1582-92. PMID: 23538603.

 

Lian LH, Jin Q, Song SZ, et al. Ginsenoside Rh2 Downregulates LPS-Induced NF-κB Activation through Inhibition of TAK1 Phosphorylation in RAW 264.7 Murine Macrophage. Evid Based Complement Alternat Med. 2013;2013:646728. PMID: 23483870.

 

Choi WY, Lim HW, Lim CJ. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes. J Pharm Pharmacol. 2013 Feb;65(2):310-6. PMID: 23278699.

" Xn Not dangerous goods.

LKT G3558 20R-Ginsenoside Rh2 25 mg 737.1 Triterpene saponin found in Panax. Ginsenoside Rh2 112246-15-8 ≥98% 622.87 C36H62O8 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C Ambient 4°C "Lv S, Yi PF, Shen HQ, et al. Ginsenoside Rh2-B1 stimulates cell proliferation and IFN-γ production by activating the p38 MAPK and ERK-dependent signaling pathways in CTLL-2 cells. Immunopharmacol Immunotoxicol. 2013 Dec 3. [Epub ahead of print]. PMID: 24294901.

 

Hou J, Xue J, Lee M, et al. Ginsenoside Rh2 improves learning and memory in mice. J Med Food. 2013 Aug;16(8):772-6. PMID: 23957360.

 

Tang XP, Tang GD, Fang CY, et al. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol. 2013 Mar 14;19(10):1582-92. PMID: 23538603.

 

Lian LH, Jin Q, Song SZ, et al. Ginsenoside Rh2 Downregulates LPS-Induced NF-κB Activation through Inhibition of TAK1 Phosphorylation in RAW 264.7 Murine Macrophage. Evid Based Complement Alternat Med. 2013;2013:646728. PMID: 23483870.

 

Choi WY, Lim HW, Lim CJ. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes. J Pharm Pharmacol. 2013 Feb;65(2):310-6. PMID: 23278699.

" Xn Not dangerous goods.

LKT T7032 Triamcinolone 50 mg 27.2 Synthetic steroid; glucocorticoid agonist. "(11β,16α)-9-Fluoro-11,16,17,21-tetrahydroxy- pregna-1,4-diene-3,20-dione

" Aristocort; Kenacort; Ledercort; Omiclon; Volon; Tricortale 124-94-7 ≥98% 394.43 C21H27FO6 CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O Ambient Ambient Slightly soluble in water. "Zhou H, Yang L, Li H, et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine. 2012;7:4649-60. PMID: 22942646.

 

McAllister IL, Vijayasekaran S, Chen SD, et al. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. PMID: 19211093.

 

Mizuno D, Matsubara A, Ogura Y. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 2008 May;49(5):2127-33. PMID: 18436845.

" Carc. Not dangerous goods.

LKT T7032 Triamcinolone 250 mg 81.6 Synthetic steroid; glucocorticoid agonist. "(11β,16α)-9-Fluoro-11,16,17,21-tetrahydroxy- pregna-1,4-diene-3,20-dione

" Aristocort; Kenacort; Ledercort; Omiclon; Volon; Tricortale 124-94-7 ≥98% 394.43 C21H27FO6 CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O Ambient Ambient Slightly soluble in water. "Zhou H, Yang L, Li H, et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine. 2012;7:4649-60. PMID: 22942646.

 

McAllister IL, Vijayasekaran S, Chen SD, et al. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. PMID: 19211093.

 

Mizuno D, Matsubara A, Ogura Y. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 2008 May;49(5):2127-33. PMID: 18436845.

" Carc. Not dangerous goods.

LKT T7032 Triamcinolone 1 g 224.3 Synthetic steroid; glucocorticoid agonist. "(11β,16α)-9-Fluoro-11,16,17,21-tetrahydroxy- pregna-1,4-diene-3,20-dione

" Aristocort; Kenacort; Ledercort; Omiclon; Volon; Tricortale 124-94-7 ≥98% 394.43 C21H27FO6 CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O Ambient Ambient Slightly soluble in water. "Zhou H, Yang L, Li H, et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine. 2012;7:4649-60. PMID: 22942646.

 

McAllister IL, Vijayasekaran S, Chen SD, et al. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. PMID: 19211093.

 

Mizuno D, Matsubara A, Ogura Y. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 2008 May;49(5):2127-33. PMID: 18436845.

" Carc. Not dangerous goods.

LKT T7032 Triamcinolone 5 g 659.2 Synthetic steroid; glucocorticoid agonist. "(11β,16α)-9-Fluoro-11,16,17,21-tetrahydroxy- pregna-1,4-diene-3,20-dione

" Aristocort; Kenacort; Ledercort; Omiclon; Volon; Tricortale 124-94-7 ≥98% 394.43 C21H27FO6 CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O Ambient Ambient Slightly soluble in water. "Zhou H, Yang L, Li H, et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine. 2012;7:4649-60. PMID: 22942646.

 

McAllister IL, Vijayasekaran S, Chen SD, et al. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. PMID: 19211093.

 

Mizuno D, Matsubara A, Ogura Y. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 2008 May;49(5):2127-33. PMID: 18436845.

" Carc. Not dangerous goods.

LKT G4434 Gliotoxin 1 mg 84.3 Toxin produced by Aspergillus. 67-99-2 ≥98% 326.39 C13H14N2O4S2 CN1C(=O)C23CC4=CC=CC(C4N2C(=O)C1(SS3)CO)O Ambient 4°C CHCl3, DMSO, Methanol, Ethanol, Ethyl acetate, Petrol-ether, Dichloromethane. Water insoluble "Nguyen VT, Lee JS, Qian ZJ, et al. Gliotoxin Isolated from Marine Fungus Aspergillus sp. Induces Apoptosis of Human Cervical Cancer and Chondrosarcoma Cells. Mar Drugs. 2013 Dec 24;12(1):69-87. PMID: 24368570.

 

Hur JM, Yun HJ, Yang SH, et al. Gliotoxin enhances radiotherapy via inhibition of radiation-induced GADD45a, p38, and NFkappaB activation. J Cell Biochem. 2008 Aug 15;104(6):2174-84. PMID: 18425744.

 

Orciuolo E, Stanzani M, Canestraro M, et al. Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis. J Leukoc Biol. 2007 Oct;82(4):839-48. PMID: 17626149.

 

Hatabu T, Hagiwara M, Taguchi N, et al. Plasmodium falciparum: the fungal metabolite gliotoxin inhibits proteasome proteolytic activity and exerts a plasmodicidal effect on P. falciparum. Exp Parasitol. 2006 Mar;112(3):179-83. PMID: 16384554.

 

Orr JG, Leel V, Cameron GA, et al. Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology. 2004 Jul;40(1):232-42. PMID: 15239107.

 

Kweon YO, Paik YH, Schnabl B, et al. Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J Hepatol. 2003 Jul;39(1):38-46. PMID: 12821042.

" "UN number: 3462     Class: 6.1     Packing Group: III

Proper shipping name: Toxins, extracted from living sources, solid, n.o.s. (Gliotoxin)"

LKT G4434 Gliotoxin 5 mg 281.2 Toxin produced by Aspergillus. 67-99-2 ≥98% 326.39 C13H14N2O4S2 CN1C(=O)C23CC4=CC=CC(C4N2C(=O)C1(SS3)CO)O Ambient 4°C CHCl3, DMSO, Methanol, Ethanol, Ethyl acetate, Petrol-ether, Dichloromethane. Water insoluble "Nguyen VT, Lee JS, Qian ZJ, et al. Gliotoxin Isolated from Marine Fungus Aspergillus sp. Induces Apoptosis of Human Cervical Cancer and Chondrosarcoma Cells. Mar Drugs. 2013 Dec 24;12(1):69-87. PMID: 24368570.

 

Hur JM, Yun HJ, Yang SH, et al. Gliotoxin enhances radiotherapy via inhibition of radiation-induced GADD45a, p38, and NFkappaB activation. J Cell Biochem. 2008 Aug 15;104(6):2174-84. PMID: 18425744.

 

Orciuolo E, Stanzani M, Canestraro M, et al. Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis. J Leukoc Biol. 2007 Oct;82(4):839-48. PMID: 17626149.

 

Hatabu T, Hagiwara M, Taguchi N, et al. Plasmodium falciparum: the fungal metabolite gliotoxin inhibits proteasome proteolytic activity and exerts a plasmodicidal effect on P. falciparum. Exp Parasitol. 2006 Mar;112(3):179-83. PMID: 16384554.

 

Orr JG, Leel V, Cameron GA, et al. Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology. 2004 Jul;40(1):232-42. PMID: 15239107.

 

Kweon YO, Paik YH, Schnabl B, et al. Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J Hepatol. 2003 Jul;39(1):38-46. PMID: 12821042.

" "UN number: 3462     Class: 6.1     Packing Group: III

Proper shipping name: Toxins, extracted from living sources, solid, n.o.s. (Gliotoxin)"

LKT G4434 Gliotoxin 10 mg 506.3 Toxin produced by Aspergillus. 67-99-2 ≥98% 326.39 C13H14N2O4S2 CN1C(=O)C23CC4=CC=CC(C4N2C(=O)C1(SS3)CO)O Ambient 4°C CHCl3, DMSO, Methanol, Ethanol, Ethyl acetate, Petrol-ether, Dichloromethane. Water insoluble "Nguyen VT, Lee JS, Qian ZJ, et al. Gliotoxin Isolated from Marine Fungus Aspergillus sp. Induces Apoptosis of Human Cervical Cancer and Chondrosarcoma Cells. Mar Drugs. 2013 Dec 24;12(1):69-87. PMID: 24368570.

 

Hur JM, Yun HJ, Yang SH, et al. Gliotoxin enhances radiotherapy via inhibition of radiation-induced GADD45a, p38, and NFkappaB activation. J Cell Biochem. 2008 Aug 15;104(6):2174-84. PMID: 18425744.

 

Orciuolo E, Stanzani M, Canestraro M, et al. Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis. J Leukoc Biol. 2007 Oct;82(4):839-48. PMID: 17626149.

 

Hatabu T, Hagiwara M, Taguchi N, et al. Plasmodium falciparum: the fungal metabolite gliotoxin inhibits proteasome proteolytic activity and exerts a plasmodicidal effect on P. falciparum. Exp Parasitol. 2006 Mar;112(3):179-83. PMID: 16384554.

 

Orr JG, Leel V, Cameron GA, et al. Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology. 2004 Jul;40(1):232-42. PMID: 15239107.

 

Kweon YO, Paik YH, Schnabl B, et al. Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J Hepatol. 2003 Jul;39(1):38-46. PMID: 12821042.

" "UN number: 3462     Class: 6.1     Packing Group: III

Proper shipping name: Toxins, extracted from living sources, solid, n.o.s. (Gliotoxin)"

LKT G4479 Glucagon (19-29), human 1 mg 60 Endogenous peptide hormone, glugagon fragment; potential Ca2+ channel blocker. Des(1-18) glucagon, Miniglucagon 64790-15-4 ≥95% 1352.54 C61H89N15O18S CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)N Ambient -20°C "Bataille D, Fontés G, Costes S, et al. The glucagon-miniglucagon interplay: a new level in the metabolic regulation. Ann N Y Acad Sci. 2006 Jul;1070:161-6. PMID: 16888159.

 

Dalle S, Fontés G, Lajoix AD, et al. Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology. Diabetes. 2002 Feb;51(2):406-12. PMID: 11812748.

 

Dalle S, Smith P, Blache P, et al. Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway. J Biol Chem. 1999 Apr 16;274(16):10869-76. PMID: 10196164.

" Not dangerous goods.

LKT G4479 Glucagon (19-29), human 2 mg 101.9 Endogenous peptide hormone, glugagon fragment; potential Ca2+ channel blocker. Des(1-18) glucagon, Miniglucagon 64790-15-4 ≥95% 1352.54 C61H89N15O18S CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)N Ambient -20°C "Bataille D, Fontés G, Costes S, et al. The glucagon-miniglucagon interplay: a new level in the metabolic regulation. Ann N Y Acad Sci. 2006 Jul;1070:161-6. PMID: 16888159.

 

Dalle S, Fontés G, Lajoix AD, et al. Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology. Diabetes. 2002 Feb;51(2):406-12. PMID: 11812748.

 

Dalle S, Smith P, Blache P, et al. Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway. J Biol Chem. 1999 Apr 16;274(16):10869-76. PMID: 10196164.

" Not dangerous goods.

LKT G4479 Glucagon (19-29), human 5 mg 180 Endogenous peptide hormone, glugagon fragment; potential Ca2+ channel blocker. Des(1-18) glucagon, Miniglucagon 64790-15-4 ≥95% 1352.54 C61H89N15O18S CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)N Ambient -20°C "Bataille D, Fontés G, Costes S, et al. The glucagon-miniglucagon interplay: a new level in the metabolic regulation. Ann N Y Acad Sci. 2006 Jul;1070:161-6. PMID: 16888159.

 

Dalle S, Fontés G, Lajoix AD, et al. Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology. Diabetes. 2002 Feb;51(2):406-12. PMID: 11812748.

 

Dalle S, Smith P, Blache P, et al. Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway. J Biol Chem. 1999 Apr 16;274(16):10869-76. PMID: 10196164.

" Not dangerous goods.

LKT G4480 Glucagon, human 1 mg 495 Endogenous peptide hormone, counteracts insulin; glucagon agonist. Glukagon; HG-factor. 16941-32-5 ≥98% 3482.78 C153H225N43O49S CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N Ambient -20°C Practically insoluble  in water. Soluble in acidic or basic media. "Xu E, Kumar M, Zhang Y, et al. Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab. 2006 Jan;3(1):47-58. PMID: 16399504.

 

Tang AW. A practical guide to anaphylaxis. Am Fam Physician. 2003 Oct 1;68(7):1325-32. Erratum in: Am Fam Physician. 2004 Mar 1;69(5):1049.  PMID: 14567487.

 

White CM. A review of potential cardiovascular uses of intravenous glucagon administration. J Clin Pharmacol. 1999 May;39(5):442-7. PMID: 10234590.

" Not dangerous goods.

LKT G4481 Glucagon-like Peptide I Amide (7-36), human 0.5 mg 228 Endogenous peptide hormone, GLP-1 fragment, involved in insulin secretion and feeding behavior; GLP1 agonist. GLP-1 107444-51-9 ≥95% 3297.7 C149H229N40O45 CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CNC=N6)N Ambient -20°C "Kim S, Wan Kim S, Bae YH. Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7-37)/polymer conjugate to isolated rat islets. Biomaterials. 2005 Jun;26(17):3597-606. PMID: 15621250.

 

Vahl TP, Paty BW, Fuller BD, et al. Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. J Clin Endocrinol Metab. 2003 Apr;88(4):1772-9. PMID: 12679472.

 

Mannucci E, Ognibene A, Cremasco F, et al. Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus. Diabet Med. 2000 Oct;17(10):713-9. PMID: 11110504.

 

Nauck MA. Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective. Acta Diabetol. 1998 Oct;35(3):117-29. PMID: 9840447.

" Not dangerous goods.

LKT G4481 Glucagon-like Peptide I Amide (7-36), human 1 mg 387 Endogenous peptide hormone, GLP-1 fragment, involved in insulin secretion and feeding behavior; GLP1 agonist. GLP-1 107444-51-9 ≥95% 3297.7 C149H229N40O45 CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CNC=N6)N Ambient -20°C "Kim S, Wan Kim S, Bae YH. Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7-37)/polymer conjugate to isolated rat islets. Biomaterials. 2005 Jun;26(17):3597-606. PMID: 15621250.

 

Vahl TP, Paty BW, Fuller BD, et al. Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. J Clin Endocrinol Metab. 2003 Apr;88(4):1772-9. PMID: 12679472.

 

Mannucci E, Ognibene A, Cremasco F, et al. Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus. Diabet Med. 2000 Oct;17(10):713-9. PMID: 11110504.

 

Nauck MA. Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective. Acta Diabetol. 1998 Oct;35(3):117-29. PMID: 9840447.

" Not dangerous goods.

LKT G4481 Glucagon-like Peptide I Amide (7-36), human 2.5 mg 684.1 Endogenous peptide hormone, GLP-1 fragment, involved in insulin secretion and feeding behavior; GLP1 agonist. GLP-1 107444-51-9 ≥95% 3297.7 C149H229N40O45 CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CNC=N6)N Ambient -20°C "Kim S, Wan Kim S, Bae YH. Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7-37)/polymer conjugate to isolated rat islets. Biomaterials. 2005 Jun;26(17):3597-606. PMID: 15621250.

 

Vahl TP, Paty BW, Fuller BD, et al. Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. J Clin Endocrinol Metab. 2003 Apr;88(4):1772-9. PMID: 12679472.

 

Mannucci E, Ognibene A, Cremasco F, et al. Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus. Diabet Med. 2000 Oct;17(10):713-9. PMID: 11110504.

 

Nauck MA. Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective. Acta Diabetol. 1998 Oct;35(3):117-29. PMID: 9840447.

" Not dangerous goods.

LKT T7031 Triflumuron 10 g 42 Insect growth regulator; chitin synthesis inhibitor. "2-Chloro-N-(((4-

(trifluoromethoxy)phenyl)amino)carbonyl)benzamide" Trifluron; BAY-SIR 8514 64628-44-0 ≥98% 358.7 C15H10ClF3N2O3 C1=CC=C(C(=C1)C(=O)NC(=O)NC2=CC=C(C=C2)OC(F)(F)F)Cl Ambient Ambient Soluble in DMF. Insoluble in water or polar solvents. Slightly soluble in acetone. "Jacups SP, Paton CJ, Ritchie SA. Residual and pre-treatment application of starycide insect growth regulator (triflumuron) to control Aedes aegypti in containers. Pest Manag Sci. 2014 Apr;70(4):572-5. PMID: 23653423.

 

Belinato TA, Martins AJ, Lima JB, et al. Effect of triflumuron, a chitin synthesis inhibitor, on Aedes aegypti, Aedes albopictus and Culex quinquefasciatus under laboratory conditions. Parasit Vectors. 2013 Apr 4;6:83. PMID: 23557173.

 

Waghorn TS, McKay CH, Heath AC. The in vitro response of field strains of sheep blowflies Lucilia sericata and L. cuprina (Calliphoridae) in New Zealand to dicyclanil and triflumuron. N Z Vet J. 2013 Sep;61(5):274-80. PMID: 23441987.

" None Not dangerous goods.

LKT T7031 Triflumuron 25 g 73.5 Insect growth regulator; chitin synthesis inhibitor. "2-Chloro-N-(((4-

(trifluoromethoxy)phenyl)amino)carbonyl)benzamide" Trifluron; BAY-SIR 8514 64628-44-0 ≥98% 358.7 C15H10ClF3N2O3 C1=CC=C(C(=C1)C(=O)NC(=O)NC2=CC=C(C=C2)OC(F)(F)F)Cl Ambient Ambient Soluble in DMF. Insoluble in water or polar solvents. Slightly soluble in acetone. "Jacups SP, Paton CJ, Ritchie SA. Residual and pre-treatment application of starycide insect growth regulator (triflumuron) to control Aedes aegypti in containers. Pest Manag Sci. 2014 Apr;70(4):572-5. PMID: 23653423.

 

Belinato TA, Martins AJ, Lima JB, et al. Effect of triflumuron, a chitin synthesis inhibitor, on Aedes aegypti, Aedes albopictus and Culex quinquefasciatus under laboratory conditions. Parasit Vectors. 2013 Apr 4;6:83. PMID: 23557173.

 

Waghorn TS, McKay CH, Heath AC. The in vitro response of field strains of sheep blowflies Lucilia sericata and L. cuprina (Calliphoridae) in New Zealand to dicyclanil and triflumuron. N Z Vet J. 2013 Sep;61(5):274-80. PMID: 23441987.

" None Not dangerous goods.

LKT G4482 Glucagon-like Peptide I (7-37) 0.5 mg 300.1 Endogenous peptide hormone, GLP-1 fragment, involved in insulin secretion and feeding behavior; GLP1 agonist. Insulinotropin, Tglp-1; GLP-1 106612-94-6 ≥95% 3355.67 C151H228N40O47 CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CNC=N6)N Ambient -20°C "Kim S, Wan Kim S, Bae YH. Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7-37)/polymer conjugate to isolated rat islets. Biomaterials. 2005 Jun;26(17):3597-606. PMID: 15621250.

 

Vahl TP, Paty BW, Fuller BD, et al. Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. J Clin Endocrinol Metab. 2003 Apr;88(4):1772-9. PMID: 12679472.

 

Mannucci E, Ognibene A, Cremasco F, et al. Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus. Diabet Med. 2000 Oct;17(10):713-9. PMID: 11110504.

 

Nauck MA. Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective. Acta Diabetol. 1998 Oct;35(3):117-29. PMID: 9840447.

" Not dangerous goods.

LKT G4482 Glucagon-like Peptide I (7-37) 1 mg 510 Endogenous peptide hormone, GLP-1 fragment, involved in insulin secretion and feeding behavior; GLP1 agonist. Insulinotropin, Tglp-1; GLP-1 106612-94-6 ≥95% 3355.67 C151H228N40O47 CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CNC=N6)N Ambient -20°C "Kim S, Wan Kim S, Bae YH. Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7-37)/polymer conjugate to isolated rat islets. Biomaterials. 2005 Jun;26(17):3597-606. PMID: 15621250.

 

Vahl TP, Paty BW, Fuller BD, et al. Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. J Clin Endocrinol Metab. 2003 Apr;88(4):1772-9. PMID: 12679472.

 

Mannucci E, Ognibene A, Cremasco F, et al. Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus. Diabet Med. 2000 Oct;17(10):713-9. PMID: 11110504.

 

Nauck MA. Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective. Acta Diabetol. 1998 Oct;35(3):117-29. PMID: 9840447.

" Not dangerous goods.

LKT T7031 Triflumuron 100 g 231.1 Insect growth regulator; chitin synthesis inhibitor. "2-Chloro-N-(((4-

(trifluoromethoxy)phenyl)amino)carbonyl)benzamide" Trifluron; BAY-SIR 8514 64628-44-0 ≥98% 358.7 C15H10ClF3N2O3 C1=CC=C(C(=C1)C(=O)NC(=O)NC2=CC=C(C=C2)OC(F)(F)F)Cl Ambient Ambient Soluble in DMF. Insoluble in water or polar solvents. Slightly soluble in acetone. "Jacups SP, Paton CJ, Ritchie SA. Residual and pre-treatment application of starycide insect growth regulator (triflumuron) to control Aedes aegypti in containers. Pest Manag Sci. 2014 Apr;70(4):572-5. PMID: 23653423.

 

Belinato TA, Martins AJ, Lima JB, et al. Effect of triflumuron, a chitin synthesis inhibitor, on Aedes aegypti, Aedes albopictus and Culex quinquefasciatus under laboratory conditions. Parasit Vectors. 2013 Apr 4;6:83. PMID: 23557173.

 

Waghorn TS, McKay CH, Heath AC. The in vitro response of field strains of sheep blowflies Lucilia sericata and L. cuprina (Calliphoridae) in New Zealand to dicyclanil and triflumuron. N Z Vet J. 2013 Sep;61(5):274-80. PMID: 23441987.

" None Not dangerous goods.

LKT G4482 Glucagon-like Peptide I (7-37) 2.5 mg 900.1 Endogenous peptide hormone, GLP-1 fragment, involved in insulin secretion and feeding behavior; GLP1 agonist. Insulinotropin, Tglp-1; GLP-1 106612-94-6 ≥95% 3355.67 C151H228N40O47 CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CNC=N6)N Ambient -20°C "Kim S, Wan Kim S, Bae YH. Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7-37)/polymer conjugate to isolated rat islets. Biomaterials. 2005 Jun;26(17):3597-606. PMID: 15621250.

 

Vahl TP, Paty BW, Fuller BD, et al. Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. J Clin Endocrinol Metab. 2003 Apr;88(4):1772-9. PMID: 12679472.

 

Mannucci E, Ognibene A, Cremasco F, et al. Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus. Diabet Med. 2000 Oct;17(10):713-9. PMID: 11110504.

 

Nauck MA. Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective. Acta Diabetol. 1998 Oct;35(3):117-29. PMID: 9840447.

" Not dangerous goods.

LKT G4483 Glucagon-like Peptide II, human 0.5 mg 276.2 Endogenous peptide hormone, involved in intestinal function; GLP2 agonist. GLP-2 223460-79-5 ≥95% 3922.38 C171H266N48O56S Ambient -20°C "Sasaki-Hamada S, Ito K, Oka JI. Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2. Life Sci. 2013 Oct 24. pii: S0024-3205(13)00618-8. [Epub ahead of print]. PMID: 24513200.

 

Hansen LB. GLP-2 and mesenteric blood flow. Dan Med J. 2013 May;60(5):B4634. PMID: 23673268.

 

Rasmussen AR, Viby NE, Hare KJ, et al. The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin. Dig Dis Sci. 2010 Oct;55(10):2785-96. PMID: 20112065.

 

Wang Y, Guan X. GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons. Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E156-66. PMID: 19920220.

 

Iwai T, Hayashi Y, Narita S, et al. Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav Brain Res. 2009 Dec 1;204(1):235-40. PMID: 19539656.

 

Mojsov S, Kopczynski MG, Habener JF. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem. 1990 May 15;265(14):8001-8. PMID: 1692320.

" Not dangerous goods.

LKT G4483 Glucagon-like Peptide II, human 1 mg 468.2 Endogenous peptide hormone, involved in intestinal function; GLP2 agonist. GLP-2 223460-79-5 ≥95% 3922.38 C171H266N48O56S Ambient -20°C "Sasaki-Hamada S, Ito K, Oka JI. Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2. Life Sci. 2013 Oct 24. pii: S0024-3205(13)00618-8. [Epub ahead of print]. PMID: 24513200.

 

Hansen LB. GLP-2 and mesenteric blood flow. Dan Med J. 2013 May;60(5):B4634. PMID: 23673268.

 

Rasmussen AR, Viby NE, Hare KJ, et al. The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin. Dig Dis Sci. 2010 Oct;55(10):2785-96. PMID: 20112065.

 

Wang Y, Guan X. GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons. Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E156-66. PMID: 19920220.

 

Iwai T, Hayashi Y, Narita S, et al. Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav Brain Res. 2009 Dec 1;204(1):235-40. PMID: 19539656.

 

Mojsov S, Kopczynski MG, Habener JF. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem. 1990 May 15;265(14):8001-8. PMID: 1692320.

" Not dangerous goods.

LKT G4483 Glucagon-like Peptide II, human 2.5 mg 828.1 Endogenous peptide hormone, involved in intestinal function; GLP2 agonist. GLP-2 223460-79-5 ≥95% 3922.38 C171H266N48O56S Ambient -20°C "Sasaki-Hamada S, Ito K, Oka JI. Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2. Life Sci. 2013 Oct 24. pii: S0024-3205(13)00618-8. [Epub ahead of print]. PMID: 24513200.

 

Hansen LB. GLP-2 and mesenteric blood flow. Dan Med J. 2013 May;60(5):B4634. PMID: 23673268.

 

Rasmussen AR, Viby NE, Hare KJ, et al. The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin. Dig Dis Sci. 2010 Oct;55(10):2785-96. PMID: 20112065.

 

Wang Y, Guan X. GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons. Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E156-66. PMID: 19920220.

 

Iwai T, Hayashi Y, Narita S, et al. Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav Brain Res. 2009 Dec 1;204(1):235-40. PMID: 19539656.

 

Mojsov S, Kopczynski MG, Habener JF. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem. 1990 May 15;265(14):8001-8. PMID: 1692320.

" Not dangerous goods.

LKT G4484 Glucagon-like Peptide II, rat 2.5 mg 1043.9 Endogenous peptide hormone, involved in intestinal function; GLP2 agonist. GLP-2 195262-56-7 ≥95% 3796.22 C166H256N44O56S Ambient -20°C "Sasaki-Hamada S, Ito K, Oka JI. Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2. Life Sci. 2013 Oct 24. pii: S0024-3205(13)00618-8. [Epub ahead of print]. PMID: 24513200.

 

Hansen LB. GLP-2 and mesenteric blood flow. Dan Med J. 2013 May;60(5):B4634. PMID: 23673268.

 

Rasmussen AR, Viby NE, Hare KJ, et al. The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin. Dig Dis Sci. 2010 Oct;55(10):2785-96. PMID: 20112065.

 

Wang Y, Guan X. GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons. Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E156-66. PMID: 19920220.

 

Iwai T, Hayashi Y, Narita S, et al. Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav Brain Res. 2009 Dec 1;204(1):235-40. PMID: 19539656.

 

Mojsov S, Kopczynski MG, Habener JF. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem. 1990 May 15;265(14):8001-8. PMID: 1692320.

" Not dangerous goods.

LKT G4484 Glucagon-like Peptide II, rat 1 mg 591 Endogenous peptide hormone, involved in intestinal function; GLP2 agonist. GLP-2 195262-56-7 ≥95% 3796.22 C166H256N44O56S Ambient -20°C "Sasaki-Hamada S, Ito K, Oka JI. Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2. Life Sci. 2013 Oct 24. pii: S0024-3205(13)00618-8. [Epub ahead of print]. PMID: 24513200.

 

Hansen LB. GLP-2 and mesenteric blood flow. Dan Med J. 2013 May;60(5):B4634. PMID: 23673268.

 

Rasmussen AR, Viby NE, Hare KJ, et al. The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin. Dig Dis Sci. 2010 Oct;55(10):2785-96. PMID: 20112065.

 

Wang Y, Guan X. GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons. Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E156-66. PMID: 19920220.

 

Iwai T, Hayashi Y, Narita S, et al. Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav Brain Res. 2009 Dec 1;204(1):235-40. PMID: 19539656.

 

Mojsov S, Kopczynski MG, Habener JF. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem. 1990 May 15;265(14):8001-8. PMID: 1692320.

" Not dangerous goods.

LKT G4484 Glucagon-like Peptide II, rat 0.5 mg 348 Endogenous peptide hormone, involved in intestinal function; GLP2 agonist. GLP-2 195262-56-7 ≥95% 3796.22 C166H256N44O56S Ambient -20°C "Sasaki-Hamada S, Ito K, Oka JI. Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2. Life Sci. 2013 Oct 24. pii: S0024-3205(13)00618-8. [Epub ahead of print]. PMID: 24513200.

 

Hansen LB. GLP-2 and mesenteric blood flow. Dan Med J. 2013 May;60(5):B4634. PMID: 23673268.

 

Rasmussen AR, Viby NE, Hare KJ, et al. The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin. Dig Dis Sci. 2010 Oct;55(10):2785-96. PMID: 20112065.

 

Wang Y, Guan X. GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons. Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E156-66. PMID: 19920220.

 

Iwai T, Hayashi Y, Narita S, et al. Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav Brain Res. 2009 Dec 1;204(1):235-40. PMID: 19539656.

 

Mojsov S, Kopczynski MG, Habener JF. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem. 1990 May 15;265(14):8001-8. PMID: 1692320.

" Not dangerous goods.

LKT G4485 [Ala19]-Glucagon-like Peptide II, rat 0.5 mg 348 Peptide hormone, GLP-2 derivative; GLP2 agonist. GLP-2 89750-15-2 ≥95% 3766.2 C165H254N44O55S CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC5=CN=CN5)N Ambient -20°C "Sasaki-Hamada S, Ito K, Oka JI. Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2. Life Sci. 2013 Oct 24. pii: S0024-3205(13)00618-8. [Epub ahead of print]. PMID: 24513200.

 

Hansen LB. GLP-2 and mesenteric blood flow. Dan Med J. 2013 May;60(5):B4634. PMID: 23673268.

 

Rasmussen AR, Viby NE, Hare KJ, et al. The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin. Dig Dis Sci. 2010 Oct;55(10):2785-96. PMID: 20112065.

 

Wang Y, Guan X. GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons. Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E156-66. PMID: 19920220.

 

Iwai T, Hayashi Y, Narita S, et al. Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav Brain Res. 2009 Dec 1;204(1):235-40. PMID: 19539656.

 

Mojsov S, Kopczynski MG, Habener JF. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem. 1990 May 15;265(14):8001-8. PMID: 1692320.

" Not dangerous goods.

LKT G4485 [Ala19]-Glucagon-like Peptide II, rat 1 mg 591 Peptide hormone, GLP-2 derivative; GLP2 agonist. GLP-2 89750-15-2 ≥95% 3766.2 C165H254N44O55S CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC5=CN=CN5)N Ambient -20°C "Sasaki-Hamada S, Ito K, Oka JI. Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2. Life Sci. 2013 Oct 24. pii: S0024-3205(13)00618-8. [Epub ahead of print]. PMID: 24513200.

 

Hansen LB. GLP-2 and mesenteric blood flow. Dan Med J. 2013 May;60(5):B4634. PMID: 23673268.

 

Rasmussen AR, Viby NE, Hare KJ, et al. The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin. Dig Dis Sci. 2010 Oct;55(10):2785-96. PMID: 20112065.

 

Wang Y, Guan X. GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons. Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E156-66. PMID: 19920220.

 

Iwai T, Hayashi Y, Narita S, et al. Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav Brain Res. 2009 Dec 1;204(1):235-40. PMID: 19539656.

 

Mojsov S, Kopczynski MG, Habener JF. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem. 1990 May 15;265(14):8001-8. PMID: 1692320.

" Not dangerous goods.

LKT G4485 [Ala19]-Glucagon-like Peptide II, rat 2.5 mg 1043.9 Peptide hormone, GLP-2 derivative; GLP2 agonist. GLP-2 89750-15-2 ≥95% 3766.2 C165H254N44O55S CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC5=CN=CN5)N Ambient -20°C "Sasaki-Hamada S, Ito K, Oka JI. Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2. Life Sci. 2013 Oct 24. pii: S0024-3205(13)00618-8. [Epub ahead of print]. PMID: 24513200.

 

Hansen LB. GLP-2 and mesenteric blood flow. Dan Med J. 2013 May;60(5):B4634. PMID: 23673268.

 

Rasmussen AR, Viby NE, Hare KJ, et al. The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin. Dig Dis Sci. 2010 Oct;55(10):2785-96. PMID: 20112065.

 

Wang Y, Guan X. GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons. Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E156-66. PMID: 19920220.

 

Iwai T, Hayashi Y, Narita S, et al. Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav Brain Res. 2009 Dec 1;204(1):235-40. PMID: 19539656.

 

Mojsov S, Kopczynski MG, Habener JF. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem. 1990 May 15;265(14):8001-8. PMID: 1692320.

" Not dangerous goods.

LKT G4518 Glucaric Acid Calcium Tetrahydrate 100 g 225 Oxidized non-cylic hexose sugar. D-Glucaric acid, calcium salt; D-Saccharic acid, calcium salt; Calcium D-glucarate 5793-89-5 ≥98% 320.3 C6H8O8Ca  4H2O C(C(C(C(=O)[O-])O)O)(C(C(=O)[O-])O)O.O.O.O.O.[Ca+2] Ambient Ambient Insoluble in water. "Shiue E, Prather KL. Improving D-glucaric acid production from myo-inositol in E. coli by increasing MIOX stability and myo-inositol transport. Metab Eng. 2014 Mar;22:22-31. PMID: 24333274.

 

Smith TN, Hash K, Davey CL, et al. Modifications in the nitric acid oxidation of D-glucose. Carbohydr Res. 2012 Mar 1;350:6-13. PMID: 22285512.

 

Bespalov VG, Aleksandrov VA. Anticarcinogenic effect of potassium salts of glucaric and glucuronic acid in induced models of cervical and esophageal tumors. Vopr Onkol. 2012;58(4):537-40. PMID: 23607211.

" Xi Not dangerous goods.

LKT G4518 Glucaric Acid Calcium Tetrahydrate 25 g 78.6 Oxidized non-cylic hexose sugar. D-Glucaric acid, calcium salt; D-Saccharic acid, calcium salt; Calcium D-glucarate 5793-89-5 ≥98% 320.3 C6H8O8Ca  4H2O C(C(C(C(=O)[O-])O)O)(C(C(=O)[O-])O)O.O.O.O.O.[Ca+2] Ambient Ambient Insoluble in water. "Shiue E, Prather KL. Improving D-glucaric acid production from myo-inositol in E. coli by increasing MIOX stability and myo-inositol transport. Metab Eng. 2014 Mar;22:22-31. PMID: 24333274.

 

Smith TN, Hash K, Davey CL, et al. Modifications in the nitric acid oxidation of D-glucose. Carbohydr Res. 2012 Mar 1;350:6-13. PMID: 22285512.

 

Bespalov VG, Aleksandrov VA. Anticarcinogenic effect of potassium salts of glucaric and glucuronic acid in induced models of cervical and esophageal tumors. Vopr Onkol. 2012;58(4):537-40. PMID: 23607211.

" Xi Not dangerous goods.

LKT T6935 Trimebutine Base 10 g 88.3 BK K+ channel and L-type Ca2+ channel blocker. "Benzoic acid, 3,4,5-trimethoxy-, 2-(dimethylamino)-2-

phenylbutyl ester 

" "EINECS 254-309-2 

 " 39133-31-8 ≥97% 387.47 C22H29NO5 CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C Ambient Ambient Soluble in methylene chloride. "Kountouras J, Sofianou D, Gavalas E, et al. Trimebutine as a potential antimicrobial agent: a preliminary in vitro approach. Hippokratia. 2012 Oct;16(4):347-9. PMID: 23935315.

 

Tan W, Zhang H, Luo HS, et al. Effects of trimebutine maleate on colonic motility through Ca²+-activated K+ channels and L-type Ca²+ channels. Arch Pharm Res. 2011 Jun;34(6):979-85. PMID: 21725819.

" None Not dangerous goods.

LKT T6935 Trimebutine Base 50 g 271.7 BK K+ channel and L-type Ca2+ channel blocker. "Benzoic acid, 3,4,5-trimethoxy-, 2-(dimethylamino)-2-

phenylbutyl ester 

" "EINECS 254-309-2 

 " 39133-31-8 ≥97% 387.47 C22H29NO5 CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C Ambient Ambient Soluble in methylene chloride. "Kountouras J, Sofianou D, Gavalas E, et al. Trimebutine as a potential antimicrobial agent: a preliminary in vitro approach. Hippokratia. 2012 Oct;16(4):347-9. PMID: 23935315.

 

Tan W, Zhang H, Luo HS, et al. Effects of trimebutine maleate on colonic motility through Ca²+-activated K+ channels and L-type Ca²+ channels. Arch Pharm Res. 2011 Jun;34(6):979-85. PMID: 21725819.

" None Not dangerous goods.

LKT G4532 Gliclazide 1 g 46.4 Sulfonylurea; SUR1 antagonist. N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]- carbonyl]-4-methylbenzenesulfonamide Diamicron; Glimicron; Nordialex 21187-98-4 ≥98% 323.41 C15H21N3O3S CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2 Ambient Ambient Insoluble in water. Soluble in dichloromethane. "Proks P, de Wet H, Ashcroft FM. Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes. Diabetes. 2013 Nov;62(11):3909-19. PMID: 23835339.

 

Sliwinska A, Rogalska A, Szwed M, et al. Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells. Mol Biol Rep. 2012 May;39(5):5253-67. PMID: 22183301.

 

Lawrence CL, Proks P, Rodrigo GC, et al. Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells. Diabetologia. 2001 Aug;44(8):1019-25. PMID: 11484080.

" Repr., Xn, Xi, Mut. Not dangerous goods.

LKT G4532 Gliclazide 5 g 129.5 Sulfonylurea; SUR1 antagonist. N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]- carbonyl]-4-methylbenzenesulfonamide Diamicron; Glimicron; Nordialex 21187-98-4 ≥98% 323.41 C15H21N3O3S CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2 Ambient Ambient Insoluble in water. Soluble in dichloromethane. "Proks P, de Wet H, Ashcroft FM. Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes. Diabetes. 2013 Nov;62(11):3909-19. PMID: 23835339.

 

Sliwinska A, Rogalska A, Szwed M, et al. Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells. Mol Biol Rep. 2012 May;39(5):5253-67. PMID: 22183301.

 

Lawrence CL, Proks P, Rodrigo GC, et al. Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells. Diabetologia. 2001 Aug;44(8):1019-25. PMID: 11484080.

" Repr., Xn, Xi, Mut. Not dangerous goods.

LKT G4532 Gliclazide 10 g 196.8 Sulfonylurea; SUR1 antagonist. N-[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]- carbonyl]-4-methylbenzenesulfonamide Diamicron; Glimicron; Nordialex 21187-98-4 ≥98% 323.41 C15H21N3O3S CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2 Ambient Ambient Insoluble in water. Soluble in dichloromethane. "Proks P, de Wet H, Ashcroft FM. Molecular mechanism of sulphonylurea block of K(ATP) channels carrying mutations that impair ATP inhibition and cause neonatal diabetes. Diabetes. 2013 Nov;62(11):3909-19. PMID: 23835339.

 

Sliwinska A, Rogalska A, Szwed M, et al. Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells. Mol Biol Rep. 2012 May;39(5):5253-67. PMID: 22183301.

 

Lawrence CL, Proks P, Rodrigo GC, et al. Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells. Diabetologia. 2001 Aug;44(8):1019-25. PMID: 11484080.

" Repr., Xn, Xi, Mut. Not dangerous goods.

LKT G4535 Glimepiride 500 mg 57.8 Sulfonylurea; ATP-sensitive K+ channel blocker. 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide HOE-490; Amarel 93479-97-1 ≥98% 490.62 C24H34N4O5S CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C Ambient 4°C Soluble in DMSO (25mg/mL). "Liu F, Wang Y, Yan M, et al. Glimepiride attenuates Aβ production via suppressing BACE1 activity in cortical neurons. Neurosci Lett. 2013 Dec 17;557 Pt B:90-4. PMID: 24184877.

 

Bashir MI, Pathan MF, Raza SA, et al. Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan. Indian J Endocrinol Metab. 2012 Jul;16(4):503-7. PMID: 22837904.

 

Abdelmoneim AS, Hasenbank SE, Seubert JM, et al. Variations in tissue selectivity amongst insulin secretagogues: a systematic review. Diabetes Obes Metab. 2012 Feb;14(2):130-8. PMID: 21923736.

" Not dangerous goods.

LKT G4535 Glimepiride 1 g 92.5 Sulfonylurea; ATP-sensitive K+ channel blocker. 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide HOE-490; Amarel 93479-97-1 ≥98% 490.62 C24H34N4O5S CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C Ambient 4°C Soluble in DMSO (25mg/mL). "Liu F, Wang Y, Yan M, et al. Glimepiride attenuates Aβ production via suppressing BACE1 activity in cortical neurons. Neurosci Lett. 2013 Dec 17;557 Pt B:90-4. PMID: 24184877.

 

Bashir MI, Pathan MF, Raza SA, et al. Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan. Indian J Endocrinol Metab. 2012 Jul;16(4):503-7. PMID: 22837904.

 

Abdelmoneim AS, Hasenbank SE, Seubert JM, et al. Variations in tissue selectivity amongst insulin secretagogues: a systematic review. Diabetes Obes Metab. 2012 Feb;14(2):130-8. PMID: 21923736.

" Not dangerous goods.

LKT G4535 Glimepiride 5 g 381.3 Sulfonylurea; ATP-sensitive K+ channel blocker. 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide HOE-490; Amarel 93479-97-1 ≥98% 490.62 C24H34N4O5S CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C Ambient 4°C Soluble in DMSO (25mg/mL). "Liu F, Wang Y, Yan M, et al. Glimepiride attenuates Aβ production via suppressing BACE1 activity in cortical neurons. Neurosci Lett. 2013 Dec 17;557 Pt B:90-4. PMID: 24184877.

 

Bashir MI, Pathan MF, Raza SA, et al. Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan. Indian J Endocrinol Metab. 2012 Jul;16(4):503-7. PMID: 22837904.

 

Abdelmoneim AS, Hasenbank SE, Seubert JM, et al. Variations in tissue selectivity amongst insulin secretagogues: a systematic review. Diabetes Obes Metab. 2012 Feb;14(2):130-8. PMID: 21923736.

" Not dangerous goods.

LKT T6934 Trimebutine Maleate 1 g 40.7 L-type Ca2+ channel blocker, BK K+ channel modulator, potential opioid agonist. 3,4,5-Trimethoxybenzoic acid 2-(dimethylamino)- 2-phenylbutyl ester maleate Cerekinon; Debridat; Digerent; Foldox; Polibutin; Spabucol; Trimedat 34140-59-5 ≥96% 503.54 C22H29NO5 C4H4O4 CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C.C(=CC(=O)O)C(=O)O Ambient Ambient "Kountouras J, Sofianou D, Gavalas E, et al. Trimebutine as a potential antimicrobial agent: a preliminary in vitro approach. Hippokratia. 2012 Oct;16(4):347-9. PMID: 23935315.

 

Tan W, Zhang H, Luo HS, et al. Effects of trimebutine maleate on colonic motility through Ca²+-activated K+ channels and L-type Ca²+ channels. Arch Pharm Res. 2011 Jun;34(6):979-85. PMID: 21725819.

" None Not dangerous goods.

LKT T6934 Trimebutine Maleate 5 g 67.9 L-type Ca2+ channel blocker, BK K+ channel modulator, potential opioid agonist. 3,4,5-Trimethoxybenzoic acid 2-(dimethylamino)- 2-phenylbutyl ester maleate Cerekinon; Debridat; Digerent; Foldox; Polibutin; Spabucol; Trimedat 34140-59-5 ≥96% 503.54 C22H29NO5 C4H4O4 CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C.C(=CC(=O)O)C(=O)O Ambient Ambient "Kountouras J, Sofianou D, Gavalas E, et al. Trimebutine as a potential antimicrobial agent: a preliminary in vitro approach. Hippokratia. 2012 Oct;16(4):347-9. PMID: 23935315.

 

Tan W, Zhang H, Luo HS, et al. Effects of trimebutine maleate on colonic motility through Ca²+-activated K+ channels and L-type Ca²+ channels. Arch Pharm Res. 2011 Jun;34(6):979-85. PMID: 21725819.

" None Not dangerous goods.

LKT G4580 Glucosamine Hydrochloride 25 g 23.4 Endogenous amino sugar precursor required for production of cartilage. 2-Amino-2-deoxy-D-glucose hydrochloride D-Glucosamine HCl;2-Amino-2-deoxy-D-glucopyranose hydrochloride; Chitosamine hydrochloride 66-84-2 ≥96% 215.6 C6H13NO5 HCl C(C1C(C(C(C(O1)O)N)O)O)O.Cl Ambient Ambient Soluble in water. "Chesnokov V, Gong B, Sun C, et al. Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation. Cancer Cell Int. 2014 May 28;14:45. PMID: 24932134.

 

Park J, Lee SY, Ooshima A, et al. Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling. J Mol Med (Berl). 2013 Nov;91(11):1273-84. PMID: 24072041.

" Not dangerous goods.

LKT G4580 Glucosamine Hydrochloride 100 g 46.4 Endogenous amino sugar precursor required for production of cartilage. 2-Amino-2-deoxy-D-glucose hydrochloride D-Glucosamine HCl;2-Amino-2-deoxy-D-glucopyranose hydrochloride; Chitosamine hydrochloride 66-84-2 ≥96% 215.6 C6H13NO5 HCl C(C1C(C(C(C(O1)O)N)O)O)O.Cl Ambient Ambient Soluble in water. "Chesnokov V, Gong B, Sun C, et al. Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation. Cancer Cell Int. 2014 May 28;14:45. PMID: 24932134.

 

Park J, Lee SY, Ooshima A, et al. Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling. J Mol Med (Berl). 2013 Nov;91(11):1273-84. PMID: 24072041.

" Not dangerous goods.

LKT G4580 Glucosamine Hydrochloride 500 g 180.2 Endogenous amino sugar precursor required for production of cartilage. 2-Amino-2-deoxy-D-glucose hydrochloride D-Glucosamine HCl;2-Amino-2-deoxy-D-glucopyranose hydrochloride; Chitosamine hydrochloride 66-84-2 ≥96% 215.6 C6H13NO5 HCl C(C1C(C(C(C(O1)O)N)O)O)O.Cl Ambient Ambient Soluble in water. "Chesnokov V, Gong B, Sun C, et al. Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation. Cancer Cell Int. 2014 May 28;14:45. PMID: 24932134.

 

Park J, Lee SY, Ooshima A, et al. Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling. J Mol Med (Berl). 2013 Nov;91(11):1273-84. PMID: 24072041.

" Not dangerous goods.

LKT T6933 Trichostatin A 1 mg 291.1 HDAC inhibitor, mammalian RNA splicing modulator. [R-(E,E)[-7-[4-(Dimethylamino)phenyl]-N-hydroxy- 4,6-dimethyl-7-oxo-2,4-heptadienamide TSA 58880-19-6 ≥98% 302.37 C17H22N2O3 CC(C=C(C)C=CC(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C Blue Ice -20°C Soluble in lower alchols. Slightly soluble in chloroform, ethyl acetate, acetone and benzene. "Liu Y, He G, Wang Y, et al. MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells. Toxicol Lett. 2013 Jul 31;221(1):23-30. PMID: 23770000.

 

Doñas C, Fritz M, Manríquez V, et al. Trichostatin A promotes the generation and suppressive functions of regulatory T cells. Clin Dev Immunol. 2013;2013:679804. PMID: 23737814.

 

Cecconi D, Donadelli M, Rinalducci S,et al. Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. Proteomics. 2007 May;7(10):1644-53. PMID: 17443844." Xn, Xi Not dangerous goods.

LKT T6933 Trichostatin A 5 mg 1279.6 HDAC inhibitor, mammalian RNA splicing modulator. [R-(E,E)[-7-[4-(Dimethylamino)phenyl]-N-hydroxy- 4,6-dimethyl-7-oxo-2,4-heptadienamide TSA 58880-19-6 ≥98% 302.37 C17H22N2O3 CC(C=C(C)C=CC(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C Blue Ice -20°C Soluble in lower alchols. Slightly soluble in chloroform, ethyl acetate, acetone and benzene. "Liu Y, He G, Wang Y, et al. MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells. Toxicol Lett. 2013 Jul 31;221(1):23-30. PMID: 23770000.

 

Doñas C, Fritz M, Manríquez V, et al. Trichostatin A promotes the generation and suppressive functions of regulatory T cells. Clin Dev Immunol. 2013;2013:679804. PMID: 23737814.

 

Cecconi D, Donadelli M, Rinalducci S,et al. Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. Proteomics. 2007 May;7(10):1644-53. PMID: 17443844." Xn, Xi Not dangerous goods.

LKT G4581 Glucosamine Sulfate Potassium 100 g 56.3 Endogenous amino acid sugar involved in cartilage development. 2-Amino-2-deoxy-D-glucose sulfate salt Dona ≥96% 425.34 C6H14NO5SO4 2KCl Ambient Ambient Soluble in water. "Chesnokov V, Gong B, Sun C, et al. Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation. Cancer Cell Int. 2014 May 28;14:45. PMID: 24932134.

 

Park J, Lee SY, Ooshima A, et al. Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling. J Mol Med (Berl). 2013 Nov;91(11):1273-84. PMID: 24072041.

" Not dangerous goods.

LKT G4581 Glucosamine Sulfate Potassium 500 g 165.1 Endogenous amino acid sugar involved in cartilage development. 2-Amino-2-deoxy-D-glucose sulfate salt Dona ≥96% 425.34 C6H14NO5SO4 2KCl Ambient Ambient Soluble in water. "Chesnokov V, Gong B, Sun C, et al. Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation. Cancer Cell Int. 2014 May 28;14:45. PMID: 24932134.

 

Park J, Lee SY, Ooshima A, et al. Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling. J Mol Med (Berl). 2013 Nov;91(11):1273-84. PMID: 24072041.

" Not dangerous goods.

LKT G4581 Glucosamine Sulfate Potassium 1 kg 285 Endogenous amino acid sugar involved in cartilage development. 2-Amino-2-deoxy-D-glucose sulfate salt Dona ≥96% 425.34 C6H14NO5SO4 2KCl Ambient Ambient Soluble in water. "Chesnokov V, Gong B, Sun C, et al. Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation. Cancer Cell Int. 2014 May 28;14:45. PMID: 24932134.

 

Park J, Lee SY, Ooshima A, et al. Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling. J Mol Med (Berl). 2013 Nov;91(11):1273-84. PMID: 24072041.

" Not dangerous goods.

LKT T6932 Triflumizole 5 g 65.6 Imidazole; PPARγ agonist, RORγ inverse agonist, 14-α demethylase and aromatase inhibitor, ubiquitin/proteasome modulator. 68694-11-1 ≥95% 345.75 C15H15ClF3N3O CCCOCC(=NC1=C(C=C(C=C1)Cl)C(F)(F)F)N2C=CN=C2 Ambient 4°C "Rhodes SL, Fitzmaurice AG, Cockburn M, et al. Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson’s disease. Environ Res. 2013 Oct;126:1-8. PMID: 23988235.

 

Li X, Pham HT, Janesick AS, et al. Triflumizole is an obesogen in mice that acts through peroxisome proliferator activated receptor gamma (PPARγ). Environ Health Perspect. 2012 Dec;120(12):1720-6. PMID: 23086663.

 

Kojima H, Muromoto R, Takahashi M, et al. Inhibitory effects of azole-type fungicides on interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):338-45. PMID: 22289359.

 

Kjærstad MB, Taxvig C, Nellemann C, et al. Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. Reprod Toxicol. 2010 Dec;30(4):573-82. PMID: 20708073.

 

Shiga N, Matano O, Goto S. Residue analysis of triflumizole and its metabolite in crops by high-performance liquid chromatography. J Chromatogr. 1987 Jun 19;396:327-35. PMID: 3624378.

" "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Triflumizole)"

LKT T6932 Triflumizole 10 g 84.3 Imidazole; PPARγ agonist, RORγ inverse agonist, 14-α demethylase and aromatase inhibitor, ubiquitin/proteasome modulator. 68694-11-1 ≥95% 345.75 C15H15ClF3N3O CCCOCC(=NC1=C(C=C(C=C1)Cl)C(F)(F)F)N2C=CN=C2 Ambient 4°C "Rhodes SL, Fitzmaurice AG, Cockburn M, et al. Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson’s disease. Environ Res. 2013 Oct;126:1-8. PMID: 23988235.

 

Li X, Pham HT, Janesick AS, et al. Triflumizole is an obesogen in mice that acts through peroxisome proliferator activated receptor gamma (PPARγ). Environ Health Perspect. 2012 Dec;120(12):1720-6. PMID: 23086663.

 

Kojima H, Muromoto R, Takahashi M, et al. Inhibitory effects of azole-type fungicides on interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):338-45. PMID: 22289359.

 

Kjærstad MB, Taxvig C, Nellemann C, et al. Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. Reprod Toxicol. 2010 Dec;30(4):573-82. PMID: 20708073.

 

Shiga N, Matano O, Goto S. Residue analysis of triflumizole and its metabolite in crops by high-performance liquid chromatography. J Chromatogr. 1987 Jun 19;396:327-35. PMID: 3624378.

" "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Triflumizole)"

LKT T6932 Triflumizole 100 g 497 Imidazole; PPARγ agonist, RORγ inverse agonist, 14-α demethylase and aromatase inhibitor, ubiquitin/proteasome modulator. 68694-11-1 ≥95% 345.75 C15H15ClF3N3O CCCOCC(=NC1=C(C=C(C=C1)Cl)C(F)(F)F)N2C=CN=C2 Ambient 4°C "Rhodes SL, Fitzmaurice AG, Cockburn M, et al. Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson’s disease. Environ Res. 2013 Oct;126:1-8. PMID: 23988235.

 

Li X, Pham HT, Janesick AS, et al. Triflumizole is an obesogen in mice that acts through peroxisome proliferator activated receptor gamma (PPARγ). Environ Health Perspect. 2012 Dec;120(12):1720-6. PMID: 23086663.

 

Kojima H, Muromoto R, Takahashi M, et al. Inhibitory effects of azole-type fungicides on interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):338-45. PMID: 22289359.

 

Kjærstad MB, Taxvig C, Nellemann C, et al. Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. Reprod Toxicol. 2010 Dec;30(4):573-82. PMID: 20708073.

 

Shiga N, Matano O, Goto S. Residue analysis of triflumizole and its metabolite in crops by high-performance liquid chromatography. J Chromatogr. 1987 Jun 19;396:327-35. PMID: 3624378.

" "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Triflumizole)"

LKT T6903 Tranylcypromine Hydrochloride 250 mg 77.9 MAO and histone demethylase LD1 inhibitor. (1R,2S)-rel-2-Phenylcyclopropylamine hydrochloride SKF-385 1986-47-6 ≥98% 169.66 C9H11N HCl C1C(C1N)C2=CC=CC=C2.Cl Ambient -20°C "Lee MG, Wynder C, Schmidt DM, et al. Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol. 2006 Jun;13(6):563-7. PMID: 16793513.

 

Preskorn SH. Recent pharmacologic advances in antidepressant therapy for the elderly. Am J Med. 1993 May 24;94(5A):2S-12S. PMID: 8503477.

" Xn, Xi, T Not dangerous goods.

LKT T6903 Tranylcypromine Hydrochloride 1 g 213.3 MAO and histone demethylase SD1 inhibitor. (1R,2S)-rel-2-Phenylcyclopropylamine hydrochloride SKF-385 1986-47-6 ≥98% 169.66 C9H11N HCl C1C(C1N)C2=CC=CC=C2.Cl Ambient -20°C "Lee MG, Wynder C, Schmidt DM, et al. Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol. 2006 Jun;13(6):563-7. PMID: 16793513.

 

Preskorn SH. Recent pharmacologic advances in antidepressant therapy for the elderly. Am J Med. 1993 May 24;94(5A):2S-12S. PMID: 8503477.

" Xn, Xi, T Not dangerous goods.

LKT T6902 Tranilast 50 mg 88.3 Mast cell stabilizer; TRPV2 antagonist, PDGFR inhibitor. 2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]- amino]benzoic acid Rizaben; N-5' 53902-12-8 ≥98% 327.34 C18H17NO5 COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC In DMSO at +4 for 2 weeks at -80 for 6 months. Ambient Ambient DMSO to 100 mM, ethanol to 2 mg/mL, DMF to 35 mg/mL. "Luo J, Li Y, Yang Y, et al. Role and mechanism of tranilast preventing the progression of tubulointerstilial fibrosis in diabetic kidney diseases. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Dec;38(12):1233-42. PMID: 24384948.

 

Zaher SS, Coe D, Chai JG, et al. Suppression of the allogeneic response by the anti-allergy drug N-(3,4-dimethoxycinnamonyl) anthranilic acid results from T-cell cycle arrest. Immunology. 2013 Feb;138(2):157-64. PMID: 23121382.

 

Subramaniam V, Chakrabarti R, Prud'homme GJ, et al. Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer. Anticancer Drugs. 2010 Apr;21(4):351-61. PMID: 20145538.

 

Li Y, Liu FY, Peng YM, et al. Mast cell, a promising therapeutic target in tubulointerstitial fibrosis. Med Hypotheses. 2007;69(1):99-103. PMID: 17257770.

 

Watanabe S, Matsuda A, Suzuki Y, et al. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors. Br J Pharmacol. 2000 May;130(2):307-14. PMID: 10807667.

 

Koyama S, Takagi H, Otani A, et al. Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells. Br J Pharmacol. 1999 May;127(2):537-45. PMID: 10385256.

" Xn Not dangerous goods.

LKT T6902 Tranilast 100 mg 115.5 Mast cell stabilizer; TRPV2 antagonist, PDGFR inhibitor. 2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]- amino]benzoic acid Rizaben; N-5' 53902-12-8 ≥98% 327.34 C18H17NO5 COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC In DMSO at +4 for 2 weeks at -80 for 6 months. Ambient Ambient DMSO to 100 mM, ethanol to 2 mg/mL, DMF to 35 mg/mL. "Luo J, Li Y, Yang Y, et al. Role and mechanism of tranilast preventing the progression of tubulointerstilial fibrosis in diabetic kidney diseases. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Dec;38(12):1233-42. PMID: 24384948.

 

Zaher SS, Coe D, Chai JG, et al. Suppression of the allogeneic response by the anti-allergy drug N-(3,4-dimethoxycinnamonyl) anthranilic acid results from T-cell cycle arrest. Immunology. 2013 Feb;138(2):157-64. PMID: 23121382.

 

Subramaniam V, Chakrabarti R, Prud'homme GJ, et al. Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer. Anticancer Drugs. 2010 Apr;21(4):351-61. PMID: 20145538.

 

Li Y, Liu FY, Peng YM, et al. Mast cell, a promising therapeutic target in tubulointerstitial fibrosis. Med Hypotheses. 2007;69(1):99-103. PMID: 17257770.

 

Watanabe S, Matsuda A, Suzuki Y, et al. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors. Br J Pharmacol. 2000 May;130(2):307-14. PMID: 10807667.

 

Koyama S, Takagi H, Otani A, et al. Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells. Br J Pharmacol. 1999 May;127(2):537-45. PMID: 10385256.

" Xn Not dangerous goods.

LKT T6902 Tranilast 500 mg 339.8 Mast cell stabilizer; TRPV2 antagonist, PDGFR inhibitor. 2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]- amino]benzoic acid Rizaben; N-5' 53902-12-8 ≥98% 327.34 C18H17NO5 COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC In DMSO at +4 for 2 weeks at -80 for 6 months. Ambient Ambient DMSO to 100 mM, ethanol to 2 mg/mL, DMF to 35 mg/mL. "Luo J, Li Y, Yang Y, et al. Role and mechanism of tranilast preventing the progression of tubulointerstilial fibrosis in diabetic kidney diseases. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Dec;38(12):1233-42. PMID: 24384948.

 

Zaher SS, Coe D, Chai JG, et al. Suppression of the allogeneic response by the anti-allergy drug N-(3,4-dimethoxycinnamonyl) anthranilic acid results from T-cell cycle arrest. Immunology. 2013 Feb;138(2):157-64. PMID: 23121382.

 

Subramaniam V, Chakrabarti R, Prud'homme GJ, et al. Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer. Anticancer Drugs. 2010 Apr;21(4):351-61. PMID: 20145538.

 

Li Y, Liu FY, Peng YM, et al. Mast cell, a promising therapeutic target in tubulointerstitial fibrosis. Med Hypotheses. 2007;69(1):99-103. PMID: 17257770.

 

Watanabe S, Matsuda A, Suzuki Y, et al. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors. Br J Pharmacol. 2000 May;130(2):307-14. PMID: 10807667.

 

Koyama S, Takagi H, Otani A, et al. Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells. Br J Pharmacol. 1999 May;127(2):537-45. PMID: 10385256.

" Xn Not dangerous goods.

LKT T6834 Triacsin C 1 mg 843.9 Acyl-CoA synthetase inhibitor. 76896-80-5 ≥95% 207.27 C11H17N3O CCCC=CCC=CC=CC=NNN=O Ambient 4°C "Gauthier MS, Miyoshi H, Souza SC, et al. AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J Biol Chem. 2008 Jun 13;283(24):16514-24. PMID: 18390901.

 

Weis MT, Crumley JL, Young LH, et al. Inhibiting long chain fatty Acyl CoA synthetase increases basal and agonist-stimulated NO synthesis in endothelium. Cardiovasc Res. 2004 Aug 1;63(2):338-46. PMID: 15249192.

 

Igal RA, Wang P, Coleman RA. Triacsin C blocks de novo synthesis of glycerolipids and cholesterol esters but not recycling of fatty acid into phospholipid: evidence for functionally separate pools of acyl-CoA. Biochem J. 1997 Jun 1;324 ( Pt 2):529-34. PMID: 9182714.

" Not dangerous goods.

LKT T6834 Triacsin C 5 mg 3314.3 Acyl-CoA synthetase inhibitor. 76896-80-5 ≥95% 207.27 C11H17N3O CCCC=CCC=CC=CC=NNN=O Ambient 4°C "Gauthier MS, Miyoshi H, Souza SC, et al. AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J Biol Chem. 2008 Jun 13;283(24):16514-24. PMID: 18390901.

 

Weis MT, Crumley JL, Young LH, et al. Inhibiting long chain fatty Acyl CoA synthetase increases basal and agonist-stimulated NO synthesis in endothelium. Cardiovasc Res. 2004 Aug 1;63(2):338-46. PMID: 15249192.

 

Igal RA, Wang P, Coleman RA. Triacsin C blocks de novo synthesis of glycerolipids and cholesterol esters but not recycling of fatty acid into phospholipid: evidence for functionally separate pools of acyl-CoA. Biochem J. 1997 Jun 1;324 ( Pt 2):529-34. PMID: 9182714.

" Not dangerous goods.

LKT G4596 Glycidamide 10 mg 165.5 Epoxide metabolite of acrylamide, induces DNA adduct formation; carcinogen. Oxirane-2-Carboxamide 5694-00-8 ≥98% 87.08 C3H5NO2 C1C(O1)C(=O)N Ambient -20°C "Von Tungeln LS, Doerge DR, Gamboa da Costa G, et al. Tumorigenicity of acrylamide and its metabolite glycidamide in the neonatal mouse bioassay. Int J Cancer. 2012 Nov 1;131(9):2008-15. PMID: 22336951.

 

Von Tungeln LS, Churchwell MI, Doerge DR, et al. DNA adduct formation and induction of micronuclei and mutations in B6C3F1/Tk mice treated neonatally with acrylamide or glycidamide. Int J Cancer. 2009 May 1;124(9):2006-15. PMID: 19123476.

" Not dangerous goods.

LKT T6832 Triamcinolone Acetonide 50 mg 33.1 Synthetic steroid; glucocorticoid agonist. 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone Adcortyl; AristocortR; Delphicort; Extracort; NasacortR 76-25-5 ≥98% 343.5 C24H31FO6 CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C Ambient Ambient Sparingly soluble in methanol, acetone or ethyl acetate. "Zhou H, Yang L, Li H, et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine. 2012;7:4649-60. PMID: 22942646.

 

McAllister IL, Vijayasekaran S, Chen SD, et al. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. PMID: 19211093.

 

Mizuno D, Matsubara A, Ogura Y. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 2008 May;49(5):2127-33. PMID: 18436845.

" Repr. Not dangerous goods.

LKT G4596 Glycidamide 25 mg 267 Epoxide metabolite of acrylamide, induces DNA adduct formation; carcinogen. Oxirane-2-Carboxamide 5694-00-8 ≥98% 87.08 C3H5NO2 C1C(O1)C(=O)N Ambient -20°C "Von Tungeln LS, Doerge DR, Gamboa da Costa G, et al. Tumorigenicity of acrylamide and its metabolite glycidamide in the neonatal mouse bioassay. Int J Cancer. 2012 Nov 1;131(9):2008-15. PMID: 22336951.

 

Von Tungeln LS, Churchwell MI, Doerge DR, et al. DNA adduct formation and induction of micronuclei and mutations in B6C3F1/Tk mice treated neonatally with acrylamide or glycidamide. Int J Cancer. 2009 May 1;124(9):2006-15. PMID: 19123476.

" Not dangerous goods.

LKT G4596 Glycidamide 100 mg 826.1 Epoxide metabolite of acrylamide, induces DNA adduct formation; carcinogen. Oxirane-2-Carboxamide 5694-00-8 ≥98% 87.08 C3H5NO2 C1C(O1)C(=O)N Ambient -20°C "Von Tungeln LS, Doerge DR, Gamboa da Costa G, et al. Tumorigenicity of acrylamide and its metabolite glycidamide in the neonatal mouse bioassay. Int J Cancer. 2012 Nov 1;131(9):2008-15. PMID: 22336951.

 

Von Tungeln LS, Churchwell MI, Doerge DR, et al. DNA adduct formation and induction of micronuclei and mutations in B6C3F1/Tk mice treated neonatally with acrylamide or glycidamide. Int J Cancer. 2009 May 1;124(9):2006-15. PMID: 19123476.

" Not dangerous goods.

LKT T6832 Triamcinolone Acetonide 250 mg 88.1 Synthetic steroid; glucocorticoid agonist. 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone Adcortyl; AristocortR; Delphicort; Extracort; NasacortR 76-25-5 ≥98% 343.5 C24H31FO6 CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C Ambient Ambient Sparingly soluble in methanol, acetone or ethyl acetate. "Zhou H, Yang L, Li H, et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine. 2012;7:4649-60. PMID: 22942646.

 

McAllister IL, Vijayasekaran S, Chen SD, et al. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. PMID: 19211093.

 

Mizuno D, Matsubara A, Ogura Y. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 2008 May;49(5):2127-33. PMID: 18436845.

" Repr. Not dangerous goods.

LKT T6832 Triamcinolone Acetonide 1 g 233.3 Synthetic steroid; glucocorticoid agonist. 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone Adcortyl; AristocortR; Delphicort; Extracort; NasacortR 76-25-5 ≥98% 343.5 C24H31FO6 CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C Ambient Ambient Sparingly soluble in methanol, acetone or ethyl acetate. "Zhou H, Yang L, Li H, et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine. 2012;7:4649-60. PMID: 22942646.

 

McAllister IL, Vijayasekaran S, Chen SD, et al. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. PMID: 19211093.

 

Mizuno D, Matsubara A, Ogura Y. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 2008 May;49(5):2127-33. PMID: 18436845.

" Repr. Not dangerous goods.

LKT T6832 Triamcinolone Acetonide 5 g 823.4 Synthetic steroid; glucocorticoid agonist. 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone Adcortyl; AristocortR; Delphicort; Extracort; NasacortR 76-25-5 ≥98% 343.5 C24H31FO6 CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C Ambient Ambient Sparingly soluble in methanol, acetone or ethyl acetate. "Zhou H, Yang L, Li H, et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine. 2012;7:4649-60. PMID: 22942646.

 

McAllister IL, Vijayasekaran S, Chen SD, et al. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol. 2009 May;147(5):838-46, 846.e1-2. PMID: 19211093.

 

Mizuno D, Matsubara A, Ogura Y. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation. Invest Ophthalmol Vis Sci. 2008 May;49(5):2127-33. PMID: 18436845.

" Repr. Not dangerous goods.

LKT T6831 Triadimenol 10 g 72.7 Triadimefon metabolite; mutagen. β-(4-Chlorophenoxy)-α-(1,1-dimethylethyl)-1H-1,2,4- triazole-1-ethanol, (1RS, 2RS, 1RS, 2RS)-1-(4-Chlorohenoxy)-3,3-dimethyl-1-(1H-1,2,4 triazol-1-yl)butan-2-ol Bayfidan; Baytan; Spinnker; Summit 55219-65-3 ≥96% 295.76 C14H18ClN3O2 CC(C)(C)C(C(N1C=NC=N1)OC2=CC=C(C=C2)Cl)O Ambient Ambient Soluble in water (0.012 g/100 g), alcohol or ketones. "Xi J, Yang Z, Zeng C, et al. Suppressive effect of triadimefon, a triazole fungicide, on spatial learning and reference memory in rats. Behav Pharmacol. 2012 Dec;23(8):727-34. PMID: 23080312.

 

Di Renzo F, Broccia ML, Giavini E, et al. Stage-dependent abnormalities induced by the fungicide triadimefon in the mouse. Reprod Toxicol. 2011 Feb;31(2):194-9. PMID: 21055463.

 

Berg D, Draber W, von Hugo H, et al. The effect of clotrimazole and triadimefon on 3-hydroxy-3-methyl-glutaryl-CoA-reductase-[EC 1.1.1.34]-activity in Saccharomyces cerevisiae. Z Naturforsch C. 1981 Sep-Oct;36(9-10):798-803. PMID: 7029940.

" Xn Not dangerous goods.

LKT T6831 Triadimenol 25 g 150 Triadimefon metabolite; mutagen. β-(4-Chlorophenoxy)-α-(1,1-dimethylethyl)-1H-1,2,4- triazole-1-ethanol, (1RS, 2RS, 1RS, 2RS)-1-(4-Chlorohenoxy)-3,3-dimethyl-1-(1H-1,2,4 triazol-1-yl)butan-2-ol Bayfidan; Baytan; Spinnker; Summit 55219-65-3 ≥96% 295.76 C14H18ClN3O2 CC(C)(C)C(C(N1C=NC=N1)OC2=CC=C(C=C2)Cl)O Ambient Ambient Soluble in water (0.012 g/100 g), alcohol or ketones. "Xi J, Yang Z, Zeng C, et al. Suppressive effect of triadimefon, a triazole fungicide, on spatial learning and reference memory in rats. Behav Pharmacol. 2012 Dec;23(8):727-34. PMID: 23080312.

 

Di Renzo F, Broccia ML, Giavini E, et al. Stage-dependent abnormalities induced by the fungicide triadimefon in the mouse. Reprod Toxicol. 2011 Feb;31(2):194-9. PMID: 21055463.

 

Berg D, Draber W, von Hugo H, et al. The effect of clotrimazole and triadimefon on 3-hydroxy-3-methyl-glutaryl-CoA-reductase-[EC 1.1.1.34]-activity in Saccharomyces cerevisiae. Z Naturforsch C. 1981 Sep-Oct;36(9-10):798-803. PMID: 7029940.

" Xn Not dangerous goods.

LKT T6831 Triadimenol 100 g 479.4 Triadimefon metabolite; mutagen. β-(4-Chlorophenoxy)-α-(1,1-dimethylethyl)-1H-1,2,4- triazole-1-ethanol, (1RS, 2RS, 1RS, 2RS)-1-(4-Chlorohenoxy)-3,3-dimethyl-1-(1H-1,2,4 triazol-1-yl)butan-2-ol Bayfidan; Baytan; Spinnker; Summit 55219-65-3 ≥96% 295.76 C14H18ClN3O2 CC(C)(C)C(C(N1C=NC=N1)OC2=CC=C(C=C2)Cl)O Ambient Ambient Soluble in water (0.012 g/100 g), alcohol or ketones. "Xi J, Yang Z, Zeng C, et al. Suppressive effect of triadimefon, a triazole fungicide, on spatial learning and reference memory in rats. Behav Pharmacol. 2012 Dec;23(8):727-34. PMID: 23080312.

 

Di Renzo F, Broccia ML, Giavini E, et al. Stage-dependent abnormalities induced by the fungicide triadimefon in the mouse. Reprod Toxicol. 2011 Feb;31(2):194-9. PMID: 21055463.

 

Berg D, Draber W, von Hugo H, et al. The effect of clotrimazole and triadimefon on 3-hydroxy-3-methyl-glutaryl-CoA-reductase-[EC 1.1.1.34]-activity in Saccharomyces cerevisiae. Z Naturforsch C. 1981 Sep-Oct;36(9-10):798-803. PMID: 7029940.

" Xn Not dangerous goods.

LKT G4634 Glipizide 500 mg 47.6 Sulfonylurea; ATP-sensitive K+ channel blocker. N-[2-[4-[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl-5-methylpyrazinecarboxamide "Glibenese; Blucotrol; Minidiab; Ozidia

 

" 29094-61-9 ≥98% 445.54 C21H27N5O4S CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3 Ambient Ambient Soluble in DMSO (48mg/mL) or methanol (1.9mg/mL).. "Barzilai N, Groop PH, Groop L, et al. A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin. Acta Diabetol. 1995 Dec;32(4):273-8. PMID: 8750768.

 

Weinhaus AJ, Poronnik P, Cook DI, et al. Insulin secretagogues, but not glucose, stimulate an increase in [Ca2+]i in the fetal rat beta-cell. Diabetes. 1995 Jan;44(1):118-24. PMID: 7529202.

 

Heurteaux C, Bertaina V, Widmann C, et al. K+ channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein, and amyloid beta-protein precursor genes and neuronal death in rat hippocampus. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9431-5. PMID: 8415718.

" None Not dangerous goods.

LKT G4634 Glipizide 1 g 81.6 Sulfonylurea; ATP-sensitive K+ channel blocker. N-[2-[4-[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl-5-methylpyrazinecarboxamide "Glibenese; Blucotrol; Minidiab; Ozidia

 

" 29094-61-9 ≥98% 445.54 C21H27N5O4S CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3 Ambient Ambient Soluble in DMSO (48mg/mL) or methanol (1.9mg/mL).. "Barzilai N, Groop PH, Groop L, et al. A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin. Acta Diabetol. 1995 Dec;32(4):273-8. PMID: 8750768.

 

Weinhaus AJ, Poronnik P, Cook DI, et al. Insulin secretagogues, but not glucose, stimulate an increase in [Ca2+]i in the fetal rat beta-cell. Diabetes. 1995 Jan;44(1):118-24. PMID: 7529202.

 

Heurteaux C, Bertaina V, Widmann C, et al. K+ channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein, and amyloid beta-protein precursor genes and neuronal death in rat hippocampus. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9431-5. PMID: 8415718.

" None Not dangerous goods.

LKT G4634 Glipizide 5 g 237.8 Sulfonylurea; ATP-sensitive K+ channel blocker. N-[2-[4-[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl-5-methylpyrazinecarboxamide "Glibenese; Blucotrol; Minidiab; Ozidia

 

" 29094-61-9 ≥98% 445.54 C21H27N5O4S CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3 Ambient Ambient Soluble in DMSO (48mg/mL) or methanol (1.9mg/mL).. "Barzilai N, Groop PH, Groop L, et al. A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin. Acta Diabetol. 1995 Dec;32(4):273-8. PMID: 8750768.

 

Weinhaus AJ, Poronnik P, Cook DI, et al. Insulin secretagogues, but not glucose, stimulate an increase in [Ca2+]i in the fetal rat beta-cell. Diabetes. 1995 Jan;44(1):118-24. PMID: 7529202.

 

Heurteaux C, Bertaina V, Widmann C, et al. K+ channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein, and amyloid beta-protein precursor genes and neuronal death in rat hippocampus. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9431-5. PMID: 8415718.

" None Not dangerous goods.

LKT G4796 Glycerol Monolaurate 25 g 100.5 Surfactant found in coconut oil. 142-18-7 ≥98% 274.4 C15H30O4 CCCCCCCCCCCC(=O)OCC(CO)O Ambient Ambient "Schlievert PM, Peterson ML. Glycerol monolaurate antibacterial activity in broth and biofilm cultures. PLoS One. 2012;7(7):e40350. PMID: 22808139.

 

Strandberg KL, Peterson ML, Lin YC, et al. Glycerol monolaurate inhibits Candida and Gardnerella vaginalis in vitro and in vivo but not Lactobacillus. Antimicrob Agents Chemother. 2010 Feb;54(2):597-601. PMID: 20008774.

 

Strandberg KL, Peterson ML, Schaefers MM, et al. Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels ue to glycerol monolaurate in tampons. Clin Infect Dis. 2009 Dec 1;49(11):1711-7. PMID: 19863450.

 

Lin YC, Schlievert PM, Anderson MJ, et al. Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo. PLoS One. 2009 Oct 19;4(10):e7499. PMID: 19838303.

 

Li Q, Estes JD, Schlievert PM, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature. 2009 Apr 23;458(7241):1034-8. PMID: 19262509.

" Xn, T Not dangerous goods.

LKT G4796 Glycerol Monolaurate 100 g 335 Surfactant found in coconut oil. 142-18-7 ≥98% 274.4 C15H30O4 CCCCCCCCCCCC(=O)OCC(CO)O Ambient Ambient "Schlievert PM, Peterson ML. Glycerol monolaurate antibacterial activity in broth and biofilm cultures. PLoS One. 2012;7(7):e40350. PMID: 22808139.

 

Strandberg KL, Peterson ML, Lin YC, et al. Glycerol monolaurate inhibits Candida and Gardnerella vaginalis in vitro and in vivo but not Lactobacillus. Antimicrob Agents Chemother. 2010 Feb;54(2):597-601. PMID: 20008774.

 

Strandberg KL, Peterson ML, Schaefers MM, et al. Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels ue to glycerol monolaurate in tampons. Clin Infect Dis. 2009 Dec 1;49(11):1711-7. PMID: 19863450.

 

Lin YC, Schlievert PM, Anderson MJ, et al. Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo. PLoS One. 2009 Oct 19;4(10):e7499. PMID: 19838303.

 

Li Q, Estes JD, Schlievert PM, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature. 2009 Apr 23;458(7241):1034-8. PMID: 19262509.

" Xn, T Not dangerous goods.

LKT G5772 Goserelin Acetate 1 mg 225 Peptide; GnRH agonist. 145781-92-6 ≥95% 1329.48 C59H84N18O14 C2H4O2 CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O Ambient -20°C "Detti L, Uhlmann RA, Zhang J, et al. Goserelin fosters bone elongation but does not prevent ovarian damage in cyclophosphamide-treated prepubertal mice. Fertil Steril. 2014 Jan 23. pii: S0015-0282(13)03460-2. [Epub ahead of print]. PMID: 24462062.

 

Zhang Y, Ding JX, Tao X, et al. Goserelin can inhibit ovarian cancer proliferation and simultaneously protect ovarian function from cisplatin: an in vitro and in vivo study. J Chemother. 2013 Apr;25(2):96-103. PMID: 23684357.

 

Wells A, Souto JC, Solava J, et al. Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling. Clin Cancer Res. 2002 Apr;8(4):1251-7. PMID: 11948140.

" Not dangerous goods.

LKT G5772 Goserelin Acetate 2.5 mg 375.1 Peptide; GnRH agonist. 145781-92-6 ≥95% 1329.48 C59H84N18O14 C2H4O2 CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O Ambient -20°C "Detti L, Uhlmann RA, Zhang J, et al. Goserelin fosters bone elongation but does not prevent ovarian damage in cyclophosphamide-treated prepubertal mice. Fertil Steril. 2014 Jan 23. pii: S0015-0282(13)03460-2. [Epub ahead of print]. PMID: 24462062.

 

Zhang Y, Ding JX, Tao X, et al. Goserelin can inhibit ovarian cancer proliferation and simultaneously protect ovarian function from cisplatin: an in vitro and in vivo study. J Chemother. 2013 Apr;25(2):96-103. PMID: 23684357.

 

Wells A, Souto JC, Solava J, et al. Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling. Clin Cancer Res. 2002 Apr;8(4):1251-7. PMID: 11948140.

" Not dangerous goods.

LKT G5874 Gossypol 25 mg 47.6 Polyphenol found in Gossypium; calcineurin and PKC inhibitor. 1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1- methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde 2,2'-bis(8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene) 303-45-7 ≥98% 518.55 C30H30O8 CC1=C(C(=C2C(=C1)C(=C(C(=C2C=O)O)O)C(C)C)O)C3=C(C=C4C(=C3O)C(=C(C(=C4C(C)C)O)O)C=O)C Ambient 4°C Soluble in DMSO, methanol  or ethanol. Insoluble in water. "Jang GH, Lee M. BH3-mimetic gossypol-induced autophagic cell death in mutant BRAF melanoma cells with high expression of p21Cip¹.). Life Sci. 2014 Apr 25;102(1):41-8. PMID: 24625733.

 

Song B, Huang G, Tong C, et al. Gossypol suppresses mouse T lymphocytes via inhibition of NFκB, NFAT and AP-1 pathways. Immunopharmacol Immunotoxicol. 2013 Oct;35(5):615-21. PMID: 23981004.

 

Lin J, Wu Y, Yang D, et al. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo. Oncol Rep. 2013 Aug;30(2):731-8. PMID: 23708869.

 

Yang J, Chen G, Li LL, et al. Synthesis and anti-H5N1 activity of chiral gossypol derivatives and its analogs implicated by a viral entry blocking mechanism. Bioorg Med Chem Lett. 2013 May 1;23(9):2619-23. PMID: 23538114.

 

Coutinho EM. Gossypol: a contraceptive for men. Contraception. 2002 Apr;65(4):259-63. PMID: 12020773.

 

Polsky B, Segal SJ, Baron PA, et al. Inactivation of human immunodeficiency virus in vitro by gossypol. Contraception. 1989 Jun;39(6):579-87. PMID: 2473865.

 

Volate SR, Kawasaki BT, Hurt EM, et al. Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells. Mol Cancer Ther. 2010 Feb;9(2):461-470. PMID: 20124455.

" Xn Not dangerous goods.

LKT G5874 Gossypol 100 mg 115.5 Polyphenol found in Gossypium; calcineurin and PKC inhibitor. 1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1- methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde 2,2'-bis(8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene) 303-45-7 ≥98% 518.55 C30H30O8 CC1=C(C(=C2C(=C1)C(=C(C(=C2C=O)O)O)C(C)C)O)C3=C(C=C4C(=C3O)C(=C(C(=C4C(C)C)O)O)C=O)C Ambient 4°C Soluble in DMSO, methanol  or ethanol. Insoluble in water. "Jang GH, Lee M. BH3-mimetic gossypol-induced autophagic cell death in mutant BRAF melanoma cells with high expression of p21Cip¹.). Life Sci. 2014 Apr 25;102(1):41-8. PMID: 24625733.

 

Song B, Huang G, Tong C, et al. Gossypol suppresses mouse T lymphocytes via inhibition of NFκB, NFAT and AP-1 pathways. Immunopharmacol Immunotoxicol. 2013 Oct;35(5):615-21. PMID: 23981004.

 

Lin J, Wu Y, Yang D, et al. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo. Oncol Rep. 2013 Aug;30(2):731-8. PMID: 23708869.

 

Yang J, Chen G, Li LL, et al. Synthesis and anti-H5N1 activity of chiral gossypol derivatives and its analogs implicated by a viral entry blocking mechanism. Bioorg Med Chem Lett. 2013 May 1;23(9):2619-23. PMID: 23538114.

 

Coutinho EM. Gossypol: a contraceptive for men. Contraception. 2002 Apr;65(4):259-63. PMID: 12020773.

 

Polsky B, Segal SJ, Baron PA, et al. Inactivation of human immunodeficiency virus in vitro by gossypol. Contraception. 1989 Jun;39(6):579-87. PMID: 2473865.

 

Volate SR, Kawasaki BT, Hurt EM, et al. Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells. Mol Cancer Ther. 2010 Feb;9(2):461-470. PMID: 20124455.

" Xn Not dangerous goods.

LKT G5874 Gossypol 250 mg 224.3 Polyphenol found in Gossypium; calcineurin and PKC inhibitor. 1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1- methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde 2,2'-bis(8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene) 303-45-7 ≥98% 518.55 C30H30O8 CC1=C(C(=C2C(=C1)C(=C(C(=C2C=O)O)O)C(C)C)O)C3=C(C=C4C(=C3O)C(=C(C(=C4C(C)C)O)O)C=O)C Ambient 4°C Soluble in DMSO, methanol  or ethanol. Insoluble in water. "Jang GH, Lee M. BH3-mimetic gossypol-induced autophagic cell death in mutant BRAF melanoma cells with high expression of p21Cip¹.). Life Sci. 2014 Apr 25;102(1):41-8. PMID: 24625733.

 

Song B, Huang G, Tong C, et al. Gossypol suppresses mouse T lymphocytes via inhibition of NFκB, NFAT and AP-1 pathways. Immunopharmacol Immunotoxicol. 2013 Oct;35(5):615-21. PMID: 23981004.

 

Lin J, Wu Y, Yang D, et al. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo. Oncol Rep. 2013 Aug;30(2):731-8. PMID: 23708869.

 

Yang J, Chen G, Li LL, et al. Synthesis and anti-H5N1 activity of chiral gossypol derivatives and its analogs implicated by a viral entry blocking mechanism. Bioorg Med Chem Lett. 2013 May 1;23(9):2619-23. PMID: 23538114.

 

Coutinho EM. Gossypol: a contraceptive for men. Contraception. 2002 Apr;65(4):259-63. PMID: 12020773.

 

Polsky B, Segal SJ, Baron PA, et al. Inactivation of human immunodeficiency virus in vitro by gossypol. Contraception. 1989 Jun;39(6):579-87. PMID: 2473865.

 

Volate SR, Kawasaki BT, Hurt EM, et al. Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells. Mol Cancer Ther. 2010 Feb;9(2):461-470. PMID: 20124455.

" Xn Not dangerous goods.

LKT G6000 Glycoprotein 38 1 mg 396.1 Transmembrane O-glycoprotein. Podoplanin; gp38 ≥95% 3054.53 C133H209N41O38S2 Ambient -20°C "Herzog BH, Fu J, Wilson SJ, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature. 2013 Oct 3;502(7469):105-9. PMID: 23995678.

 

Krishnan H, Ochoa-Alvarez JA, Shen Y, et al. Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility. J Biol Chem. 2013 Apr 26;288(17):12215-21. PMID: 23530051.

 

Konishi S, Yasuchika K, Ishii T, et al. A transmembrane glycoprotein, gp38, is a novel marker for immature hepatic progenitor cells in fetal mouse livers. In Vitro Cell Dev Biol Anim. 2011 Jan;47(1):45-53. PMID: 21104040.

 

Uhrin P, Zaujec J, Breuss JM, et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood. 2010 May 13;115(19):3997-4005. PMID: 20110424.

" Not dangerous goods.

LKT G6000 Glycoprotein 38 2 mg 672.2 Transmembrane O-glycoprotein. Podoplanin; gp38 ≥95% 3054.53 C133H209N41O38S2 Ambient -20°C "Herzog BH, Fu J, Wilson SJ, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature. 2013 Oct 3;502(7469):105-9. PMID: 23995678.

 

Krishnan H, Ochoa-Alvarez JA, Shen Y, et al. Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility. J Biol Chem. 2013 Apr 26;288(17):12215-21. PMID: 23530051.

 

Konishi S, Yasuchika K, Ishii T, et al. A transmembrane glycoprotein, gp38, is a novel marker for immature hepatic progenitor cells in fetal mouse livers. In Vitro Cell Dev Biol Anim. 2011 Jan;47(1):45-53. PMID: 21104040.

 

Uhrin P, Zaujec J, Breuss JM, et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood. 2010 May 13;115(19):3997-4005. PMID: 20110424.

" Not dangerous goods.

LKT G6000 Glycoprotein 38 5 mg 1188.1 Transmembrane O-glycoprotein. Podoplanin; gp38 ≥95% 3054.53 C133H209N41O38S2 Ambient -20°C "Herzog BH, Fu J, Wilson SJ, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature. 2013 Oct 3;502(7469):105-9. PMID: 23995678.

 

Krishnan H, Ochoa-Alvarez JA, Shen Y, et al. Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility. J Biol Chem. 2013 Apr 26;288(17):12215-21. PMID: 23530051.

 

Konishi S, Yasuchika K, Ishii T, et al. A transmembrane glycoprotein, gp38, is a novel marker for immature hepatic progenitor cells in fetal mouse livers. In Vitro Cell Dev Biol Anim. 2011 Jan;47(1):45-53. PMID: 21104040.

 

Uhrin P, Zaujec J, Breuss JM, et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood. 2010 May 13;115(19):3997-4005. PMID: 20110424.

" Not dangerous goods.

LKT G6368 GPR 25 mg 216.1 Peptide, fibrinogen E analog found in Amaranthus; fibrin assembly inhibitor. 47295-77-2 ≥95% 328.18 C13H24N6O4 C1CC(N(C1)C(=O)CN)C(=O)NC(CCCN=C(N)N)C(=O)O Ambient -20°C "Montoya-Rodríguez A, de Mejía EG, Dia VP, et al. Extrusion improved the anti-inflammatory effect of amaranth (Amaranthus hypochondriacus) hydrolysates in LPS-induced human THP-1 macrophage-like and mouse RAW 264.7 macrophages by preventing activation of NF-κB signaling. Mol Nutr Food Res. 2014 Jan 15. [Epub ahead of print]. PMID: 24431078.

 

Zhou B, Li CL, Hao YQ, et al. Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro. Bioorg Med Chem. 2013 Jan 15;21(2):395-402. PMID: 23245572.

 

Ioudina M, Uemura E. A three amino acid peptide, Gly-Pro-Arg, protects and rescues cell death induced by amyloid beta-peptide. Exp Neurol. 2003 Dec;184(2):923-9. PMID: 14769384.

 

Lorand L, Parameswaran KN, Murthy SN. A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):537-41. PMID: 9435227.

 

Nonaka I, Katsuda S, Ohmori T, et al. In vitro and in vivo anti-platelet effects of enzymatic hydrolysates of collagen and collagen-related peptides. Biosci Biotechnol Biochem. 1997 May;61(5):772-5. PMID: 9178551.

"

LKT G6368 GPR 10 mg 123.1 Peptide, fibrinogen E analog found in Amaranthus; fibrin assembly inhibitor. 47295-77-2 ≥95% 328.18 C13H24N6O4 C1CC(N(C1)C(=O)CN)C(=O)NC(CCCN=C(N)N)C(=O)O Ambient -20°C "Montoya-Rodríguez A, de Mejía EG, Dia VP, et al. Extrusion improved the anti-inflammatory effect of amaranth (Amaranthus hypochondriacus) hydrolysates in LPS-induced human THP-1 macrophage-like and mouse RAW 264.7 macrophages by preventing activation of NF-κB signaling. Mol Nutr Food Res. 2014 Jan 15. [Epub ahead of print]. PMID: 24431078.

 

Zhou B, Li CL, Hao YQ, et al. Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro. Bioorg Med Chem. 2013 Jan 15;21(2):395-402. PMID: 23245572.

 

Ioudina M, Uemura E. A three amino acid peptide, Gly-Pro-Arg, protects and rescues cell death induced by amyloid beta-peptide. Exp Neurol. 2003 Dec;184(2):923-9. PMID: 14769384.

 

Lorand L, Parameswaran KN, Murthy SN. A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):537-41. PMID: 9435227.

 

Nonaka I, Katsuda S, Ohmori T, et al. In vitro and in vivo anti-platelet effects of enzymatic hydrolysates of collagen and collagen-related peptides. Biosci Biotechnol Biochem. 1997 May;61(5):772-5. PMID: 9178551.

"

LKT G6368 GPR 5 mg 72.1 Peptide, fibrinogen E analog found in Amaranthus; fibrin assembly inhibitor. 47295-77-2 ≥95% 328.18 C13H24N6O4 C1CC(N(C1)C(=O)CN)C(=O)NC(CCCN=C(N)N)C(=O)O Ambient -20°C "Montoya-Rodríguez A, de Mejía EG, Dia VP, et al. Extrusion improved the anti-inflammatory effect of amaranth (Amaranthus hypochondriacus) hydrolysates in LPS-induced human THP-1 macrophage-like and mouse RAW 264.7 macrophages by preventing activation of NF-κB signaling. Mol Nutr Food Res. 2014 Jan 15. [Epub ahead of print]. PMID: 24431078.

 

Zhou B, Li CL, Hao YQ, et al. Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro. Bioorg Med Chem. 2013 Jan 15;21(2):395-402. PMID: 23245572.

 

Ioudina M, Uemura E. A three amino acid peptide, Gly-Pro-Arg, protects and rescues cell death induced by amyloid beta-peptide. Exp Neurol. 2003 Dec;184(2):923-9. PMID: 14769384.

 

Lorand L, Parameswaran KN, Murthy SN. A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):537-41. PMID: 9435227.

 

Nonaka I, Katsuda S, Ohmori T, et al. In vitro and in vivo anti-platelet effects of enzymatic hydrolysates of collagen and collagen-related peptides. Biosci Biotechnol Biochem. 1997 May;61(5):772-5. PMID: 9178551.

"

LKT G6400 Glycylglutamine 5 mg 72.1 Endogenous dipeptide, beta-endorphin derivative. GQ 13115-71-4 ≥95% 203.2 C7H13N3O4 C(CC(=O)N)C(C(=O)O)NC(=O)CN Ambient -20°C "Zhang Y, Yan H, Lv SG, et al. Effects of glycyl-glutamine dipeptide supplementation on myocardial damage and cardiac function in rats after severe burn injury. Int J Clin Exp Pathol. 2013 Apr 15;6(5):821-30. PMID: 23638213.

 

Jiang JW, Ren ZG, Chen LY, et al. Enteral supplementation with glycyl-glutamine improves intestinal barrier function after liver transplantation in rats. Hepatobiliary Pancreat Dis Int. 2011 Aug;10(4):380-5. PMID: 21813386.

 

Basaran NF, Buyukuysal RL, Millington WR, et al. Glycyl-glutamine (beta-endorphin(30-31)) inhibits morphine-induced dopamine efflux in the nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol. 2010 May;381(5):467-75. PMID: 20349045.

 

Göktalay G, Cavun S, Levendusky MC, et al. Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal. Eur J Pharmacol. 2006 Jan 13;530(1-2):95-102. PMID: 16364288.

 

Resch GE, Millington WR. Inhibition of interleukin-1beta and prostaglandin E(2) thermogenesis by glycyl-glutamine, a pro-opiomelanocortin-derived peptide. Brain Res. 2001 Mar 16;894(2):316-20. PMID: 11251208.

" Xi Not dangerous goods.

LKT G6400 Glycylglutamine 10 mg 123.1 Endogenous dipeptide, beta-endorphin derivative. GQ 13115-71-4 ≥95% 203.2 C7H13N3O4 C(CC(=O)N)C(C(=O)O)NC(=O)CN Ambient -20°C "Zhang Y, Yan H, Lv SG, et al. Effects of glycyl-glutamine dipeptide supplementation on myocardial damage and cardiac function in rats after severe burn injury. Int J Clin Exp Pathol. 2013 Apr 15;6(5):821-30. PMID: 23638213.

 

Jiang JW, Ren ZG, Chen LY, et al. Enteral supplementation with glycyl-glutamine improves intestinal barrier function after liver transplantation in rats. Hepatobiliary Pancreat Dis Int. 2011 Aug;10(4):380-5. PMID: 21813386.

 

Basaran NF, Buyukuysal RL, Millington WR, et al. Glycyl-glutamine (beta-endorphin(30-31)) inhibits morphine-induced dopamine efflux in the nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol. 2010 May;381(5):467-75. PMID: 20349045.

 

Göktalay G, Cavun S, Levendusky MC, et al. Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal. Eur J Pharmacol. 2006 Jan 13;530(1-2):95-102. PMID: 16364288.

 

Resch GE, Millington WR. Inhibition of interleukin-1beta and prostaglandin E(2) thermogenesis by glycyl-glutamine, a pro-opiomelanocortin-derived peptide. Brain Res. 2001 Mar 16;894(2):316-20. PMID: 11251208.

" Xi Not dangerous goods.

LKT G6400 Glycylglutamine 25 mg 216.1 Endogenous dipeptide, beta-endorphin derivative. GQ 13115-71-4 ≥95% 203.2 C7H13N3O4 C(CC(=O)N)C(C(=O)O)NC(=O)CN Ambient -20°C "Zhang Y, Yan H, Lv SG, et al. Effects of glycyl-glutamine dipeptide supplementation on myocardial damage and cardiac function in rats after severe burn injury. Int J Clin Exp Pathol. 2013 Apr 15;6(5):821-30. PMID: 23638213.

 

Jiang JW, Ren ZG, Chen LY, et al. Enteral supplementation with glycyl-glutamine improves intestinal barrier function after liver transplantation in rats. Hepatobiliary Pancreat Dis Int. 2011 Aug;10(4):380-5. PMID: 21813386.

 

Basaran NF, Buyukuysal RL, Millington WR, et al. Glycyl-glutamine (beta-endorphin(30-31)) inhibits morphine-induced dopamine efflux in the nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol. 2010 May;381(5):467-75. PMID: 20349045.

 

Göktalay G, Cavun S, Levendusky MC, et al. Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal. Eur J Pharmacol. 2006 Jan 13;530(1-2):95-102. PMID: 16364288.

 

Resch GE, Millington WR. Inhibition of interleukin-1beta and prostaglandin E(2) thermogenesis by glycyl-glutamine, a pro-opiomelanocortin-derived peptide. Brain Res. 2001 Mar 16;894(2):316-20. PMID: 11251208.

" Xi Not dangerous goods.

LKT G6802 Granisetron Hydrochloride 25 mg 65.6 5-HT3 antagonist. Endo-1-methyl-N-(9-methyl-9-aza bicyclo [3.3.1]non-3-yl)-1H-Indazole-3-carboxamide hydrochloride 107007-99-8 ≥98% 348.87 C18H24N4O HCl CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl Ambient Ambient Soluble in water, DMSO, methanol, and ethanol. "Hsu ES. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Am J Ther. 2010 Sep-Oct;17(5):476-86. PMID: 20844345.

 

Choi YD, Sung TS, Kim HJ, et al. Increased 5-hydroxytryptamine mediates post-inflammatory visceral hypersensitivity via the 5-hydroxytryptamine 3 receptor in rats. Dig Dis Sci. 2008 Nov;53(11):2909-16. PMID: 18357529.

 

Martin C, Roman V, Agay D, et al. Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation. Radiat Res. 1998 Jun;149(6):631-6. PMID: 9611102.

" Not dangerous goods.

LKT G6802 Granisetron Hydrochloride 100 mg 187.4 5-HT3 antagonist. Endo-1-methyl-N-(9-methyl-9-aza bicyclo [3.3.1]non-3-yl)-1H-Indazole-3-carboxamide hydrochloride 107007-99-8 ≥98% 348.87 C18H24N4O HCl CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl Ambient Ambient Soluble in water, DMSO, methanol, and ethanol. "Hsu ES. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Am J Ther. 2010 Sep-Oct;17(5):476-86. PMID: 20844345.

 

Choi YD, Sung TS, Kim HJ, et al. Increased 5-hydroxytryptamine mediates post-inflammatory visceral hypersensitivity via the 5-hydroxytryptamine 3 receptor in rats. Dig Dis Sci. 2008 Nov;53(11):2909-16. PMID: 18357529.

 

Martin C, Roman V, Agay D, et al. Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation. Radiat Res. 1998 Jun;149(6):631-6. PMID: 9611102.

" Not dangerous goods.

LKT G6802 Granisetron Hydrochloride 500 mg 750.1 5-HT3 antagonist. Endo-1-methyl-N-(9-methyl-9-aza bicyclo [3.3.1]non-3-yl)-1H-Indazole-3-carboxamide hydrochloride 107007-99-8 ≥98% 348.87 C18H24N4O HCl CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl Ambient Ambient Soluble in water, DMSO, methanol, and ethanol. "Hsu ES. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Am J Ther. 2010 Sep-Oct;17(5):476-86. PMID: 20844345.

 

Choi YD, Sung TS, Kim HJ, et al. Increased 5-hydroxytryptamine mediates post-inflammatory visceral hypersensitivity via the 5-hydroxytryptamine 3 receptor in rats. Dig Dis Sci. 2008 Nov;53(11):2909-16. PMID: 18357529.

 

Martin C, Roman V, Agay D, et al. Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation. Radiat Res. 1998 Jun;149(6):631-6. PMID: 9611102.

" Not dangerous goods.

LKT T6830 Triadimefon 5 g 63.8 Neurotoxin, mutagen. 1-(4-Chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-trazol-1-yl)-2-butanone BAY MEB 6447; Bayleton 43121-43-3 ≥98% 293.75 C14H16ClN3O2 CC(C)(C)C(=O)C(N1C=NC=N1)OC2=CC=C(C=C2)Cl Ambient Ambient Soluble in water. Moderately soluble in most organic solvents "Xi J, Yang Z, Zeng C, et al. Suppressive effect of triadimefon, a triazole fungicide, on spatial learning and reference memory in rats. Behav Pharmacol. 2012 Dec;23(8):727-34. PMID: 23080312.

 

Di Renzo F, Broccia ML, Giavini E, et al. Stage-dependent abnormalities induced by the fungicide triadimefon in the mouse. Reprod Toxicol. 2011 Feb;31(2):194-9. PMID: 21055463.

 

Berg D, Draber W, von Hugo H, et al. The effect of clotrimazole and triadimefon on 3-hydroxy-3-methyl-glutaryl-CoA-reductase-[EC 1.1.1.34]-activity in Saccharomyces cerevisiae. Z Naturforsch C. 1981 Sep-Oct;36(9-10):798-803. PMID: 7029940.

" Xn, N "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Triadimefon)"

LKT T6830 Triadimefon 10 g 101.7 Neurotoxin, mutagen. 1-(4-Chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-trazol-1-yl)-2-butanone BAY MEB 6447; Bayleton 43121-43-3 ≥98% 293.75 C14H16ClN3O2 CC(C)(C)C(=O)C(N1C=NC=N1)OC2=CC=C(C=C2)Cl Ambient Ambient Soluble in water. Moderately soluble in most organic solvents "Xi J, Yang Z, Zeng C, et al. Suppressive effect of triadimefon, a triazole fungicide, on spatial learning and reference memory in rats. Behav Pharmacol. 2012 Dec;23(8):727-34. PMID: 23080312.

 

Di Renzo F, Broccia ML, Giavini E, et al. Stage-dependent abnormalities induced by the fungicide triadimefon in the mouse. Reprod Toxicol. 2011 Feb;31(2):194-9. PMID: 21055463.

 

Berg D, Draber W, von Hugo H, et al. The effect of clotrimazole and triadimefon on 3-hydroxy-3-methyl-glutaryl-CoA-reductase-[EC 1.1.1.34]-activity in Saccharomyces cerevisiae. Z Naturforsch C. 1981 Sep-Oct;36(9-10):798-803. PMID: 7029940.

" Xn, N "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Triadimefon)"

LKT T6830 Triadimefon 25 g 216.3 Neurotoxin, mutagen. 1-(4-Chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-trazol-1-yl)-2-butanone BAY MEB 6447; Bayleton 43121-43-3 ≥98% 293.75 C14H16ClN3O2 CC(C)(C)C(=O)C(N1C=NC=N1)OC2=CC=C(C=C2)Cl Ambient Ambient Soluble in water. Moderately soluble in most organic solvents "Xi J, Yang Z, Zeng C, et al. Suppressive effect of triadimefon, a triazole fungicide, on spatial learning and reference memory in rats. Behav Pharmacol. 2012 Dec;23(8):727-34. PMID: 23080312.

 

Di Renzo F, Broccia ML, Giavini E, et al. Stage-dependent abnormalities induced by the fungicide triadimefon in the mouse. Reprod Toxicol. 2011 Feb;31(2):194-9. PMID: 21055463.

 

Berg D, Draber W, von Hugo H, et al. The effect of clotrimazole and triadimefon on 3-hydroxy-3-methyl-glutaryl-CoA-reductase-[EC 1.1.1.34]-activity in Saccharomyces cerevisiae. Z Naturforsch C. 1981 Sep-Oct;36(9-10):798-803. PMID: 7029940.

" Xn, N "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Triadimefon)"

LKT G6803 Granuliberin R 1 mg 83.9 Antimicrobial peptide found in amphibians. 64704-41-2 ≥95% 1422.71 C69H103N19O14 CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)N2CCCC2C(=O)NC(C)C(=O)NC(CO)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC(C)C)NC(=O)C(CC4=CC=CC=C4)NC(=O)CNC(=O)C(CC5=CC=CC=C5)N Ambient -20°C "Nakao S, Komagoe K, Inoue T, et al. Comparative study of the membrane-permeabilizing activities of mastoparans and related histamine-releasing agents in bacteria, erythrocytes, and mast cells. Biochim Biophys Acta. 2011 Jan;1808(1):490-7. PMID: 20955685.

 

Kozakiewicz M, Godlewski A. Modulation of the mitotic activity and population of the mast cells in the oral mucosa by substance P. Cell Mol Biol Lett. 2003;8(3):727-34. PMID: 12949612.

" Not dangerous goods.

LKT G6803 Granuliberin R 2 mg 144 Antimicrobial peptide found in amphibians. 64704-41-2 ≥95% 1422.71 C69H103N19O14 CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)N2CCCC2C(=O)NC(C)C(=O)NC(CO)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC(C)C)NC(=O)C(CC4=CC=CC=C4)NC(=O)CNC(=O)C(CC5=CC=CC=C5)N Ambient -20°C "Nakao S, Komagoe K, Inoue T, et al. Comparative study of the membrane-permeabilizing activities of mastoparans and related histamine-releasing agents in bacteria, erythrocytes, and mast cells. Biochim Biophys Acta. 2011 Jan;1808(1):490-7. PMID: 20955685.

 

Kozakiewicz M, Godlewski A. Modulation of the mitotic activity and population of the mast cells in the oral mucosa by substance P. Cell Mol Biol Lett. 2003;8(3):727-34. PMID: 12949612.

" Not dangerous goods.

LKT G6803 Granuliberin R 5 mg 252.1 Antimicrobial peptide found in amphibians. 64704-41-2 ≥95% 1422.71 C69H103N19O14 CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)N2CCCC2C(=O)NC(C)C(=O)NC(CO)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC(C)C)NC(=O)C(CC4=CC=CC=C4)NC(=O)CNC(=O)C(CC5=CC=CC=C5)N Ambient -20°C "Nakao S, Komagoe K, Inoue T, et al. Comparative study of the membrane-permeabilizing activities of mastoparans and related histamine-releasing agents in bacteria, erythrocytes, and mast cells. Biochim Biophys Acta. 2011 Jan;1808(1):490-7. PMID: 20955685.

 

Kozakiewicz M, Godlewski A. Modulation of the mitotic activity and population of the mast cells in the oral mucosa by substance P. Cell Mol Biol Lett. 2003;8(3):727-34. PMID: 12949612.

" Not dangerous goods.

LKT T6803 Trandolapril 100 mg 285.2 ACE inhibitor. 87679-37-6 ≥98% 430.54 C24H34N2O5 CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O Ambient Ambient Soluble in methanol, dichloromethane, DMSO, and ethanol "Tanaka H, Takai S, Jin D, et al. Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats. Hypertens Res. 2007 May;30(5):469-75. PMID: 17587759.

 

Toyoshima H, Nasa Y, Kohsaka Y, et al. The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure. Br J Pharmacol. 1998 Jan;123(2):344-52. PMID: 9489624.

 

Sanbe A, Tanonaka K, Kobayasi R, et al. Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction. J Mol Cell Cardiol. 1995 Oct;27(10):2209-22. PMID: 8576937.

" Not dangerous goods.

LKT T6803 Trandolapril 250 mg 546 ACE inhibitor. 87679-37-6 ≥98% 430.54 C24H34N2O5 CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O Ambient Ambient Soluble in methanol, dichloromethane, DMSO, and ethanol "Tanaka H, Takai S, Jin D, et al. Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats. Hypertens Res. 2007 May;30(5):469-75. PMID: 17587759.

 

Toyoshima H, Nasa Y, Kohsaka Y, et al. The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure. Br J Pharmacol. 1998 Jan;123(2):344-52. PMID: 9489624.

 

Sanbe A, Tanonaka K, Kobayasi R, et al. Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction. J Mol Cell Cardiol. 1995 Oct;27(10):2209-22. PMID: 8576937.

" Not dangerous goods.

LKT G6856 Growth Hormone Releasing Factor, human 1 mg 773.1 Endogenous peptide hormone, increases GH production; GHRH agonist. Growth Hormone Releasing Hormone, GRF, GHRF, GHRH 83930-13-6 ≥98% 5039.7 C215H358N72O66S CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N Ambient -20°C "Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Shiraga H, Stallwood D, Ebadi M, et al. Inhibition of calmodulin-dependent myosin light-chain kinase by growth-hormone-releasing factor and vasoactive intestinal peptide. Biochem J. 1994 Jun 15;300 ( Pt 3):901-5. PMID: 8010976.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT T6803 Trandolapril 500 mg 903.9 ACE inhibitor. 87679-37-6 ≥98% 430.54 C24H34N2O5 CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O Ambient Ambient Soluble in methanol, dichloromethane, DMSO, and ethanol "Tanaka H, Takai S, Jin D, et al. Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats. Hypertens Res. 2007 May;30(5):469-75. PMID: 17587759.

 

Toyoshima H, Nasa Y, Kohsaka Y, et al. The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure. Br J Pharmacol. 1998 Jan;123(2):344-52. PMID: 9489624.

 

Sanbe A, Tanonaka K, Kobayasi R, et al. Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction. J Mol Cell Cardiol. 1995 Oct;27(10):2209-22. PMID: 8576937.

" Not dangerous goods.

LKT G8101 Guaifenesin 25 g 28.8 Expectorant. 3-(2-Methoxyphenoxy)-1,2-propanediol Glycerol guaiacolate; Equicol; Glycodex; Miocaina; Oresol; Relaxil G; Sirotol; Tulyn 93-14-1 ≥98% 198.22 C10H14O4 COC1=CC=CC=C1OCC(CO)O Ambient Ambient Soluble in water (14 mg/mL), ethanol, chloroform, DMF, or glycerol. "Seagrave J, Albrecht H, Park YS, et al. Effect of guaifenesin on mucin production, rheology, and mucociliary transport in differentiated human airway epithelial cells. Exp Lung Res. 2011 Dec;37(10):606-14. PMID: 22044398.

 

Kagan L, Lavy E, Hoffman A. Effect of mode of administration on guaifenesin pharmacokinetics and expectorant action in the rat model. Pulm Pharmacol Ther. 2009 Jun;22(3):260-5. PMID: 19166957.

" Xn, Xi Not dangerous goods.

LKT G8101 Guaifenesin 100 g 77.1 Expectorant. 3-(2-Methoxyphenoxy)-1,2-propanediol Glycerol guaiacolate; Equicol; Glycodex; Miocaina; Oresol; Relaxil G; Sirotol; Tulyn 93-14-1 ≥98% 198.22 C10H14O4 COC1=CC=CC=C1OCC(CO)O Ambient Ambient Soluble in water (14 mg/mL), ethanol, chloroform, DMF, or glycerol. "Seagrave J, Albrecht H, Park YS, et al. Effect of guaifenesin on mucin production, rheology, and mucociliary transport in differentiated human airway epithelial cells. Exp Lung Res. 2011 Dec;37(10):606-14. PMID: 22044398.

 

Kagan L, Lavy E, Hoffman A. Effect of mode of administration on guaifenesin pharmacokinetics and expectorant action in the rat model. Pulm Pharmacol Ther. 2009 Jun;22(3):260-5. PMID: 19166957.

" Xn, Xi Not dangerous goods.

LKT G8101 Guaifenesin 500 g 220.1 Expectorant. 3-(2-Methoxyphenoxy)-1,2-propanediol Glycerol guaiacolate; Equicol; Glycodex; Miocaina; Oresol; Relaxil G; Sirotol; Tulyn 93-14-1 ≥98% 198.22 C10H14O4 COC1=CC=CC=C1OCC(CO)O Ambient Ambient Soluble in water (14 mg/mL), ethanol, chloroform, DMF, or glycerol. "Seagrave J, Albrecht H, Park YS, et al. Effect of guaifenesin on mucin production, rheology, and mucociliary transport in differentiated human airway epithelial cells. Exp Lung Res. 2011 Dec;37(10):606-14. PMID: 22044398.

 

Kagan L, Lavy E, Hoffman A. Effect of mode of administration on guaifenesin pharmacokinetics and expectorant action in the rat model. Pulm Pharmacol Ther. 2009 Jun;22(3):260-5. PMID: 19166957.

" Xn, Xi Not dangerous goods.

LKT G8103 Guanylin, human 0.5 mg 348 Endogenous peptide hormone; guanyl cyclase C agonist. 145319-90-0 ≥95% 1458.68 C58H87N15O21S4 Ambient -20°C "Basu N, Saha S, Khan I, et al. Intestinal cell proliferation and senescence are regulated by receptor guanylyl cyclase C and p21. J Biol Chem. 2014 Jan 3;289(1):581-93. PMID: 24217248.

 

Fonteles MC, do Nascimento NR. Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives. Can J Physiol Pharmacol. 2011 Aug;89(8):575-85. PMID: 21815750.

 

Forte LR, Freeman RH, Krause WJ, et al. Guanylin peptides: cyclic GMP signaling mechanisms. Braz J Med Biol Res. 1999 Nov;32(11):1329-36. PMID: 10559833.

" Not dangerous goods.

LKT G8103 Guanylin, human 1 mg 591 Endogenous peptide hormone; guanyl cyclase C agonist. 145319-90-0 ≥95% 1458.68 C58H87N15O21S4 Ambient -20°C "Basu N, Saha S, Khan I, et al. Intestinal cell proliferation and senescence are regulated by receptor guanylyl cyclase C and p21. J Biol Chem. 2014 Jan 3;289(1):581-93. PMID: 24217248.

 

Fonteles MC, do Nascimento NR. Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives. Can J Physiol Pharmacol. 2011 Aug;89(8):575-85. PMID: 21815750.

 

Forte LR, Freeman RH, Krause WJ, et al. Guanylin peptides: cyclic GMP signaling mechanisms. Braz J Med Biol Res. 1999 Nov;32(11):1329-36. PMID: 10559833.

" Not dangerous goods.

LKT G8103 Guanylin, human 2.5 mg 1043.9 Endogenous peptide hormone; guanyl cyclase C agonist. 145319-90-0 ≥95% 1458.68 C58H87N15O21S4 Ambient -20°C "Basu N, Saha S, Khan I, et al. Intestinal cell proliferation and senescence are regulated by receptor guanylyl cyclase C and p21. J Biol Chem. 2014 Jan 3;289(1):581-93. PMID: 24217248.

 

Fonteles MC, do Nascimento NR. Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives. Can J Physiol Pharmacol. 2011 Aug;89(8):575-85. PMID: 21815750.

 

Forte LR, Freeman RH, Krause WJ, et al. Guanylin peptides: cyclic GMP signaling mechanisms. Braz J Med Biol Res. 1999 Nov;32(11):1329-36. PMID: 10559833.

" Not dangerous goods.

LKT G8104 Guanylin, rat/mouse 0.5 mg 348 Endogenous peptide hormone; guanyl cyclase C agonist. 145257-03-0 ≥95% 1515.74 C60H90N16O22S4 CCC(C)C(C(=O)NC(CS)C(=O)NC(C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CS)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C2CCCN2 Ambient -20°C "Basu N, Saha S, Khan I, et al. Intestinal cell proliferation and senescence are regulated by receptor guanylyl cyclase C and p21. J Biol Chem. 2014 Jan 3;289(1):581-93. PMID: 24217248.

 

Fonteles MC, do Nascimento NR. Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives. Can J Physiol Pharmacol. 2011 Aug;89(8):575-85. PMID: 21815750.

 

Forte LR, Freeman RH, Krause WJ, et al. Guanylin peptides: cyclic GMP signaling mechanisms. Braz J Med Biol Res. 1999 Nov;32(11):1329-36. PMID: 10559833.

" Not dangerous goods.

LKT G8104 Guanylin, rat/mouse 1 mg 591 Endogenous peptide hormone; guanyl cyclase C agonist. 145257-03-0 ≥95% 1515.74 C60H90N16O22S4 CCC(C)C(C(=O)NC(CS)C(=O)NC(C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CS)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C2CCCN2 Ambient -20°C "Basu N, Saha S, Khan I, et al. Intestinal cell proliferation and senescence are regulated by receptor guanylyl cyclase C and p21. J Biol Chem. 2014 Jan 3;289(1):581-93. PMID: 24217248.

 

Fonteles MC, do Nascimento NR. Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives. Can J Physiol Pharmacol. 2011 Aug;89(8):575-85. PMID: 21815750.

 

Forte LR, Freeman RH, Krause WJ, et al. Guanylin peptides: cyclic GMP signaling mechanisms. Braz J Med Biol Res. 1999 Nov;32(11):1329-36. PMID: 10559833.

" Not dangerous goods.

LKT G8104 Guanylin, rat/mouse 2.5 mg 1043.9 Endogenous peptide hormone; guanyl cyclase C agonist. 145257-03-0 ≥95% 1515.74 C60H90N16O22S4 CCC(C)C(C(=O)NC(CS)C(=O)NC(C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CS)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C2CCCN2 Ambient -20°C "Basu N, Saha S, Khan I, et al. Intestinal cell proliferation and senescence are regulated by receptor guanylyl cyclase C and p21. J Biol Chem. 2014 Jan 3;289(1):581-93. PMID: 24217248.

 

Fonteles MC, do Nascimento NR. Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives. Can J Physiol Pharmacol. 2011 Aug;89(8):575-85. PMID: 21815750.

 

Forte LR, Freeman RH, Krause WJ, et al. Guanylin peptides: cyclic GMP signaling mechanisms. Braz J Med Biol Res. 1999 Nov;32(11):1329-36. PMID: 10559833.

" Not dangerous goods.

LKT G8225 Guggulsterone 5 mg 104.9 Steroid found in myrrh; FXR antagonist. "(17E)-Pregna-4,17(20)-diene-3,16-dione

" Pregna-4,17-diene-3,16-dione 95975-55-6 ≥98% 312.45 C21H28O2 CC=C1C(=O)CC2C1(CCC3C2CCC4=CC(=O)CCC34C)C Ambient Ambient "Macha MA, Rachagani S, Gupta S, et al. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. Cancer Lett. 2013 Dec 1;341(2):166-77. PMID: 23920124.

 

Kim BH, Yoon JH, Yang JI, et al. Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis. J Gastroenterol Hepatol. 2013 Dec;28(12):1859-68. PMID: 23808824.

 

Wang WC, Uen YH, Chang ML, et al. Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro..BMC Complement Altern Med. 2012 Aug 27;12:138. PMID: 22920231.

 

Song JJ, Kwon SK, Cho CG, et al Guggulsterone suppresses LPS induced inflammation of human middle ear epithelial cells (HMEEC). Int J Pediatr Otorhinolaryngol. 2010 Dec;74(12):1384-7. PMID: 20971513.

 

Kim ES, Hong SY, Lee HK, et al. Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells. Oncol Rep. 2008 Dec;20(6):1321-7. PMID: 19020709.

 

Ahn KS, Sethi G, Sung B, et al. Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res. 2008 Jun 1;68(11):4406-15. PMID: 18519703.

 

Yang JY, Della-Fera MA, Baile CA. Guggulsterone inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 cells. Obesity (Silver Spring). 2008 Jan;16(1):16-22. PMID: 18223606.

" Xi Not dangerous goods.

LKT G8225 Guggulsterone 25 mg 420.1 Steroid found in myrrh; FXR antagonist. "(17E)-Pregna-4,17(20)-diene-3,16-dione

" Pregna-4,17-diene-3,16-dione 95975-55-6 ≥98% 312.45 C21H28O2 CC=C1C(=O)CC2C1(CCC3C2CCC4=CC(=O)CCC34C)C Ambient Ambient "Macha MA, Rachagani S, Gupta S, et al. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. Cancer Lett. 2013 Dec 1;341(2):166-77. PMID: 23920124.

 

Kim BH, Yoon JH, Yang JI, et al. Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis. J Gastroenterol Hepatol. 2013 Dec;28(12):1859-68. PMID: 23808824.

 

Wang WC, Uen YH, Chang ML, et al. Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro..BMC Complement Altern Med. 2012 Aug 27;12:138. PMID: 22920231.

 

Song JJ, Kwon SK, Cho CG, et al Guggulsterone suppresses LPS induced inflammation of human middle ear epithelial cells (HMEEC). Int J Pediatr Otorhinolaryngol. 2010 Dec;74(12):1384-7. PMID: 20971513.

 

Kim ES, Hong SY, Lee HK, et al. Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells. Oncol Rep. 2008 Dec;20(6):1321-7. PMID: 19020709.

 

Ahn KS, Sethi G, Sung B, et al. Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res. 2008 Jun 1;68(11):4406-15. PMID: 18519703.

 

Yang JY, Della-Fera MA, Baile CA. Guggulsterone inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 cells. Obesity (Silver Spring). 2008 Jan;16(1):16-22. PMID: 18223606.

" Xi Not dangerous goods.

LKT T5946 Toltrazuril 1 g 67.9 Coccidiostat; mitochondrial respiration inhibitor, pyrimidine synthesis inhibitor. 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione,1-methyl-3-(3- methyl-4-(4-((trifluoromethyl)thio)phenoxy)phenyl)- Baycox; Bay Vi 9142 69004-03-1 ≥98% 425.38 C18H14F3N3O4S CC1=C(C=CC(=C1)N2C(=O)NC(=O)N(C2=O)C)OC3=CC=C(C=C3)SC(F)(F)F Protect from light. Store in a dry place. Ambient Ambient Soluble in water. "Iqbal A, Tariq KA, Wazir VS, et al.  Antiparasitic efficacy of Artemisia absinthium, toltrazuril and amprolium against intestinal coccidiosis in goats. J Parasit Dis. 2013 Apr;37(1):88-93. PMID: 24431547.

 

Kul O, Yildiz K, Ocal N, et al. In-vivo efficacy of toltrazuril on experimentally induced Toxoplasma gondii tissue cysts in lambs: a novel strategy for prevention of human exposure to meat-borne toxoplasmosis. Res Vet Sci. 2013 Apr;94(2):269-76. PMID: 22954788.

 

Harder A, Haberkorn A. Possible mode of action of toltrazuril: studies on two Eimeria species and mammalian and Ascaris suum enzymes. Parasitol Res. 1989;76(1):8-12. PMID: 2560189.

" N Not dangerous goods.

LKT T5946 Toltrazuril 5 g 244.5 Coccidiostat; mitochondrial respiration inhibitor, pyrimidine synthesis inhibitor. 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione,1-methyl-3-(3- methyl-4-(4-((trifluoromethyl)thio)phenoxy)phenyl)- Baycox; Bay Vi 9142 69004-03-1 ≥98% 425.38 C18H14F3N3O4S CC1=C(C=CC(=C1)N2C(=O)NC(=O)N(C2=O)C)OC3=CC=C(C=C3)SC(F)(F)F Protect from light. Store in a dry place. Ambient Ambient Soluble in water. "Iqbal A, Tariq KA, Wazir VS, et al.  Antiparasitic efficacy of Artemisia absinthium, toltrazuril and amprolium against intestinal coccidiosis in goats. J Parasit Dis. 2013 Apr;37(1):88-93. PMID: 24431547.

 

Kul O, Yildiz K, Ocal N, et al. In-vivo efficacy of toltrazuril on experimentally induced Toxoplasma gondii tissue cysts in lambs: a novel strategy for prevention of human exposure to meat-borne toxoplasmosis. Res Vet Sci. 2013 Apr;94(2):269-76. PMID: 22954788.

 

Harder A, Haberkorn A. Possible mode of action of toltrazuril: studies on two Eimeria species and mammalian and Ascaris suum enzymes. Parasitol Res. 1989;76(1):8-12. PMID: 2560189.

" N Not dangerous goods.

LKT T5946 Toltrazuril 10 g 407.7 Coccidiostat; mitochondrial respiration inhibitor, pyrimidine synthesis inhibitor. 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione,1-methyl-3-(3- methyl-4-(4-((trifluoromethyl)thio)phenoxy)phenyl)- Baycox; Bay Vi 9142 69004-03-1 ≥98% 425.38 C18H14F3N3O4S CC1=C(C=CC(=C1)N2C(=O)NC(=O)N(C2=O)C)OC3=CC=C(C=C3)SC(F)(F)F Protect from light. Store in a dry place. Ambient Ambient Soluble in water. "Iqbal A, Tariq KA, Wazir VS, et al.  Antiparasitic efficacy of Artemisia absinthium, toltrazuril and amprolium against intestinal coccidiosis in goats. J Parasit Dis. 2013 Apr;37(1):88-93. PMID: 24431547.

 

Kul O, Yildiz K, Ocal N, et al. In-vivo efficacy of toltrazuril on experimentally induced Toxoplasma gondii tissue cysts in lambs: a novel strategy for prevention of human exposure to meat-borne toxoplasmosis. Res Vet Sci. 2013 Apr;94(2):269-76. PMID: 22954788.

 

Harder A, Haberkorn A. Possible mode of action of toltrazuril: studies on two Eimeria species and mammalian and Ascaris suum enzymes. Parasitol Res. 1989;76(1):8-12. PMID: 2560189.

" N Not dangerous goods.

LKT H0001 H7 10 mg 154 PKC and PKG inhibitor. (-)-1-(5-Isoquinolinesulfonyl)-2-methylpiperazine di-HCl salt 108930-17-2 ≥98% 364.4 C14H17N3O2S 2HCl CC1CNCCN1S(=O)(=O)C2=CC=CC3=C2C=CN=C3.Cl.Cl Ambient 4°C Soluble in water. "Chen JJ, Zhang J, Cai Y, et al.  C-type natriuretic peptide inhibiting vascular calcification might involve decreasing bone morphogenic protein 2 and osteopontin levels. Mol Cell Biochem. 2014 Jul;392(1-2):65-76. PMID: 24710639.

 

Zhang Y, Bao S, Kuang Z, et al. Urotensin II promotes monocyte chemoattractant protein-1 expression in aortic adventitial fibroblasts of rat. Chin Med J (Engl). 2014 May;127(10):1907-12. PMID: 24824254.

" Not dangerous goods.

LKT H0001 H7 25 mg 268.9 PKC and PKG inhibitor. (-)-1-(5-Isoquinolinesulfonyl)-2-methylpiperazine di-HCl salt 108930-17-2 ≥98% 364.4 C14H17N3O2S 2HCl CC1CNCCN1S(=O)(=O)C2=CC=CC3=C2C=CN=C3.Cl.Cl Ambient 4°C Soluble in water. "Chen JJ, Zhang J, Cai Y, et al.  C-type natriuretic peptide inhibiting vascular calcification might involve decreasing bone morphogenic protein 2 and osteopontin levels. Mol Cell Biochem. 2014 Jul;392(1-2):65-76. PMID: 24710639.

 

Zhang Y, Bao S, Kuang Z, et al. Urotensin II promotes monocyte chemoattractant protein-1 expression in aortic adventitial fibroblasts of rat. Chin Med J (Engl). 2014 May;127(10):1907-12. PMID: 24824254.

" Not dangerous goods.

LKT H0002 H8 dihydrochloride 5 mg 83.9 PKA inhibitor. "N-(2-(methylamino)ethyl)- dihydrochloride 5-Isoquinolinesulfonamide

" H8 dihydrochloride salt 113276-94-1 ≥98% 338.25 C12H15N3O2S 2HC1 CNCCNS(=O)(=O)C1=CC=CC2=C1C=CN=C2.Cl.Cl Ambient 4°C "Sui HY, Luan HY, Liu YJ. Involvement of protein kinase A activation and phospholipase A(2) inhibition in the adenosine-activated basolateral 50 pS K(+) channels in the thick ascending limb of the rat kidney. Sheng Li Xue Bao. 2012 Aug 25;64(4):449-54. PMID: 22907306.

 

Hou L, Wang X. PKC and PKA, but not PKG mediate LPS-induced CGRP release and [Ca(2+)](i) elevation in DRG neurons of neonatal rats. J Neurosci Res. 2001 Nov 15;66(4):592-600. PMID: 11746379.

" Not dangerous goods.

LKT H0002 H8 dihydrochloride 25 mg 241.6 PKA inhibitor. "N-(2-(methylamino)ethyl)- dihydrochloride 5-Isoquinolinesulfonamide

" H8 dihydrochloride salt 113276-94-1 ≥98% 338.25 C12H15N3O2S 2HC1 CNCCNS(=O)(=O)C1=CC=CC2=C1C=CN=C2.Cl.Cl Ambient 4°C "Sui HY, Luan HY, Liu YJ. Involvement of protein kinase A activation and phospholipase A(2) inhibition in the adenosine-activated basolateral 50 pS K(+) channels in the thick ascending limb of the rat kidney. Sheng Li Xue Bao. 2012 Aug 25;64(4):449-54. PMID: 22907306.

 

Hou L, Wang X. PKC and PKA, but not PKG mediate LPS-induced CGRP release and [Ca(2+)](i) elevation in DRG neurons of neonatal rats. J Neurosci Res. 2001 Nov 15;66(4):592-600. PMID: 11746379.

" Not dangerous goods.

LKT H0003 H89 5 mg 184.8 PKA inhibitor, potential ROCK, S6K1, MSK1, PKB inhibitor. N-(2-[P-Bromocinnamylamino]-ethyl)-5-isoquinolinesulfonmide 127243-85-0 ≥98% 446.36 C20H22BrN3O2S C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCNCC=CC3=CC=C(C=C3)Br.Cl.Cl Ambient -20°C Soluble in DMSO or ethanol:water (1:1). "Choi S, Kim MY, Joo KY, et al. Modafinil inhibits K(Ca)3.1 currents and muscle contraction via a cAMP-dependent mechanism. Pharmacol Res. 2012 Jul;66(1):51-9. PMID: 22414869.

 

Rogers RC, Hermann GE. Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids. J Neurosci. 2012 Apr 11;32(15):5237-41. PMID: 22496569.

" Xn, T Not dangerous goods.

LKT H0003 H89 1 mg 73.5 PKA inhibitor, potential ROCK, S6K1, MSK1, PKB inhibitor. N-(2-[P-Bromocinnamylamino]-ethyl)-5-isoquinolinesulfonmide 127243-85-0 ≥98% 446.36 C20H22BrN3O2S C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCNCC=CC3=CC=C(C=C3)Br.Cl.Cl Ambient -20°C Soluble in DMSO or ethanol:water (1:1). "Choi S, Kim MY, Joo KY, et al. Modafinil inhibits K(Ca)3.1 currents and muscle contraction via a cAMP-dependent mechanism. Pharmacol Res. 2012 Jul;66(1):51-9. PMID: 22414869.

 

Rogers RC, Hermann GE. Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids. J Neurosci. 2012 Apr 11;32(15):5237-41. PMID: 22496569.

" Xn, T Not dangerous goods.

LKT T5944 Tolmetin Sodium 1 g 35.8 NSAID; COX-1/2 inhibitor. 1-Methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic acid sodium salt dihydrate Tolmetin sodium salt dihydrate; Reutol; Tolectine; Tolmene 64490-92-2 ≥98% 315.3 C15H14NNaO3 CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)[O-].[Na+] Ambient Ambient Soluble in water. "Fernandes E, Costa D, Toste SA, et al. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic Biol Med. 2004 Dec 1;37(11):1895-905. PMID: 15528048.

 

Davies J, Dixon AS, Steele CE. Tolmetin sodium and indomethacin in the treatment of osteoarthrosis of the hip: a double-blind crossover study. Curr Med Res Opin. 1980;7(2):115-20. PMID: 7002480.

 

Cordrey LJ. Tolmetin sodium, a new anti-arthritis drug: double-blind and long-term studies. J Am Geriatr Soc. 1976 Oct;24(10):440-6. PMID: 61224.

" Xn Not dangerous goods.

LKT T5944 Tolmetin Sodium 5 g 101.7 NSAID; COX-1/2 inhibitor. 1-Methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic acid sodium salt dihydrate Tolmetin sodium salt dihydrate; Reutol; Tolectine; Tolmene 64490-92-2 ≥98% 315.3 C15H14NNaO3 CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)[O-].[Na+] Ambient Ambient Soluble in water. "Fernandes E, Costa D, Toste SA, et al. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic Biol Med. 2004 Dec 1;37(11):1895-905. PMID: 15528048.

 

Davies J, Dixon AS, Steele CE. Tolmetin sodium and indomethacin in the treatment of osteoarthrosis of the hip: a double-blind crossover study. Curr Med Res Opin. 1980;7(2):115-20. PMID: 7002480.

 

Cordrey LJ. Tolmetin sodium, a new anti-arthritis drug: double-blind and long-term studies. J Am Geriatr Soc. 1976 Oct;24(10):440-6. PMID: 61224.

" Xn Not dangerous goods.

LKT T5944 Tolmetin Sodium 25 g 368.8 NSAID; COX-1/2 inhibitor. 1-Methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic acid sodium salt dihydrate Tolmetin sodium salt dihydrate; Reutol; Tolectine; Tolmene 64490-92-2 ≥98% 315.3 C15H14NNaO3 CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)[O-].[Na+] Ambient Ambient Soluble in water. "Fernandes E, Costa D, Toste SA, et al. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic Biol Med. 2004 Dec 1;37(11):1895-905. PMID: 15528048.

 

Davies J, Dixon AS, Steele CE. Tolmetin sodium and indomethacin in the treatment of osteoarthrosis of the hip: a double-blind crossover study. Curr Med Res Opin. 1980;7(2):115-20. PMID: 7002480.

 

Cordrey LJ. Tolmetin sodium, a new anti-arthritis drug: double-blind and long-term studies. J Am Geriatr Soc. 1976 Oct;24(10):440-6. PMID: 61224.

" Xn Not dangerous goods.

LKT H0100 Hemagglutinin-1 Peptide 1 mg 120 Peptide, hemagglutinin epitope. HA1 fragment 98-106, HA tag peptide, Influenza Hemagglutinin (HA) Peptide 92000-76-5 ≥95% 1102.18 C53H67N9O17 CC(C)C(C(=O)N1CCCC1C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(C)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)N Ambient -20°C Hatzifoti C, Heath AW. CD40-mediated enhancement of immune responses against three forms of influenza vaccine. Immunology. 2007 Sep;122(1):98-106. PMID: 17472718. Not dangerous goods.

LKT H0100 Hemagglutinin-1 Peptide 2 mg 204.1 Peptide, hemagglutinin epitope. HA1 fragment 98-106, HA tag peptide, Influenza Hemagglutinin (HA) Peptide 92000-76-5 ≥95% 1102.18 C53H67N9O17 CC(C)C(C(=O)N1CCCC1C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(C)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)N Ambient -20°C Hatzifoti C, Heath AW. CD40-mediated enhancement of immune responses against three forms of influenza vaccine. Immunology. 2007 Sep;122(1):98-106. PMID: 17472718. Not dangerous goods.

LKT H0100 Hemagglutinin-1 Peptide 5 mg 359.9 Peptide, hemagglutinin epitope. HA1 fragment 98-106, HA tag peptide, Influenza Hemagglutinin (HA) Peptide 92000-76-5 ≥95% 1102.18 C53H67N9O17 CC(C)C(C(=O)N1CCCC1C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(C)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)N Ambient -20°C Hatzifoti C, Heath AW. CD40-mediated enhancement of immune responses against three forms of influenza vaccine. Immunology. 2007 Sep;122(1):98-106. PMID: 17472718. Not dangerous goods.

LKT H0142 Haloperidol 5 g 67.9 Butyrophenone; σ2 agonist, α1-adrenergic, D2, 5-HT2A, σ1 antagonist. "1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-

1-(4-fluorophenyl)- 

" Haldol; Halosten; Linton; Keselan; Aloperidin; Brotopon; Dozic. 52-86-8 ≥95% 375.86 C21H23ClFNO2 C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F Ambient Ambient Soluble in chloroform, ethanol (16 mg/mL),methanol, acetone or benzene.  Insoluble in water. "Cobos EJ, del Pozo E, Baeyens JM. Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells. J Neurochem. 2007 Aug;102(3):812-25. PMID: 17419803.

 

Colabufo NA, Berardi F, Contino M, et al. Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines. Naunyn Schmiedebergs Arch Pharmacol. 2004 Aug;370(2):106-13. PMID: 15322732.

 

Seeman P, Tallerico T. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry. 1998 Mar;3(2):123-34. PMID: 9577836.

 

Schotte A, Janssen PF, Megens AA, et al. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res. 1993 Dec 24;631(2):191-202. PMID: 7510574.

" Repr., T, Xi "UN number: 2811     Class:  6.1     Packing group:  III

Proper shipping name:  Toxic solids, organic, n.o.s.  (Haloperidol)

Reportable quantity (RQ):     Marine pollutant:  No     Poison inhalation hazard:  No"

LKT H0142 Haloperidol 10 g 101.9 Butyrophenone; σ2 agonist, α1-adrenergic, D2, 5-HT2A, σ1 antagonist. "1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-

1-(4-fluorophenyl)- 

" Haldol; Halosten; Linton; Keselan; Aloperidin; Brotopon; Dozic. 52-86-8 ≥95% 375.86 C21H23ClFNO2 C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F Ambient Ambient Soluble in chloroform, ethanol (16 mg/mL),methanol, acetone or benzene.  Insoluble in water. "Cobos EJ, del Pozo E, Baeyens JM. Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells. J Neurochem. 2007 Aug;102(3):812-25. PMID: 17419803.

 

Colabufo NA, Berardi F, Contino M, et al. Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines. Naunyn Schmiedebergs Arch Pharmacol. 2004 Aug;370(2):106-13. PMID: 15322732.

 

Seeman P, Tallerico T. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry. 1998 Mar;3(2):123-34. PMID: 9577836.

 

Schotte A, Janssen PF, Megens AA, et al. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res. 1993 Dec 24;631(2):191-202. PMID: 7510574.

" Repr., T, Xi "UN number: 2811     Class:  6.1     Packing group:  III

Proper shipping name:  Toxic solids, organic, n.o.s.  (Haloperidol)

Reportable quantity (RQ):     Marine pollutant:  No     Poison inhalation hazard:  No"

LKT H0142 Haloperidol 25 g 285.4 Butyrophenone; σ2 agonist, α1-adrenergic, D2, 5-HT2A, σ1 antagonist. "1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-

1-(4-fluorophenyl)- 

" Haldol; Halosten; Linton; Keselan; Aloperidin; Brotopon; Dozic. 52-86-8 ≥95% 375.86 C21H23ClFNO2 C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F Ambient Ambient Soluble in chloroform, ethanol (16 mg/mL),methanol, acetone or benzene.  Insoluble in water. "Cobos EJ, del Pozo E, Baeyens JM. Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells. J Neurochem. 2007 Aug;102(3):812-25. PMID: 17419803.

 

Colabufo NA, Berardi F, Contino M, et al. Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines. Naunyn Schmiedebergs Arch Pharmacol. 2004 Aug;370(2):106-13. PMID: 15322732.

 

Seeman P, Tallerico T. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry. 1998 Mar;3(2):123-34. PMID: 9577836.

 

Schotte A, Janssen PF, Megens AA, et al. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res. 1993 Dec 24;631(2):191-202. PMID: 7510574.

" Repr., T, Xi "UN number: 2811     Class:  6.1     Packing group:  III

Proper shipping name:  Toxic solids, organic, n.o.s.  (Haloperidol)

Reportable quantity (RQ):     Marine pollutant:  No     Poison inhalation hazard:  No"

LKT T5846 Tolfenamic Acid 5 g 47.6 NSAID; COX-1/2 inhibitor. 2-[(3-Chloro-2-methylphenyl)amino]benzoic acid Clotam; Tolfedine; Tolfine 13710-19-5 ≥98% 261.7 C14H12ClNO2 CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O Ambient Ambient Slightly soluble in water; freely sol in buffers with pH >8.2 "Pathi S, Li X, Safe S. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors. Mol Carcinog. 2014 Feb;53 Suppl 1:E53-61. PMID: 23670891.

 

Zhang X, Lee SH, Min KW, et al. The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid. Cancer Prev Res (Phila). 2013 Dec;6(12):1337-47. PMID: 24104354.

 

Kankaanranta H, Moilanen E, Vapaatalo H. Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions. Inflammation. 1993 Aug;17(4):417-25. PMID: 8406686.

" Xn "UN number: 2811     Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Tolfenamic acid)"

LKT T5846 Tolfenamic Acid 25 g 163.2 NSAID; COX-1/2 inhibitor. 2-[(3-Chloro-2-methylphenyl)amino]benzoic acid Clotam; Tolfedine; Tolfine 13710-19-5 ≥98% 261.7 C14H12ClNO2 CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O Ambient Ambient Slightly soluble in water; freely sol in buffers with pH >8.2 "Pathi S, Li X, Safe S. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors. Mol Carcinog. 2014 Feb;53 Suppl 1:E53-61. PMID: 23670891.

 

Zhang X, Lee SH, Min KW, et al. The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid. Cancer Prev Res (Phila). 2013 Dec;6(12):1337-47. PMID: 24104354.

 

Kankaanranta H, Moilanen E, Vapaatalo H. Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions. Inflammation. 1993 Aug;17(4):417-25. PMID: 8406686.

" Xn "UN number: 2811     Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Tolfenamic acid)"

LKT T5846 Tolfenamic Acid 50 g 251.5 NSAID; COX-1/2 inhibitor. 2-[(3-Chloro-2-methylphenyl)amino]benzoic acid Clotam; Tolfedine; Tolfine 13710-19-5 ≥98% 261.7 C14H12ClNO2 CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O Ambient Ambient Slightly soluble in water; freely sol in buffers with pH >8.2 "Pathi S, Li X, Safe S. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors. Mol Carcinog. 2014 Feb;53 Suppl 1:E53-61. PMID: 23670891.

 

Zhang X, Lee SH, Min KW, et al. The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid. Cancer Prev Res (Phila). 2013 Dec;6(12):1337-47. PMID: 24104354.

 

Kankaanranta H, Moilanen E, Vapaatalo H. Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions. Inflammation. 1993 Aug;17(4):417-25. PMID: 8406686.

" Xn "UN number: 2811     Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Tolfenamic acid)"

LKT H0207 Hepatitis B Virus Core Protein (128-140) 0.5 mg 72.1 B cell epitope found on hepatitis B viral core protein. HBV Core protein (128-140) ≥95% 1406.64 Ambient -20°C Yang J, Liu N, Zhang T, et al. Prediction and identification of B-cell linear epitopes of hepatitis B e antigen. Nan Fang Yi Ke Da Xue Xue Bao. 2013 Feb;33(2):253-7. PMID: 23443783. "Not dangerous goods.

"

LKT H0207 Hepatitis B Virus Core Protein (128-140) 1 mg 123.1 B cell epitope found on hepatitis B viral core protein. HBV Core protein (128-140) ≥95% 1406.64 Ambient -20°C Yang J, Liu N, Zhang T, et al. Prediction and identification of B-cell linear epitopes of hepatitis B e antigen. Nan Fang Yi Ke Da Xue Xue Bao. 2013 Feb;33(2):253-7. PMID: 23443783. "Not dangerous goods.

"

LKT H0207 Hepatitis B Virus Core Protein (128-140) 2.5 mg 216.1 B cell epitope found on hepatitis B viral core protein. HBV Core protein (128-140) ≥95% 1406.64 Ambient -20°C Yang J, Liu N, Zhang T, et al. Prediction and identification of B-cell linear epitopes of hepatitis B e antigen. Nan Fang Yi Ke Da Xue Xue Bao. 2013 Feb;33(2):253-7. PMID: 23443783. "Not dangerous goods.

"

LKT T5769 Toremifene Base 500 mg 72.2 SERM, androgen modulator. 2-[4-[(1Z)-4-Chloro-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethylethanamine Toremifene 89778-26-7 ≥98% 405.96 C26H28ClNO CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3 Ambient Ambient "Chang BY, Kim SA, Malla B, et al. The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells. Toxicol Res. 2011 Jun;27(2):85-93. PMID: 24278556.

 

Kawashima H, Tanaka T, Cheng JS, et al. Effect of anti-estrogens on the androgen receptor activity and cell proliferation in prostate cancer cells. Urol Res. 2004 Dec;32(6):406-10. PMID: 15316697.

 

Heidemann J, Ogawa H, Otterson MF, et al. Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases. Dis Colon Rectum. 2004 Jan;47(1):118-22. PMID: 14719159.

 

Raghow S, Hooshdaran MZ, Katiyar S, et al. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model. Cancer Res. 2002 Mar 1;62(5):1370-6. PMID: 11888907.

" "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Toremifene)

Marine pollutant: Yes"

LKT T5769 Toremifene Base 1 g 115.4 SERM, androgen modulator. 2-[4-[(1Z)-4-Chloro-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethylethanamine Toremifene 89778-26-7 ≥98% 405.96 C26H28ClNO CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3 Ambient Ambient "Chang BY, Kim SA, Malla B, et al. The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells. Toxicol Res. 2011 Jun;27(2):85-93. PMID: 24278556.

 

Kawashima H, Tanaka T, Cheng JS, et al. Effect of anti-estrogens on the androgen receptor activity and cell proliferation in prostate cancer cells. Urol Res. 2004 Dec;32(6):406-10. PMID: 15316697.

 

Heidemann J, Ogawa H, Otterson MF, et al. Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases. Dis Colon Rectum. 2004 Jan;47(1):118-22. PMID: 14719159.

 

Raghow S, Hooshdaran MZ, Katiyar S, et al. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model. Cancer Res. 2002 Mar 1;62(5):1370-6. PMID: 11888907.

" "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Toremifene)

Marine pollutant: Yes"

LKT T5769 Toremifene Base 5 g 432.3 SERM, androgen modulator. 2-[4-[(1Z)-4-Chloro-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethylethanamine Toremifene 89778-26-7 ≥98% 405.96 C26H28ClNO CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3 Ambient Ambient "Chang BY, Kim SA, Malla B, et al. The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells. Toxicol Res. 2011 Jun;27(2):85-93. PMID: 24278556.

 

Kawashima H, Tanaka T, Cheng JS, et al. Effect of anti-estrogens on the androgen receptor activity and cell proliferation in prostate cancer cells. Urol Res. 2004 Dec;32(6):406-10. PMID: 15316697.

 

Heidemann J, Ogawa H, Otterson MF, et al. Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases. Dis Colon Rectum. 2004 Jan;47(1):118-22. PMID: 14719159.

 

Raghow S, Hooshdaran MZ, Katiyar S, et al. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model. Cancer Res. 2002 Mar 1;62(5):1370-6. PMID: 11888907.

" "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Toremifene)

Marine pollutant: Yes"

LKT H1643 Helodermin 0.5 mg 228 Peptide originally found in Heloderma. Exendin 2 89468-62-2 ≥95% 3845.49 C176H283N45O51 CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N Ambient -20°C "Uddman R, Goadsby PJ, Jansen-Olesen I, et al. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999 Jan;19(1):61-7. PMID: 9886356.

 

Tanaka Y, Horikawa N, Ishiro H, et al. Glibenclamide-sensitive mechanism is involved in helodermin-produced vasodilatation in rat mesenteric artery. Res Commun Mol Pathol Pharmacol. 1997 Nov;98(2):141-56. PMID: 9467823.

 

Maruno K, Said SI. Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody. Life Sci. 1993;52(24):PL267-71. PMID: 8389407.

 

Grundemar L, Högestätt ED. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP). Br J Pharmacol. 1990 Mar;99(3):526-8. PMID: 2331581.

" Not dangerous goods.

LKT H1643 Helodermin 1 mg 387 Peptide originally found in Heloderma. Exendin 2 89468-62-2 ≥95% 3845.49 C176H283N45O51 CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N Ambient -20°C "Uddman R, Goadsby PJ, Jansen-Olesen I, et al. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999 Jan;19(1):61-7. PMID: 9886356.

 

Tanaka Y, Horikawa N, Ishiro H, et al. Glibenclamide-sensitive mechanism is involved in helodermin-produced vasodilatation in rat mesenteric artery. Res Commun Mol Pathol Pharmacol. 1997 Nov;98(2):141-56. PMID: 9467823.

 

Maruno K, Said SI. Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody. Life Sci. 1993;52(24):PL267-71. PMID: 8389407.

 

Grundemar L, Högestätt ED. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP). Br J Pharmacol. 1990 Mar;99(3):526-8. PMID: 2331581.

" Not dangerous goods.

LKT H1643 Helodermin 2.5 mg 684.1 Peptide originally found in Heloderma. Exendin 2 89468-62-2 ≥95% 3845.49 C176H283N45O51 CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N Ambient -20°C "Uddman R, Goadsby PJ, Jansen-Olesen I, et al. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999 Jan;19(1):61-7. PMID: 9886356.

 

Tanaka Y, Horikawa N, Ishiro H, et al. Glibenclamide-sensitive mechanism is involved in helodermin-produced vasodilatation in rat mesenteric artery. Res Commun Mol Pathol Pharmacol. 1997 Nov;98(2):141-56. PMID: 9467823.

 

Maruno K, Said SI. Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody. Life Sci. 1993;52(24):PL267-71. PMID: 8389407.

 

Grundemar L, Högestätt ED. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP). Br J Pharmacol. 1990 Mar;99(3):526-8. PMID: 2331581.

" Not dangerous goods.

LKT H1644 Helodormin 1 mg 690.2 Helodermin analog, peptide found in Heloderma. "5-L-isoleucine-8-L-glutamine-9-L-glutamine-

24-L-alanine-30-L-arginine-34-de-L-arginine-36-L-

prolinamide-37-de-L-serine-38-de-L-serine- Helospectin I

" Exendin 2; Helodermin; Heliodermin. 89468-62-2 ≥98% 3843.47 C176H285N47O49 CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N Ambient -20°C "Uddman R, Goadsby PJ, Jansen-Olesen I, et al. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999 Jan;19(1):61-7. PMID: 9886356.

 

Tanaka Y, Horikawa N, Ishiro H, et al. Glibenclamide-sensitive mechanism is involved in helodermin-produced vasodilatation in rat mesenteric artery. Res Commun Mol Pathol Pharmacol. 1997 Nov;98(2):141-56. PMID: 9467823.

 

Maruno K, Said SI. Small-cell lung carcinoma: inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by anti-bombesin antibody. Life Sci. 1993;52(24):PL267-71. PMID: 8389407.

 

Grundemar L, Högestätt ED. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP). Br J Pharmacol. 1990 Mar;99(3):526-8. PMID: 2331581.

"

LKT T5761 Topotecan Hydrochloride 1 mg 40.7 Captothecin derivative; topoisomerase I inhibitor. (4S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9- dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]- quinoline-3,14(4H,12H)-dione hydrochloride Hycamtin; NSC-609669; SKF-104864A 119413-54-6 ≥98% 457.91 C23H25N3O5 HCl CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O.Cl Hygroscopic Ambient Ambient Soluble in methanol, water (92 mg/ml at 25 °C), DMSO (92 mg/ml at 25 °C), ethanol (<1 mg/ml at 25 °C), and 1: 1 solution of DMSO: PBS (pH 7.2, ~0.5 mg/ml). "Attia SM, Ahmad SF, Abd-Ellah MF, et al. Germ cell mutagenicity of topoisomerase I inhibitor topotecan detected in the male mouse-dominant lethal study. Food Chem Toxicol. 2013 Dec;62:470-4. PMID: 24036143.

 

Zhang M, Shan BE, Yuan NF, et al. Effect of topotecan on retinocytoma cell apoptosis and expression of Livin and PTEN. Chin Med J (Engl). 2013 Jan;126(2):340-4. PMID: 23324287.

 

Caltová K, Cervinka M. Antiproliferative effects of selected chemotherapeutics in human ovarian cancer cell line A2780. Acta Medica (Hradec Kralove). 2012;55(3):116-24. PMID: 23297519.

 

Sonabend AM, Stuart RM, Yun J, et al. Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump. Neuro Oncol. 2011 Aug;13(8):886-893. PMID: 21750007.

" Mut., T ,Xi Not dangerous goods.

LKT T5761 Topotecan Hydrochloride 5 mg 61.1 Captothecin derivative; topoisomerase I inhibitor. (4S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9- dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]- quinoline-3,14(4H,12H)-dione hydrochloride Hycamtin; NSC-609669; SKF-104864A 119413-54-6 ≥98% 457.91 C23H25N3O5 HCl CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O.Cl Hygroscopic Ambient Ambient Soluble in methanol, water (92 mg/ml at 25 °C), DMSO (92 mg/ml at 25 °C), ethanol (<1 mg/ml at 25 °C), and 1: 1 solution of DMSO: PBS (pH 7.2, ~0.5 mg/ml). "Attia SM, Ahmad SF, Abd-Ellah MF, et al. Germ cell mutagenicity of topoisomerase I inhibitor topotecan detected in the male mouse-dominant lethal study. Food Chem Toxicol. 2013 Dec;62:470-4. PMID: 24036143.

 

Zhang M, Shan BE, Yuan NF, et al. Effect of topotecan on retinocytoma cell apoptosis and expression of Livin and PTEN. Chin Med J (Engl). 2013 Jan;126(2):340-4. PMID: 23324287.

 

Caltová K, Cervinka M. Antiproliferative effects of selected chemotherapeutics in human ovarian cancer cell line A2780. Acta Medica (Hradec Kralove). 2012;55(3):116-24. PMID: 23297519.

 

Sonabend AM, Stuart RM, Yun J, et al. Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump. Neuro Oncol. 2011 Aug;13(8):886-893. PMID: 21750007.

" Mut., T ,Xi Not dangerous goods.

LKT H1645 Helospectin I 1 mg 564 Peptide originally found in Heloderma. Exendin 1 93438-37-0 ≥95% 4095.66 C183H293N47O59 CCC(C)C(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)O)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N Ambient -20°C "Tsueshita T, Onyükusel H, Sethi V, et al. Helospectin I and II evoke vasodilation in the intact peripheral microcirculation. Peptides. 2004 Jan;25(1):65-9. PMID: 15003357.

 

Uddman R, Goadsby PJ, Jansen-Olesen I, et al. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999 Jan;19(1):61-7. PMID: 9886356.

 

Ahrén B. Effects of helospectin I on insulin and glucagon secretion in the mouse. Br J Pharmacol. 1991 Apr;102(4):916-8. PMID: 1855119.

 

Grundemar L, Högestätt ED. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP). Br J Pharmacol. 1990 Mar;99(3):526-8. PMID: 2331581.

"

LKT H1645 Helospectin I 2 mg 960 Peptide originally found in Heloderma. Exendin 1 93438-37-0 ≥95% 4095.66 C183H293N47O59 CCC(C)C(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)O)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N Ambient -20°C "Tsueshita T, Onyükusel H, Sethi V, et al. Helospectin I and II evoke vasodilation in the intact peripheral microcirculation. Peptides. 2004 Jan;25(1):65-9. PMID: 15003357.

 

Uddman R, Goadsby PJ, Jansen-Olesen I, et al. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999 Jan;19(1):61-7. PMID: 9886356.

 

Ahrén B. Effects of helospectin I on insulin and glucagon secretion in the mouse. Br J Pharmacol. 1991 Apr;102(4):916-8. PMID: 1855119.

 

Grundemar L, Högestätt ED. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP). Br J Pharmacol. 1990 Mar;99(3):526-8. PMID: 2331581.

"

LKT H1645 Helospectin I 5 mg 1692.2 Peptide originally found in Heloderma. Exendin 1 93438-37-0 ≥95% 4095.66 C183H293N47O59 CCC(C)C(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)O)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N Ambient -20°C "Tsueshita T, Onyükusel H, Sethi V, et al. Helospectin I and II evoke vasodilation in the intact peripheral microcirculation. Peptides. 2004 Jan;25(1):65-9. PMID: 15003357.

 

Uddman R, Goadsby PJ, Jansen-Olesen I, et al. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999 Jan;19(1):61-7. PMID: 9886356.

 

Ahrén B. Effects of helospectin I on insulin and glucagon secretion in the mouse. Br J Pharmacol. 1991 Apr;102(4):916-8. PMID: 1855119.

 

Grundemar L, Högestätt ED. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP). Br J Pharmacol. 1990 Mar;99(3):526-8. PMID: 2331581.

"

LKT H1646 Helospectin II 5 mg 1692.2 Peptide originally found in Heloderma. 93585-83-2 ≥95% 4008.58 C180H288N46O57 CCC(C)C(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(CO)C(=O)O)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N Ambient -20°C "Tsueshita T, Onyükusel H, Sethi V, et al. Helospectin I and II evoke vasodilation in the intact peripheral microcirculation. Peptides. 2004 Jan;25(1):65-9. PMID: 15003357.

 

Uddman R, Goadsby PJ, Jansen-Olesen I, et al. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999 Jan;19(1):61-7. PMID: 9886356.

 

Grundemar L, Högestätt ED. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP). Br J Pharmacol. 1990 Mar;99(3):526-8. PMID: 2331581.

"

LKT H1646 Helospectin II 2 mg 960 Peptide originally found in Heloderma. 93585-83-2 ≥95% 4008.58 C180H288N46O57 CCC(C)C(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(CO)C(=O)O)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N Ambient -20°C "Tsueshita T, Onyükusel H, Sethi V, et al. Helospectin I and II evoke vasodilation in the intact peripheral microcirculation. Peptides. 2004 Jan;25(1):65-9. PMID: 15003357.

 

Uddman R, Goadsby PJ, Jansen-Olesen I, et al. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999 Jan;19(1):61-7. PMID: 9886356.

 

Grundemar L, Högestätt ED. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP). Br J Pharmacol. 1990 Mar;99(3):526-8. PMID: 2331581.

"

LKT H1646 Helospectin II 1 mg 564 Peptide originally found in Heloderma. 93585-83-2 ≥95% 4008.58 C180H288N46O57 CCC(C)C(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(CO)C(=O)O)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N Ambient -20°C "Tsueshita T, Onyükusel H, Sethi V, et al. Helospectin I and II evoke vasodilation in the intact peripheral microcirculation. Peptides. 2004 Jan;25(1):65-9. PMID: 15003357.

 

Uddman R, Goadsby PJ, Jansen-Olesen I, et al. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999 Jan;19(1):61-7. PMID: 9886356.

 

Grundemar L, Högestätt ED. Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP). Br J Pharmacol. 1990 Mar;99(3):526-8. PMID: 2331581.

"

LKT H1648 Hemorphin-7 1 mg 120 Endogenous opioid peptide derived from the β-chain of hemoglobin; opioid agonist, ACE inhibitor. ≥95% 997.12 C49H64N12O11 CC(C(C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)N)O Ambient -20°C "Lantz I, Glämsta EL, Talbäck L, et al. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity. FEBS Lett. 1991 Aug 5;287(1-2):39-41. PMID: 1652464.

 

Liebmann C, Schrader U, Brantl V. Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin. Eur J Pharmacol. 1989 Aug 3;166(3):523-6. PMID: 2553436.

 

Davis TP, Gillespie TJ, Porreca F. Peptide fragments derived from the beta-chain of hemoglobin (hemorphins) are centrally active in vivo. Peptides. 1989 Jul-Aug;10(4):747-51. PMID: 2587417.

 

Brantl V, Gramsch C, Lottspeich F, et al. Novel opioid peptides derived from hemoglobin: hemorphins. Eur J Pharmacol. 1986 Jun 17;125(2):309-10. PMID: 3743640.

"

LKT H1648 Hemorphin-7 2 mg 204.1 Endogenous opioid peptide derived from the β-chain of hemoglobin; opioid agonist, ACE inhibitor. ≥95% 997.12 C49H64N12O11 CC(C(C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)N)O Ambient -20°C "Lantz I, Glämsta EL, Talbäck L, et al. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity. FEBS Lett. 1991 Aug 5;287(1-2):39-41. PMID: 1652464.

 

Liebmann C, Schrader U, Brantl V. Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin. Eur J Pharmacol. 1989 Aug 3;166(3):523-6. PMID: 2553436.

 

Davis TP, Gillespie TJ, Porreca F. Peptide fragments derived from the beta-chain of hemoglobin (hemorphins) are centrally active in vivo. Peptides. 1989 Jul-Aug;10(4):747-51. PMID: 2587417.

 

Brantl V, Gramsch C, Lottspeich F, et al. Novel opioid peptides derived from hemoglobin: hemorphins. Eur J Pharmacol. 1986 Jun 17;125(2):309-10. PMID: 3743640.

"

LKT H1648 Hemorphin-7 5 mg 359.9 Endogenous opioid peptide derived from the β-chain of hemoglobin; opioid agonist, ACE inhibitor. ≥95% 997.12 C49H64N12O11 CC(C(C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)N)O Ambient -20°C "Lantz I, Glämsta EL, Talbäck L, et al. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity. FEBS Lett. 1991 Aug 5;287(1-2):39-41. PMID: 1652464.

 

Liebmann C, Schrader U, Brantl V. Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin. Eur J Pharmacol. 1989 Aug 3;166(3):523-6. PMID: 2553436.

 

Davis TP, Gillespie TJ, Porreca F. Peptide fragments derived from the beta-chain of hemoglobin (hemorphins) are centrally active in vivo. Peptides. 1989 Jul-Aug;10(4):747-51. PMID: 2587417.

 

Brantl V, Gramsch C, Lottspeich F, et al. Novel opioid peptides derived from hemoglobin: hemorphins. Eur J Pharmacol. 1986 Jun 17;125(2):309-10. PMID: 3743640.

"

LKT H1657 Heparin-binding Peptide 0.5 mg 72.1 Peptide, binds heparin. Fibronectin Adhesion-Promoting Peptide 125720-21-0 ≥95% 1023.22 C47H74N16O10 CCC(C)C(C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C2CCCN2C(=O)C(CCC(=O)N)NC(=O)C(CC3=CNC4=CC=CC=C43)N Ambient -20°C "Chen HL, Her SY, Huang KC, et al. Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein. Biopolymers. 2010;94(3):331-8. PMID: 20069543.

 

Chon JH, Chaikof EL. Soluble heparin-binding peptides regulate chemokinesis and cell adhesive forces. Am J Physiol Cell Physiol. 2001 Jun;280(6):C1394-402. PMID: 11350734.

" Not dangerous goods.

LKT H1657 Heparin-binding Peptide 1 mg 123.1 Peptide, binds heparin. Fibronectin Adhesion-Promoting Peptide 125720-21-0 ≥95% 1023.22 C47H74N16O10 CCC(C)C(C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C2CCCN2C(=O)C(CCC(=O)N)NC(=O)C(CC3=CNC4=CC=CC=C43)N Ambient -20°C "Chen HL, Her SY, Huang KC, et al. Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein. Biopolymers. 2010;94(3):331-8. PMID: 20069543.

 

Chon JH, Chaikof EL. Soluble heparin-binding peptides regulate chemokinesis and cell adhesive forces. Am J Physiol Cell Physiol. 2001 Jun;280(6):C1394-402. PMID: 11350734.

" Not dangerous goods.

LKT H1657 Heparin-binding Peptide 2.5 mg 216.1 Peptide, binds heparin. Fibronectin Adhesion-Promoting Peptide 125720-21-0 ≥95% 1023.22 C47H74N16O10 CCC(C)C(C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C2CCCN2C(=O)C(CCC(=O)N)NC(=O)C(CC3=CNC4=CC=CC=C43)N Ambient -20°C "Chen HL, Her SY, Huang KC, et al. Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein. Biopolymers. 2010;94(3):331-8. PMID: 20069543.

 

Chon JH, Chaikof EL. Soluble heparin-binding peptides regulate chemokinesis and cell adhesive forces. Am J Physiol Cell Physiol. 2001 Jun;280(6):C1394-402. PMID: 11350734.

" Not dangerous goods.

LKT H1658 Heparin Sodium 1 g 109.4 Endogenous glycosaminoglycan that is produced by mast cells and basophils; Factor Xa inhibitor. Heparin sodium salt; Heprinar; Hepsal; Monoparin; Panheprin; Liquaemin Sodium; Minihep; Thrombophob; Unihep 9041-08-1 ≥98% 40006000 C12H17NO20S3 C(C1C(C(C(C(O1)O)NS(=O)(=O)[O-])O)OC2C(C(C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-] Hygroscopic. In DMSO at +4 for 2 weeks at -80 for 6 months. Ambient 4°C Soluble in water (50mg/mL) and saline solutions. Practically insoluble in alcohol, acetone, benzene, chloroform or ether. DMSO <1 mg/mL "Murray PB, Lax I, Reshetnyak A, et al. Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK. Sci Signal. 2015 Jan 20;8(360):ra6. PMID: 25605972.

 

Brkljacic J, Pauk M, Erjavec I, et al. Exogenous heparin binds and inhibits bone morphogenetic protein 6 biological activity. Int Orthop. 2013 Mar;37(3):529-41. PMID: 23307015.

 

Chuang YJ, Swanson R, Raja SM, et al. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin. J Biol Chem. 2001 May 4;276(18):14961-71. PMID: 11278930.

 

Yokoyama T, Takeuchi A, Yamamoto M, et al. Heparin enhances the cell-protein misfolding cyclic amplification efficiency of variant Creutzfeldt-Jakob disease. Neurosci Lett. 2011 Jul 8;498(2):119-123. PMID: 21565253. 

" None Not dangerous goods.

LKT H1662 HER2/neu (654-662) GP2 1 mg 120 Peptide fragment of HER2/neu/erbB2 receptor. ErbB2; EGFR2; CD340 ≥95% 884.12 C42H77N9O11 Ambient -20°C "Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.

 

Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.

"

LKT H1662 HER2/neu (654-662) GP2 2 mg 204.1 Peptide fragment of HER2/neu/erbB2 receptor. ErbB2; EGFR2; CD340 ≥95% 884.12 C42H77N9O11 Ambient -20°C "Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.

 

Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.

"

LKT H1662 HER2/neu (654-662) GP2 5 mg 359.9 Peptide fragment of HER2/neu/erbB2 receptor. ErbB2; EGFR2; CD340 ≥95% 884.12 C42H77N9O11 Ambient -20°C "Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.

 

Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.

"

LKT H1663 HER2/neu Fragment (869-877) 1 mg 72.1 Peptide, HER2/neu receptor fragment. ErbB2; EGFR2 ≥95% 1110.19 C49H75N9O20 Ambient -20°C "Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.

 

Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.

"

LKT H1663 HER2/neu Fragment (869-877) 2 mg 123.1 Peptide, HER2/neu receptor fragment. ErbB2; EGFR2 ≥95% 1110.19 C49H75N9O20 Ambient -20°C "Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.

 

Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.

"

LKT H1663 HER2/neu Fragment (869-877) 5 mg 216.1 Peptide, HER2/neu receptor fragment. ErbB2; EGFR2 ≥95% 1110.19 C49H75N9O20 Ambient -20°C "Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.

 

Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.

"

LKT T5677 Total Cell Death Assay Kit 125 Tests 606.9 Apoptosis measuring kit. Ambient 4°C

LKT T5677 Total Cell Death Assay Kit 250 Tests 1006 Apoptosis measuring kit. Ambient 4°C

LKT T5605 Tobramycin Sulfate 100 mg 52.3 Aminoglycoside; protein translation inhibitor. O-3-Amino-3-deoxy-α-D-glucopyranosyl-(1->6)-O- [2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl- (1->4)]-2-deoxy-D-streptamine sulfate Gernebcin; Nebcin; Nebicina; Tobra; Tobradistin 79645-27-5 ≥98% 1425.45 (C18H37N5O9)2 5H2SO4 C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N.OS(=O)(=O)O Ambient Ambient Soluble in water. "Papich MG. Antibiotic treatment of resistant infections in small animals. Vet Clin North Am Small Anim Pract. 2013 Sep;43(5):1091-107. PMID: 23890241.

 

Gziut M, MacGregor HJ, Nevell TG, et al. Anti-inflammatory effects of tobramycin and a copper-tobramycin complex with superoxide dismutase-like activity. Br J Pharmacol. 2013 Mar;168(5):1165-81. PMID: 23072509.

 

Nakamura S, Yanagihara K, Araki N, et al. High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells. Eur J Pharmacol. 2011 Mar 21. [Epub ahead of print]. PMID: 21414310.

 

Periti P. Tobramycin--clinical pharmacology and chemotherapy. J Chemother. 1996 Jan;8 Suppl 1:3-30. PMID: 8948764.

 

King P, Citron DM, Griffith DC, et al. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients. Diagn Microbiol Infect Dis. 2010 Feb;66(2):181-186. PMID: 19828274. " T Not dangerous goods.

LKT T5605 Tobramycin Sulfate 500 mg 224.3 Aminoglycoside; protein translation inhibitor. O-3-Amino-3-deoxy-α-D-glucopyranosyl-(1->6)-O- [2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl- (1->4)]-2-deoxy-D-streptamine sulfate Gernebcin; Nebcin; Nebicina; Tobra; Tobradistin 79645-27-5 ≥98% 1425.45 (C18H37N5O9)2 5H2SO4 C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N.OS(=O)(=O)O Ambient Ambient Soluble in water. "Papich MG. Antibiotic treatment of resistant infections in small animals. Vet Clin North Am Small Anim Pract. 2013 Sep;43(5):1091-107. PMID: 23890241.

 

Gziut M, MacGregor HJ, Nevell TG, et al. Anti-inflammatory effects of tobramycin and a copper-tobramycin complex with superoxide dismutase-like activity. Br J Pharmacol. 2013 Mar;168(5):1165-81. PMID: 23072509.

 

Nakamura S, Yanagihara K, Araki N, et al. High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells. Eur J Pharmacol. 2011 Mar 21. [Epub ahead of print]. PMID: 21414310.

 

Periti P. Tobramycin--clinical pharmacology and chemotherapy. J Chemother. 1996 Jan;8 Suppl 1:3-30. PMID: 8948764.

 

King P, Citron DM, Griffith DC, et al. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients. Diagn Microbiol Infect Dis. 2010 Feb;66(2):181-186. PMID: 19828274. " T Not dangerous goods.

LKT T5605 Tobramycin Sulfate 1 g 285.4 Aminoglycoside; protein translation inhibitor. O-3-Amino-3-deoxy-α-D-glucopyranosyl-(1->6)-O- [2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl- (1->4)]-2-deoxy-D-streptamine sulfate Gernebcin; Nebcin; Nebicina; Tobra; Tobradistin 79645-27-5 ≥98% 1425.45 (C18H37N5O9)2 5H2SO4 C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N.OS(=O)(=O)O Ambient Ambient Soluble in water. "Papich MG. Antibiotic treatment of resistant infections in small animals. Vet Clin North Am Small Anim Pract. 2013 Sep;43(5):1091-107. PMID: 23890241.

 

Gziut M, MacGregor HJ, Nevell TG, et al. Anti-inflammatory effects of tobramycin and a copper-tobramycin complex with superoxide dismutase-like activity. Br J Pharmacol. 2013 Mar;168(5):1165-81. PMID: 23072509.

 

Nakamura S, Yanagihara K, Araki N, et al. High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells. Eur J Pharmacol. 2011 Mar 21. [Epub ahead of print]. PMID: 21414310.

 

Periti P. Tobramycin--clinical pharmacology and chemotherapy. J Chemother. 1996 Jan;8 Suppl 1:3-30. PMID: 8948764.

 

King P, Citron DM, Griffith DC, et al. Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients. Diagn Microbiol Infect Dis. 2010 Feb;66(2):181-186. PMID: 19828274. " T Not dangerous goods.

LKT T5604 Tobramycin, Free Base 25 mg 49.5 Aminoglycoside; protein translation inhibitor. O-3-Amino-3-deoxy-α-d-glucopyranosyl-(1->6)-O- [2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl- (1->4)]-2-deoxy-D-streptamine Nebramycin factor 6; NF 6; Tobracin; Tobralex; Tobramaxin; Tobrex 32986-56-4 ≥98% 467.51 C18H37N5O9 C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N Ambient Ambient Soluble in water. Slightly soluble in ethanol. Practically insoluble in ether or chloroform. "Papich MG. Antibiotic treatment of resistant infections in small animals. Vet Clin North Am Small Anim Pract. 2013 Sep;43(5):1091-107. PMID: 23890241.

 

Gziut M, MacGregor HJ, Nevell TG, et al. Anti-inflammatory effects of tobramycin and a copper-tobramycin complex with superoxide dismutase-like activity. Br J Pharmacol. 2013 Mar;168(5):1165-81. PMID: 23072509.

 

Nakamura S, Yanagihara K, Araki N, et al. High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells. Eur J Pharmacol. 2011 Mar 21. [Epub ahead of print]. PMID: 21414310.

 

Periti P. Tobramycin--clinical pharmacology and chemotherapy. J Chemother. 1996 Jan;8 Suppl 1:3-30. PMID: 8948764.

" None Not dangerous goods.

LKT H1794 Hexamethonium Bromide Hydrate 10 g 46.2 Non-depolarizing NMJ blocker; nAChR antagonist. N,N,N,N',N',N'-Hexamethyl-1,6-hexanediaminium Hexamethonium bromide; C-6; Bistrium bromide; Esametine; Gangliostate; Simpatoblock; Vegolysin 55-97-0 ≥98% 362.2 C12H30Br2N2 xH2O C[N+](C)(C)CCCCCC[N+](C)(C)C.[Br-].[Br-] Hygroscopic. Ambient Ambient Soluble in water or alcohol. Insoluble in acetone, chloroform or ether. Barnett AJ, Fraser JR. The mechanism of arterial hypertension: a comparison of the effects of hexamethonium bromide in hypertensive and normotensive persons. Australas Ann Med. 1954 May;3(2):152-9. PMID: 13159745. None Not dangerous goods.

LKT H1794 Hexamethonium Bromide Hydrate 25 g 81 Non-depolarizing NMJ blocker; nAChR antagonist. N,N,N,N',N',N'-Hexamethyl-1,6-hexanediaminium Hexamethonium bromide; C-6; Bistrium bromide; Esametine; Gangliostate; Simpatoblock; Vegolysin 55-97-0 ≥98% 362.2 C12H30Br2N2 xH2O C[N+](C)(C)CCCCCC[N+](C)(C)C.[Br-].[Br-] Hygroscopic. Ambient Ambient Soluble in water or alcohol. Insoluble in acetone, chloroform or ether. Barnett AJ, Fraser JR. The mechanism of arterial hypertension: a comparison of the effects of hexamethonium bromide in hypertensive and normotensive persons. Australas Ann Med. 1954 May;3(2):152-9. PMID: 13159745. None Not dangerous goods.

LKT T5604 Tobramycin, Free Base 100 mg 74.8 Aminoglycoside; protein translation inhibitor. O-3-Amino-3-deoxy-α-d-glucopyranosyl-(1->6)-O- [2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl- (1->4)]-2-deoxy-D-streptamine Nebramycin factor 6; NF 6; Tobracin; Tobralex; Tobramaxin; Tobrex 32986-56-4 ≥98% 467.51 C18H37N5O9 C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N Ambient Ambient Soluble in water. Slightly soluble in ethanol. Practically insoluble in ether or chloroform. "Papich MG. Antibiotic treatment of resistant infections in small animals. Vet Clin North Am Small Anim Pract. 2013 Sep;43(5):1091-107. PMID: 23890241.

 

Gziut M, MacGregor HJ, Nevell TG, et al. Anti-inflammatory effects of tobramycin and a copper-tobramycin complex with superoxide dismutase-like activity. Br J Pharmacol. 2013 Mar;168(5):1165-81. PMID: 23072509.

 

Nakamura S, Yanagihara K, Araki N, et al. High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells. Eur J Pharmacol. 2011 Mar 21. [Epub ahead of print]. PMID: 21414310.

 

Periti P. Tobramycin--clinical pharmacology and chemotherapy. J Chemother. 1996 Jan;8 Suppl 1:3-30. PMID: 8948764.

" None Not dangerous goods.

LKT H1794 Hexamethonium Bromide Hydrate 100 g 236.3 Non-depolarizing NMJ blocker; nAChR antagonist. N,N,N,N',N',N'-Hexamethyl-1,6-hexanediaminium Hexamethonium bromide; C-6; Bistrium bromide; Esametine; Gangliostate; Simpatoblock; Vegolysin 55-97-0 ≥98% 362.2 C12H30Br2N2 xH2O C[N+](C)(C)CCCCCC[N+](C)(C)C.[Br-].[Br-] Hygroscopic. Ambient Ambient Soluble in water or alcohol. Insoluble in acetone, chloroform or ether. Barnett AJ, Fraser JR. The mechanism of arterial hypertension: a comparison of the effects of hexamethonium bromide in hypertensive and normotensive persons. Australas Ann Med. 1954 May;3(2):152-9. PMID: 13159745. None Not dangerous goods.

LKT T5604 Tobramycin, Free Base 500 mg 336.4 Aminoglycoside; protein translation inhibitor. O-3-Amino-3-deoxy-α-d-glucopyranosyl-(1->6)-O- [2,6-diamino-2,3,6-trideoxy-α-D-ribo-hexopyranosyl- (1->4)]-2-deoxy-D-streptamine Nebramycin factor 6; NF 6; Tobracin; Tobralex; Tobramaxin; Tobrex 32986-56-4 ≥98% 467.51 C18H37N5O9 C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N Ambient Ambient Soluble in water. Slightly soluble in ethanol. Practically insoluble in ether or chloroform. "Papich MG. Antibiotic treatment of resistant infections in small animals. Vet Clin North Am Small Anim Pract. 2013 Sep;43(5):1091-107. PMID: 23890241.

 

Gziut M, MacGregor HJ, Nevell TG, et al. Anti-inflammatory effects of tobramycin and a copper-tobramycin complex with superoxide dismutase-like activity. Br J Pharmacol. 2013 Mar;168(5):1165-81. PMID: 23072509.

 

Nakamura S, Yanagihara K, Araki N, et al. High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells. Eur J Pharmacol. 2011 Mar 21. [Epub ahead of print]. PMID: 21414310.

 

Periti P. Tobramycin--clinical pharmacology and chemotherapy. J Chemother. 1996 Jan;8 Suppl 1:3-30. PMID: 8948764.

" None Not dangerous goods.

LKT H1892 Hexamethylene Bisacetamide 25 g 57.8 HEXIM1 activator. N,N'-Hexamethylene (bis)acetamide N,N'-Diacetyl-1,6-hexanediamine; HMBA 3073-59-4 ≥98% 200.28 C10H20N2O2 CC(=O)NCCCCCCNC(=O)C Ambient Ambient Soluble in water or ethanol. "Lew QJ, Chia YL, Chu KL, et al. Identification of HEXIM1 as a positive regulator of p53. J Biol Chem. 2012 Oct 19;287(43):36443-54. PMID: 22948151.

 

Dey A, Wong E, Kua N, et al. Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF kappaB activity: implications for cancer therapy. Cell Cycle. 2008 Dec;7(23):3759-67. PMID: 19029824.

 

Zhang Z, Liong EC, Lau TY, et al. Induction of apoptosis by hexamethylene bisacetamide is p53-dependent associated with telomerase activity but not with terminal differentiation. Int J Oncol. 2000 May;16(5):887-92. PMID: 10762623.

" Not dangerous goods.

LKT H1892 Hexamethylene Bisacetamide 50 g 92.2 HEXIM1 activator. N,N'-Hexamethylene (bis)acetamide N,N'-Diacetyl-1,6-hexanediamine; HMBA 3073-59-4 ≥98% 200.28 C10H20N2O2 CC(=O)NCCCCCCNC(=O)C Ambient Ambient Soluble in water or ethanol. "Lew QJ, Chia YL, Chu KL, et al. Identification of HEXIM1 as a positive regulator of p53. J Biol Chem. 2012 Oct 19;287(43):36443-54. PMID: 22948151.

 

Dey A, Wong E, Kua N, et al. Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF kappaB activity: implications for cancer therapy. Cell Cycle. 2008 Dec;7(23):3759-67. PMID: 19029824.

 

Zhang Z, Liong EC, Lau TY, et al. Induction of apoptosis by hexamethylene bisacetamide is p53-dependent associated with telomerase activity but not with terminal differentiation. Int J Oncol. 2000 May;16(5):887-92. PMID: 10762623.

" Not dangerous goods.

LKT H1893 Hexarelin 1 mg 161.2 Synthetic ghrelin analog; ghrelin agonist. "L-histidyl-2-methyl-D-tryptophyl-L-alanyl-L-

tryptophyl-D-phenylalanyl-L-Lysinamide

 

" Examorelin 140703-51-1 ≥95% 887 C47H58N12O6 CC1=C(C2=CC=CC=C2N1)CC(C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CN=CN6)N Stable at room temperature for about 3 weeks. Ambient -20°C Soluble in water. "Mao Y, Tokudome T, Kishimoto I, et al. One dose of oral hexarelin protects chronic cardiac function after myocardial infarction. Peptides. 2014 Apr 18;56C:156-162. PMID: 24747279.

 

Xu X, Ding F, Pang J, et al. Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2012 Sep 15;303(6):H703-11. PMID: 22842067.

 

Puechagut PB, Martini AC, Stutz G, et al. Reproductive performance and fertility in male and female adult mice chronically treated with hexarelin. Reprod Fertil Dev. 2012;24(3):451-60. PMID: 22401277.

" Not dangerous goods.

LKT H1893 Hexarelin 5 mg 672.2 Synthetic ghrelin analog; ghrelin agonist. "L-histidyl-2-methyl-D-tryptophyl-L-alanyl-L-

tryptophyl-D-phenylalanyl-L-Lysinamide

 

" Examorelin 140703-51-1 ≥95% 887 C47H58N12O6 CC1=C(C2=CC=CC=C2N1)CC(C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CN=CN6)N Stable at room temperature for about 3 weeks. Ambient -20°C Soluble in water. "Mao Y, Tokudome T, Kishimoto I, et al. One dose of oral hexarelin protects chronic cardiac function after myocardial infarction. Peptides. 2014 Apr 18;56C:156-162. PMID: 24747279.

 

Xu X, Ding F, Pang J, et al. Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2012 Sep 15;303(6):H703-11. PMID: 22842067.

 

Puechagut PB, Martini AC, Stutz G, et al. Reproductive performance and fertility in male and female adult mice chronically treated with hexarelin. Reprod Fertil Dev. 2012;24(3):451-60. PMID: 22401277.

" Not dangerous goods.

LKT H1893 Hexarelin 50 mg 3360.2 Synthetic ghrelin analog; ghrelin agonist. "L-histidyl-2-methyl-D-tryptophyl-L-alanyl-L-

tryptophyl-D-phenylalanyl-L-Lysinamide

 

" Examorelin 140703-51-1 ≥95% 887 C47H58N12O6 CC1=C(C2=CC=CC=C2N1)CC(C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CN=CN6)N Stable at room temperature for about 3 weeks. Ambient -20°C Soluble in water. "Mao Y, Tokudome T, Kishimoto I, et al. One dose of oral hexarelin protects chronic cardiac function after myocardial infarction. Peptides. 2014 Apr 18;56C:156-162. PMID: 24747279.

 

Xu X, Ding F, Pang J, et al. Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2012 Sep 15;303(6):H703-11. PMID: 22842067.

 

Puechagut PB, Martini AC, Stutz G, et al. Reproductive performance and fertility in male and female adult mice chronically treated with hexarelin. Reprod Fertil Dev. 2012;24(3):451-60. PMID: 22401277.

" Not dangerous goods.

LKT H1894 Hexestrol 1 g 47.6 Synthetic catechol; ER agonist, microtubule polymerization inhibitor, potential carcinogen. 4,4'-(1,2-Diethylethyl-1,2-ethanediyl)bisphenol Dihydrodiethylstilbestrol; Synthovo; Cycloestrol; Hormoestrol; Syntrogene 84-16-2 ≥98% 270.37 C18H22O2 CCC(C1=CC=C(C=C1)O)C(CC)C2=CC=C(C=C2)O Ambient Ambient Soluble in ether, acetone, alcohol, and methanol. Slightly soluble in benzene and chloroform. "Cavalieri EL, Rogan EG. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann N Y Acad Sci. 2004 Dec;1028:247-57. PMID: 15650250.

 

Chaudoreille MM, Peyrot V, Braguer D, et al. Qualitative study of the interaction mechanism of estrogenic drugs with tubulin. Biochem Pharmacol. 1991 Mar 1;41(5):685-93. PMID: 1847811.

 

Wheeler WJ, Cherry LM, Downs T, et al. Mitotic inhibition and aneuploidy induction by naturally occurring and synthetic estrogens in Chinese hamster cells in vitro. Mutat Res. 1986 Jul;171(1):31-41. PMID: 3724781.

" Carc. Not dangerous goods.

LKT H1894 Hexestrol 5 g 163.2 Synthetic catechol; ER agonist, microtubule polymerization inhibitor, potential carcinogen. 4,4'-(1,2-Diethylethyl-1,2-ethanediyl)bisphenol Dihydrodiethylstilbestrol; Synthovo; Cycloestrol; Hormoestrol; Syntrogene 84-16-2 ≥98% 270.37 C18H22O2 CCC(C1=CC=C(C=C1)O)C(CC)C2=CC=C(C=C2)O Ambient Ambient Soluble in ether, acetone, alcohol, and methanol. Slightly soluble in benzene and chloroform. "Cavalieri EL, Rogan EG. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann N Y Acad Sci. 2004 Dec;1028:247-57. PMID: 15650250.

 

Chaudoreille MM, Peyrot V, Braguer D, et al. Qualitative study of the interaction mechanism of estrogenic drugs with tubulin. Biochem Pharmacol. 1991 Mar 1;41(5):685-93. PMID: 1847811.

 

Wheeler WJ, Cherry LM, Downs T, et al. Mitotic inhibition and aneuploidy induction by naturally occurring and synthetic estrogens in Chinese hamster cells in vitro. Mutat Res. 1986 Jul;171(1):31-41. PMID: 3724781.

" Carc. Not dangerous goods.

LKT H2876 H-Trp-Gly-OH 1 mg 209.8 Dipeptide, used in UV absorption and fluorescence studies. Trp-Gly ≥98% 261.28 C13H13N3O2 Ambient -20°C "Ehlerding A, Wyer JA, Zettergren H, et al. UV photodissociation of protonated Gly-Trp and Trp-Gly dipeptides and their complexes with crown ether in an electrostatic ion storage ring. J Phys Chem A. 2010 Jan 14;114(1):299-303. PMID: 19958010.

 

Valdés H, Reha D, Hobza P. Structure of isolated tryptophyl-glycine dipeptide and tryptophyl-glycyl-glycine tripeptide: ab initio SCC-DFTB-D molecular dynamics simulations and high-level correlated ab initio quantum chemical calculations. J Phys Chem B. 2006 Mar 30;110(12):6385-96. PMID: 16553458.

" Not dangerous goods.

LKT H2980 Humanin, human 0.5 mg 228 Endogenous peptide; FPRL1/2 agonist. 330936-69-1 ≥95% 2687.28 C119H204N34O32S2 CCC(C)C(C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CS)NC(=O)C(CO)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C3CCCN3C(=O)C(C)NC(=O)C(CCSC)N Ambient -20°C "Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M, Sepehrizadeh Z, et al. Genome expression analysis by suppression subtractive hybridization identified overexpression of Humanin, a target gene in gastric cancer chemoresistance. Daru. 2014 Jan 8;22(1):14. PMID: 24401285.

 

Zhao ST, Huang XT, Zhang C, et al. Humanin protects cortical neurons from ischemia and reperfusion injury by the increased activity of superoxide dismutase. Neurochem Res. 2012 Jan;37(1):153-60. PMID: 21935731.

 

Zapała B, Kaczyński Ł, Kieć-Wilk B, et al. Humanins, the neuroprotective and cytoprotective peptides with antiapoptotic and anti-inflammatory properties. Pharmacol Rep. 2010 Sep-Oct;62(5):767-77. PMID: 21098860.

 

Niikura T, Tajima H, Kita Y. Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin. Curr Neuropharmacol. 2006 Apr;4(2):139-47. PMID: 18615127.

 

Zhai D, Luciano F, Zhu X, et al. Humanin binds and nullifies Bid activity by blocking its activation of Bax and Bak. J Biol Chem. 2005 Apr 22;280(16):15815-24. PMID: 15661737.

 

Ying G, Iribarren P, Zhou Y, et al. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol. 2004 Jun 1;172(11):7078-85. PMID: 15153530.

" Not dangerous goods.

LKT H2980 Humanin, human 1 mg 390.2 Endogenous peptide; FPRL1/2 agonist. 330936-69-1 ≥95% 2687.28 C119H204N34O32S2 CCC(C)C(C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CS)NC(=O)C(CO)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C3CCCN3C(=O)C(C)NC(=O)C(CCSC)N Ambient -20°C "Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M, Sepehrizadeh Z, et al. Genome expression analysis by suppression subtractive hybridization identified overexpression of Humanin, a target gene in gastric cancer chemoresistance. Daru. 2014 Jan 8;22(1):14. PMID: 24401285.

 

Zhao ST, Huang XT, Zhang C, et al. Humanin protects cortical neurons from ischemia and reperfusion injury by the increased activity of superoxide dismutase. Neurochem Res. 2012 Jan;37(1):153-60. PMID: 21935731.

 

Zapała B, Kaczyński Ł, Kieć-Wilk B, et al. Humanins, the neuroprotective and cytoprotective peptides with antiapoptotic and anti-inflammatory properties. Pharmacol Rep. 2010 Sep-Oct;62(5):767-77. PMID: 21098860.

 

Niikura T, Tajima H, Kita Y. Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin. Curr Neuropharmacol. 2006 Apr;4(2):139-47. PMID: 18615127.

 

Zhai D, Luciano F, Zhu X, et al. Humanin binds and nullifies Bid activity by blocking its activation of Bax and Bak. J Biol Chem. 2005 Apr 22;280(16):15815-24. PMID: 15661737.

 

Ying G, Iribarren P, Zhou Y, et al. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol. 2004 Jun 1;172(11):7078-85. PMID: 15153530.

" Not dangerous goods.

LKT H2980 Humanin, human 2.5 mg 684.1 Endogenous peptide; FPRL1/2 agonist. 330936-69-1 ≥95% 2687.28 C119H204N34O32S2 CCC(C)C(C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CS)NC(=O)C(CO)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C3CCCN3C(=O)C(C)NC(=O)C(CCSC)N Ambient -20°C "Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M, Sepehrizadeh Z, et al. Genome expression analysis by suppression subtractive hybridization identified overexpression of Humanin, a target gene in gastric cancer chemoresistance. Daru. 2014 Jan 8;22(1):14. PMID: 24401285.

 

Zhao ST, Huang XT, Zhang C, et al. Humanin protects cortical neurons from ischemia and reperfusion injury by the increased activity of superoxide dismutase. Neurochem Res. 2012 Jan;37(1):153-60. PMID: 21935731.

 

Zapała B, Kaczyński Ł, Kieć-Wilk B, et al. Humanins, the neuroprotective and cytoprotective peptides with antiapoptotic and anti-inflammatory properties. Pharmacol Rep. 2010 Sep-Oct;62(5):767-77. PMID: 21098860.

 

Niikura T, Tajima H, Kita Y. Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin. Curr Neuropharmacol. 2006 Apr;4(2):139-47. PMID: 18615127.

 

Zhai D, Luciano F, Zhu X, et al. Humanin binds and nullifies Bid activity by blocking its activation of Bax and Bak. J Biol Chem. 2005 Apr 22;280(16):15815-24. PMID: 15661737.

 

Ying G, Iribarren P, Zhou Y, et al. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol. 2004 Jun 1;172(11):7078-85. PMID: 15153530.

" Not dangerous goods.

LKT T3468 Tirapazamine 10 mg 60.7 Topoisomerase II inhibitor, RPA modulator. SR 4233 27314-97-2  ≥98% 178.15 C7H6N4O2 C1=CC=C2C(=C1)N(C(=N)N=[N+]2[O-])O Ambient Ambient "Zhang J, Cao J, Weng Q, et al. Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway. PLoS One. 2010 Nov 9;5(11):e13910. PMID: 21085474.

 

Yang B, Reynolds CP. Tirapazamine cytotoxicity for neuroblastoma is p53 dependent. Clin Cancer Res. 2005 Apr 1;11(7):2774-80. PMID: 15814660.

 

Peters KB, Wang H, Brown JM, et al. Inhibition of DNA replication by tirapazamine. Cancer Res. 2001 Jul 15;61(14):5425-31. PMID: 11454687.

 

Brown JM, Wang LH. Tirapazamine: laboratory data relevant to clinical activity. Anticancer Drug Des. 1998 Sep;13(6):529-39. PMID: 9755717.

" Xi Not dangerous goods.

LKT T3468 Tirapazamine 25 mg 121.4 Topoisomerase II inhibitor, RPA modulator. SR 4233 27314-97-2  ≥98% 178.15 C7H6N4O2 C1=CC=C2C(=C1)N(C(=N)N=[N+]2[O-])O Ambient Ambient "Zhang J, Cao J, Weng Q, et al. Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway. PLoS One. 2010 Nov 9;5(11):e13910. PMID: 21085474.

 

Yang B, Reynolds CP. Tirapazamine cytotoxicity for neuroblastoma is p53 dependent. Clin Cancer Res. 2005 Apr 1;11(7):2774-80. PMID: 15814660.

 

Peters KB, Wang H, Brown JM, et al. Inhibition of DNA replication by tirapazamine. Cancer Res. 2001 Jul 15;61(14):5425-31. PMID: 11454687.

 

Brown JM, Wang LH. Tirapazamine: laboratory data relevant to clinical activity. Anticancer Drug Des. 1998 Sep;13(6):529-39. PMID: 9755717.

" Xi Not dangerous goods.

LKT T3468 Tirapazamine 100 mg 339.8 Topoisomerase II inhibitor, RPA modulator. SR 4233 27314-97-2  ≥98% 178.15 C7H6N4O2 C1=CC=C2C(=C1)N(C(=N)N=[N+]2[O-])O Ambient Ambient "Zhang J, Cao J, Weng Q, et al. Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway. PLoS One. 2010 Nov 9;5(11):e13910. PMID: 21085474.

 

Yang B, Reynolds CP. Tirapazamine cytotoxicity for neuroblastoma is p53 dependent. Clin Cancer Res. 2005 Apr 1;11(7):2774-80. PMID: 15814660.

 

Peters KB, Wang H, Brown JM, et al. Inhibition of DNA replication by tirapazamine. Cancer Res. 2001 Jul 15;61(14):5425-31. PMID: 11454687.

 

Brown JM, Wang LH. Tirapazamine: laboratory data relevant to clinical activity. Anticancer Drug Des. 1998 Sep;13(6):529-39. PMID: 9755717.

" Xi Not dangerous goods.

LKT H3272 His Tag 5 mg 359.9 Six-histidine peptide used for affinity column purification. polyhistidine-tag, hex histidine-tag, 6xHis-tag, His-tagR ≥98% 822.85 C36H42N18O6 Ambient -20°C Zhao C, Hellman LM, Zhan X, et al. Hexahistidine-tag-specific optical probes for analyses of proteins and their interactions. Anal Biochem. 2010 Apr 15;399(2):237-45. PMID: 20036207.

LKT H3273 Histatin 5 0.5 mg 228 Endogenous antimicrobial peptide, binds bacterial DNA. 115966-68-2 ≥95% 3036.36 C133H195N51O33 CC(C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CN=CN2)C(=O)NCC(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC5=CN=CN5)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC6=CN=CN6)C(=O)NC(CC7=CN=CN7)C(=O)NC(CO)C(=O)NC(CC8=CN=CN8)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC9=CC=C(C=C9)O)C(=O)O)NC(=O)C(CC1=CN=CN1)NC(=O)C(CO)NC(=O)C(CC(=O)O)N Ambient -20°C "Borgwardt DS, Martin AD, Van Hemert JR, et al. Histatin 5 binds to Porphyromonas gingivalis hemagglutinin B (HagB) and alters HagB-induced chemokine responses. Sci Rep. 2014 Jan 29;4:3904. PMID: 24473528.

 

Huo L, Zhang K, Ling J, et al. Antimicrobial and DNA-binding activities of the peptide fragments of human lactoferrin and histatin 5 against Streptococcus mutans. Arch Oral Biol. 2011 Sep;56(9):869-76. PMID: 21382611.

 

Peters BM, Zhu J, Fidel PL Jr, et al. Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection. FEMS Yeast Res. 2010 Aug 1;10(5):597-604. PMID: 20491938.

 

Jang WS, Bajwa JS, Sun JN, et al. Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans. Mol Microbiol. 2010 Jul;77(2):354-70. PMID: 20487276.

" Not dangerous goods.

LKT H3273 Histatin 5 1 mg 387 Endogenous antimicrobial peptide, binds bacterial DNA. 115966-68-2 ≥95% 3036.36 C133H195N51O33 CC(C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CN=CN2)C(=O)NCC(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC5=CN=CN5)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC6=CN=CN6)C(=O)NC(CC7=CN=CN7)C(=O)NC(CO)C(=O)NC(CC8=CN=CN8)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC9=CC=C(C=C9)O)C(=O)O)NC(=O)C(CC1=CN=CN1)NC(=O)C(CO)NC(=O)C(CC(=O)O)N Ambient -20°C "Borgwardt DS, Martin AD, Van Hemert JR, et al. Histatin 5 binds to Porphyromonas gingivalis hemagglutinin B (HagB) and alters HagB-induced chemokine responses. Sci Rep. 2014 Jan 29;4:3904. PMID: 24473528.

 

Huo L, Zhang K, Ling J, et al. Antimicrobial and DNA-binding activities of the peptide fragments of human lactoferrin and histatin 5 against Streptococcus mutans. Arch Oral Biol. 2011 Sep;56(9):869-76. PMID: 21382611.

 

Peters BM, Zhu J, Fidel PL Jr, et al. Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection. FEMS Yeast Res. 2010 Aug 1;10(5):597-604. PMID: 20491938.

 

Jang WS, Bajwa JS, Sun JN, et al. Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans. Mol Microbiol. 2010 Jul;77(2):354-70. PMID: 20487276.

" Not dangerous goods.

LKT H3273 Histatin 5 2.5 mg 684.1 Endogenous antimicrobial peptide, binds bacterial DNA. 115966-68-2 ≥95% 3036.36 C133H195N51O33 CC(C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CN=CN2)C(=O)NCC(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC5=CN=CN5)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC6=CN=CN6)C(=O)NC(CC7=CN=CN7)C(=O)NC(CO)C(=O)NC(CC8=CN=CN8)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC9=CC=C(C=C9)O)C(=O)O)NC(=O)C(CC1=CN=CN1)NC(=O)C(CO)NC(=O)C(CC(=O)O)N Ambient -20°C "Borgwardt DS, Martin AD, Van Hemert JR, et al. Histatin 5 binds to Porphyromonas gingivalis hemagglutinin B (HagB) and alters HagB-induced chemokine responses. Sci Rep. 2014 Jan 29;4:3904. PMID: 24473528.

 

Huo L, Zhang K, Ling J, et al. Antimicrobial and DNA-binding activities of the peptide fragments of human lactoferrin and histatin 5 against Streptococcus mutans. Arch Oral Biol. 2011 Sep;56(9):869-76. PMID: 21382611.

 

Peters BM, Zhu J, Fidel PL Jr, et al. Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection. FEMS Yeast Res. 2010 Aug 1;10(5):597-604. PMID: 20491938.

 

Jang WS, Bajwa JS, Sun JN, et al. Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans. Mol Microbiol. 2010 Jul;77(2):354-70. PMID: 20487276.

" Not dangerous goods.

LKT T3454 Tinidazole 100 g 88.3 Nitroimidazole, binds DNA; nucleic acid synthesis inhibitor. 1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitroimidazole Fasigin; Trimonase; Pletil; Simplotan; Tinidazol 19387-91-8 ≥98% 247.27 C8H13N3O4S CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C Ambient Ambient Insoluble in water; soluble in most organic solvents.  Soluble in DMSO to 49 mg/ml. "Penuliar GM, Furukawa A, Sato D, et al. Mechanism of trifluoromethionine resistance in Entamoeba histolytica. J Antimicrob Chemother. 2011 Sep;66(9):2045-52. PMID: 21676903.

 

Hsu CC, Chen JJ, Hu TH, et al. Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2001 Aug;13(8):921-6. PMID: 11507356.

" Carc., Xn Not dangerous goods.

LKT T3454 Tinidazole 250 g 163.2 Nitroimidazole, binds DNA; nucleic acid synthesis inhibitor. 1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitroimidazole Fasigin; Trimonase; Pletil; Simplotan; Tinidazol 19387-91-8 ≥98% 247.27 C8H13N3O4S CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C Ambient Ambient Insoluble in water; soluble in most organic solvents.  Soluble in DMSO to 49 mg/ml. "Penuliar GM, Furukawa A, Sato D, et al. Mechanism of trifluoromethionine resistance in Entamoeba histolytica. J Antimicrob Chemother. 2011 Sep;66(9):2045-52. PMID: 21676903.

 

Hsu CC, Chen JJ, Hu TH, et al. Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2001 Aug;13(8):921-6. PMID: 11507356.

" Carc., Xn Not dangerous goods.

LKT H3274 HIV p17 Gag (77-85) 1 mg 149.9 Immunodominant HIV Gag epitope. ≥98% 981.1 C44H72N10O15 Ambient -20°C "Kan-Mitchell J, Bajcz M, Schaubert KL, et al. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response. J Immunol. 2006 Jun 1;176(11):6690-701. PMID: 16709828.

 

Kan-Mitchell J, Bisikirska B, Wong-Staal F, et al. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. J Immunol. 2004 May 1;172(9):5249-61. PMID: 15100263.

"

LKT H3274 HIV p17 Gag (77-85) 2 mg 255 Immunodominant HIV Gag epitope. ≥98% 981.1 C44H72N10O15 Ambient -20°C "Kan-Mitchell J, Bajcz M, Schaubert KL, et al. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response. J Immunol. 2006 Jun 1;176(11):6690-701. PMID: 16709828.

 

Kan-Mitchell J, Bisikirska B, Wong-Staal F, et al. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. J Immunol. 2004 May 1;172(9):5249-61. PMID: 15100263.

"

LKT H3274 HIV p17 Gag (77-85) 5 mg 450 Immunodominant HIV Gag epitope. ≥98% 981.1 C44H72N10O15 Ambient -20°C "Kan-Mitchell J, Bajcz M, Schaubert KL, et al. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response. J Immunol. 2006 Jun 1;176(11):6690-701. PMID: 16709828.

 

Kan-Mitchell J, Bisikirska B, Wong-Staal F, et al. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. J Immunol. 2004 May 1;172(9):5249-61. PMID: 15100263.

"

LKT H3275 HIV Integrase Protein Inhibitor HCKFWW 1 mg 60 HIV integrase inhibitor. HCKFWW ≥95% 906.1 C46H55N11O7S Ambient -20°C Puras Lutzke RA, Eppens NA, Weber PA, et al. Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60. PMID: 8524782.

LKT T3357 Tioconazole 1 g 61.1 Imidazole; 14-α demethylase inhibitor. 1-[2-[(2-Chloro-3-thienyl)methoxy]-2-(2,4- dichlorophenyl)ethyl]-1H-imidazole Vagistat; Fungibacid; Trosyd; Zoniden 65899-73-2 ≥98% 387.71 C16H13Cl3N2OS C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl Ambient Ambient Moderately soluble in chloroform, ethanol, methanol or ethyl acetate. "Jones RN, Bale MJ, Hoban D, et al. In vitro antimicrobial activity of tioconazole and its concentrations in vaginal fluids following topical (vagistat-1 6.5%) application. Diagn Microbiol Infect Dis. 1993 Jul;17(1):45-51. PMID: 8359005.

 

Odds FC, Cheesman SL, Abbott AB. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents. Sabouraudia. 1985 Dec;23(6):415-24. PMID: 3913012.

" Xn Not dangerous goods.

LKT H3275 HIV Integrase Protein Inhibitor HCKFWW 2 mg 101.9 HIV integrase inhibitor. HCKFWW ≥95% 906.1 C46H55N11O7S Ambient -20°C Puras Lutzke RA, Eppens NA, Weber PA, et al. Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60. PMID: 8524782.

LKT T3357 Tioconazole 5 g 95.1 Imidazole; 14-α demethylase inhibitor. 1-[2-[(2-Chloro-3-thienyl)methoxy]-2-(2,4- dichlorophenyl)ethyl]-1H-imidazole Vagistat; Fungibacid; Trosyd; Zoniden 65899-73-2 ≥98% 387.71 C16H13Cl3N2OS C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl Ambient Ambient Moderately soluble in chloroform, ethanol, methanol or ethyl acetate. "Jones RN, Bale MJ, Hoban D, et al. In vitro antimicrobial activity of tioconazole and its concentrations in vaginal fluids following topical (vagistat-1 6.5%) application. Diagn Microbiol Infect Dis. 1993 Jul;17(1):45-51. PMID: 8359005.

 

Odds FC, Cheesman SL, Abbott AB. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents. Sabouraudia. 1985 Dec;23(6):415-24. PMID: 3913012.

" Xn Not dangerous goods.

LKT H3275 HIV Integrase Protein Inhibitor HCKFWW 5 mg 180 HIV integrase inhibitor. HCKFWW ≥95% 906.1 C46H55N11O7S Ambient -20°C Puras Lutzke RA, Eppens NA, Weber PA, et al. Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60. PMID: 8524782.

LKT T3357 Tioconazole 25 g 271.7 Imidazole; 14-α demethylase inhibitor. 1-[2-[(2-Chloro-3-thienyl)methoxy]-2-(2,4- dichlorophenyl)ethyl]-1H-imidazole Vagistat; Fungibacid; Trosyd; Zoniden 65899-73-2 ≥98% 387.71 C16H13Cl3N2OS C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl Ambient Ambient Moderately soluble in chloroform, ethanol, methanol or ethyl acetate. "Jones RN, Bale MJ, Hoban D, et al. In vitro antimicrobial activity of tioconazole and its concentrations in vaginal fluids following topical (vagistat-1 6.5%) application. Diagn Microbiol Infect Dis. 1993 Jul;17(1):45-51. PMID: 8359005.

 

Odds FC, Cheesman SL, Abbott AB. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents. Sabouraudia. 1985 Dec;23(6):415-24. PMID: 3913012.

" Xn Not dangerous goods.

LKT H3276 HIV Protease Substrate ARVLAEA 1 mg 180 HIV protease binding epitope. ≥98% 769.9 C33H59N11O10 Ambient -20°C Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.

LKT H3278 HIV Reverse Transcriptase A2.1 Peptide 1 mg 72.1 Peptide, HIV-1 RT A2.1 epitope. HIV-1 RT ≥95% 991.21 C46H78N12O12 Ambient -20°C "Peter K, Men Y, Pantaleo G, et al. Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants. Vaccine. 2001 Jul 20;19(30):4121-9. PMID: 11457536.

 

Shankar P, Sprang H, Lieberman J. Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):111-20. PMID: 9768618.

"

LKT H3278 HIV Reverse Transcriptase A2.1 Peptide 2 mg 123.1 Peptide, HIV-1 RT A2.1 epitope. HIV-1 RT ≥95% 991.21 C46H78N12O12 Ambient -20°C "Peter K, Men Y, Pantaleo G, et al. Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants. Vaccine. 2001 Jul 20;19(30):4121-9. PMID: 11457536.

 

Shankar P, Sprang H, Lieberman J. Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):111-20. PMID: 9768618.

"

LKT H3278 HIV Reverse Transcriptase A2.1 Peptide 5 mg 216.1 Peptide, HIV-1 RT A2.1 epitope. HIV-1 RT ≥95% 991.21 C46H78N12O12 Ambient -20°C "Peter K, Men Y, Pantaleo G, et al. Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants. Vaccine. 2001 Jul 20;19(30):4121-9. PMID: 11457536.

 

Shankar P, Sprang H, Lieberman J. Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):111-20. PMID: 9768618.

"

LKT H5654 Honokiol 10 mg 54 Lignan found in species of Magnolia; GABA-A potentiator. 3',5-Di-2-propenyl-[1,1'-biphenyl]-2,4'-diol 5,3'-diallyl-2,4'-dihydroxydiphenyl 35354-74-6 ≥98% 266.33 C18H18O2 C=CCC1=CC(=C(C=C1)O)C2=CC(=C(C=C2)O)CC=C Ambient 4°C Soluble in organic solvents and caustic alkali.DMSO to 53 mg/ml, "Atanasov AG, Wang JN, Gu SP, et al. Honokiol: a non-adipogenic PPARγ agonist from nature. Biochim Biophys Acta. 2013 Oct;1830(10):4813-9. PMID: 23811337.

 

Zhang P, Liu X, Zhu Y, et al. Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-κB activation and cytokine production of glial cells. Neurosci Lett. 2013 Feb 8;534:123-7. PMID: 23262090.

 

Lan KH, Wang YW, Lee WP, et al. Multiple effects of Honokiol on the life cycle of hepatitis C virus. Liver Int. 2012 Jul;32(6):989-97. PMID: 22098176.

 

Ku TH, Lee YJ, Wang SJ, et al. Effect of honokiol on activity of GAD(65) and GAD(67) in the cortex and hippocampus of mice. Phytomedicine. 2011 Oct 15;18(13):1126-9. PMID: 21561750.

 

Chen XR, Lu R, Dan HX, et al. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells. Int J Oral Sci. 2011 Jan;3(1):34-42. PMID: 21449214

 

Hu H, Zhang XX, Wang YY, et al. Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin. Acta Pharmacol Sin. 2005 Sep;26(9):1063-8. PMID: 16115372.

 

Liou KT, Shen YC, Chen CF, et al. Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res. 2003 Dec 5;992(2):159-66. PMID: 14625055.

 

Bai X, Cerimele F, Ushio-Fukai M, et al. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem. 2003 Sep 12;278(37):35501-7. PMID: 12816951.

" Xi "UN number: 3077     Class:  9     Packing group:  III

Proper shipping name:  Environmentally hazardous substance, solid, n.o.s. (Honokiol)

Marine pollutant:  Yes.     Poison Inhalation Hazard:  No"

LKT H5654 Honokiol 25 mg 112.1 Lignan found in species of Magnolia; GABA-A potentiator. 3',5-Di-2-propenyl-[1,1'-biphenyl]-2,4'-diol 5,3'-diallyl-2,4'-dihydroxydiphenyl 35354-74-6 ≥98% 266.33 C18H18O2 C=CCC1=CC(=C(C=C1)O)C2=CC(=C(C=C2)O)CC=C Ambient 4°C Soluble in organic solvents and caustic alkali.DMSO to 53 mg/ml, "Atanasov AG, Wang JN, Gu SP, et al. Honokiol: a non-adipogenic PPARγ agonist from nature. Biochim Biophys Acta. 2013 Oct;1830(10):4813-9. PMID: 23811337.

 

Zhang P, Liu X, Zhu Y, et al. Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-κB activation and cytokine production of glial cells. Neurosci Lett. 2013 Feb 8;534:123-7. PMID: 23262090.

 

Lan KH, Wang YW, Lee WP, et al. Multiple effects of Honokiol on the life cycle of hepatitis C virus. Liver Int. 2012 Jul;32(6):989-97. PMID: 22098176.

 

Ku TH, Lee YJ, Wang SJ, et al. Effect of honokiol on activity of GAD(65) and GAD(67) in the cortex and hippocampus of mice. Phytomedicine. 2011 Oct 15;18(13):1126-9. PMID: 21561750.

 

Chen XR, Lu R, Dan HX, et al. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells. Int J Oral Sci. 2011 Jan;3(1):34-42. PMID: 21449214

 

Hu H, Zhang XX, Wang YY, et al. Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin. Acta Pharmacol Sin. 2005 Sep;26(9):1063-8. PMID: 16115372.

 

Liou KT, Shen YC, Chen CF, et al. Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res. 2003 Dec 5;992(2):159-66. PMID: 14625055.

 

Bai X, Cerimele F, Ushio-Fukai M, et al. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem. 2003 Sep 12;278(37):35501-7. PMID: 12816951.

" Xi "UN number: 3077     Class:  9     Packing group:  III

Proper shipping name:  Environmentally hazardous substance, solid, n.o.s. (Honokiol)

Marine pollutant:  Yes.     Poison Inhalation Hazard:  No"

LKT H5654 Honokiol 100 mg 373.7 Lignan found in species of Magnolia; GABA-A potentiator. 3',5-Di-2-propenyl-[1,1'-biphenyl]-2,4'-diol 5,3'-diallyl-2,4'-dihydroxydiphenyl 35354-74-6 ≥98% 266.33 C18H18O2 C=CCC1=CC(=C(C=C1)O)C2=CC(=C(C=C2)O)CC=C Ambient 4°C Soluble in organic solvents and caustic alkali.DMSO to 53 mg/ml, "Atanasov AG, Wang JN, Gu SP, et al. Honokiol: a non-adipogenic PPARγ agonist from nature. Biochim Biophys Acta. 2013 Oct;1830(10):4813-9. PMID: 23811337.

 

Zhang P, Liu X, Zhu Y, et al. Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-κB activation and cytokine production of glial cells. Neurosci Lett. 2013 Feb 8;534:123-7. PMID: 23262090.

 

Lan KH, Wang YW, Lee WP, et al. Multiple effects of Honokiol on the life cycle of hepatitis C virus. Liver Int. 2012 Jul;32(6):989-97. PMID: 22098176.

 

Ku TH, Lee YJ, Wang SJ, et al. Effect of honokiol on activity of GAD(65) and GAD(67) in the cortex and hippocampus of mice. Phytomedicine. 2011 Oct 15;18(13):1126-9. PMID: 21561750.

 

Chen XR, Lu R, Dan HX, et al. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells. Int J Oral Sci. 2011 Jan;3(1):34-42. PMID: 21449214

 

Hu H, Zhang XX, Wang YY, et al. Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin. Acta Pharmacol Sin. 2005 Sep;26(9):1063-8. PMID: 16115372.

 

Liou KT, Shen YC, Chen CF, et al. Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res. 2003 Dec 5;992(2):159-66. PMID: 14625055.

 

Bai X, Cerimele F, Ushio-Fukai M, et al. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem. 2003 Sep 12;278(37):35501-7. PMID: 12816951.

" Xi "UN number: 3077     Class:  9     Packing group:  III

Proper shipping name:  Environmentally hazardous substance, solid, n.o.s. (Honokiol)

Marine pollutant:  Yes.     Poison Inhalation Hazard:  No"

LKT T3350 Timolol Maleate 100 mg 69.3 β-adrenergic antagonist. (2S)-1-[(1,1-Dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol maleate Betime; Blocadren; Istalol; Timacar; Timoptol: Proflax 26921-17-5 ≥98% 432.5 C13H24N4O3S C4H4O4 CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O Ambient Ambient Soluble in water, methanol, and ethanol. "Johnson TV, Fan S, Zhan G, et al. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment. J Glaucoma. 2010 Aug;19(6):356-64. PMID: 20179619.

 

Dong Y, Ishikawa H, Wu Y, et al. Effect and mechanism of betaxolol and timolol on vascular relaxation in isolated rabbit ciliary artery. Jpn J Ophthalmol. 2006 Nov-Dec;50(6):504-8. PMID: 17180523.

" Repr., Xn Not dangerous goods.

LKT T3350 Timolol Maleate 250 mg 146.2 β-adrenergic antagonist. (2S)-1-[(1,1-Dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol maleate Betime; Blocadren; Istalol; Timacar; Timoptol: Proflax 26921-17-5 ≥98% 432.5 C13H24N4O3S C4H4O4 CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O Ambient Ambient Soluble in water, methanol, and ethanol. "Johnson TV, Fan S, Zhan G, et al. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment. J Glaucoma. 2010 Aug;19(6):356-64. PMID: 20179619.

 

Dong Y, Ishikawa H, Wu Y, et al. Effect and mechanism of betaxolol and timolol on vascular relaxation in isolated rabbit ciliary artery. Jpn J Ophthalmol. 2006 Nov-Dec;50(6):504-8. PMID: 17180523.

" Repr., Xn Not dangerous goods.

LKT T3350 Timolol Maleate 1 g 415.8 β-adrenergic antagonist. (2S)-1-[(1,1-Dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol maleate Betime; Blocadren; Istalol; Timacar; Timoptol: Proflax 26921-17-5 ≥98% 432.5 C13H24N4O3S C4H4O4 CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O Ambient Ambient Soluble in water, methanol, and ethanol. "Johnson TV, Fan S, Zhan G, et al. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment. J Glaucoma. 2010 Aug;19(6):356-64. PMID: 20179619.

 

Dong Y, Ishikawa H, Wu Y, et al. Effect and mechanism of betaxolol and timolol on vascular relaxation in isolated rabbit ciliary artery. Jpn J Ophthalmol. 2006 Nov-Dec;50(6):504-8. PMID: 17180523.

" Repr., Xn Not dangerous goods.

LKT T3310 Ticlopidine Hydrochloride 1 g 29.8 Thienopyridine; P2Y12 antagonist. 5-[(2-Chlorophenyl)-methyl]4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride Panaldine; TIclid; Ticlodix; Ticlodone; Caudaline 53885-35-1 ≥98% 300.25 C14H14ClNS HCl C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl Ambient Ambient Soluble in ethanol, methanol or chloroform. "Cohen MV, Downey JM. Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered. J Cardiovasc Pharmacol Ther. 2014 Mar;19(2):179-90. PMID: 24298192.

 

Secco GG, Parisi R, Mirabella F, et al. P2Y12 inhibitors: pharmacologic mechanism and clinical relevance. Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):101-5. PMID: 22963529.

" Xn Not dangerous goods.

LKT T3310 Ticlopidine Hydrochloride 5 g 94.6 Thienopyridine; P2Y12 antagonist. 5-[(2-Chlorophenyl)-methyl]4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride Panaldine; TIclid; Ticlodix; Ticlodone; Caudaline 53885-35-1 ≥98% 300.25 C14H14ClNS HCl C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl Ambient Ambient Soluble in ethanol, methanol or chloroform. "Cohen MV, Downey JM. Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered. J Cardiovasc Pharmacol Ther. 2014 Mar;19(2):179-90. PMID: 24298192.

 

Secco GG, Parisi R, Mirabella F, et al. P2Y12 inhibitors: pharmacologic mechanism and clinical relevance. Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):101-5. PMID: 22963529.

" Xn Not dangerous goods.

LKT T3310 Ticlopidine Hydrochloride 25 g 315.5 Thienopyridine; P2Y12 antagonist. 5-[(2-Chlorophenyl)-methyl]4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride Panaldine; TIclid; Ticlodix; Ticlodone; Caudaline 53885-35-1 ≥98% 300.25 C14H14ClNS HCl C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl Ambient Ambient Soluble in ethanol, methanol or chloroform. "Cohen MV, Downey JM. Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered. J Cardiovasc Pharmacol Ther. 2014 Mar;19(2):179-90. PMID: 24298192.

 

Secco GG, Parisi R, Mirabella F, et al. P2Y12 inhibitors: pharmacologic mechanism and clinical relevance. Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):101-5. PMID: 22963529.

" Xn Not dangerous goods.

LKT T3305 Tibolone 100 mg 203.8 Synthetic steroid hormone used in HRT; SERM, PR and AR agonist, aromatase inhibitor, glucocorticoid and mineralocorticoid antagonist. (7α,17α)-17-Hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one Org-OD-14; Livial 5630-53-5 ≥98% 312.45 C21H28O2 CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O Ambient Ambient Soluble in ethanol, DMSO, and DMF. "Campisi R, Marengo FD. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovasc Drug Rev. 2007 Summer;25(2):132-45. PMID: 17614936.

 

Raobaikady B, Parsons MF, Reed MJ, et al. Tibolone and its delta-4, 7alpha-methyl norethisterone metabolite are reversible inhibitors of human aromatase. J Steroid Biochem Mol Biol. 2007 May;104(3-5):154-60. PMID: 17467267.

 

Vanhoecke BW, Bracke ME, Kloosterboer HJ, et al. Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro. Maturitas. 2006 Jun 20;54(3):229-37. PMID: 16581209.

 

Lund CO, Nilas L, Pedersen SH, et al. Tibolone and its metabolites acutely relax rabbit coronary arteries in vitro. Maturitas. 2004 Nov 15;49(3):179-88. PMID: 15488346.

 

Kloosterboer HJ. Tissue-selectivity: the mechanism of action of tibolone. Maturitas. 2004 Aug 30;48 Suppl 1:S30-40. PMID: 15337246.

" N Not dangerous goods.

LKT T3305 Tibolone 500 mg 747.5 Synthetic steroid hormone used in HRT; SERM, PR and AR agonist, aromatase inhibitor, glucocorticoid and mineralocorticoid antagonist. (7α,17α)-17-Hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one Org-OD-14; Livial 5630-53-5 ≥98% 312.45 C21H28O2 CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O Ambient Ambient Soluble in ethanol, DMSO, and DMF. "Campisi R, Marengo FD. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovasc Drug Rev. 2007 Summer;25(2):132-45. PMID: 17614936.

 

Raobaikady B, Parsons MF, Reed MJ, et al. Tibolone and its delta-4, 7alpha-methyl norethisterone metabolite are reversible inhibitors of human aromatase. J Steroid Biochem Mol Biol. 2007 May;104(3-5):154-60. PMID: 17467267.

 

Vanhoecke BW, Bracke ME, Kloosterboer HJ, et al. Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro. Maturitas. 2006 Jun 20;54(3):229-37. PMID: 16581209.

 

Lund CO, Nilas L, Pedersen SH, et al. Tibolone and its metabolites acutely relax rabbit coronary arteries in vitro. Maturitas. 2004 Nov 15;49(3):179-88. PMID: 15488346.

 

Kloosterboer HJ. Tissue-selectivity: the mechanism of action of tibolone. Maturitas. 2004 Aug 30;48 Suppl 1:S30-40. PMID: 15337246.

" N Not dangerous goods.

LKT T3305 Tibolone 1 g 1155.2 Synthetic steroid hormone used in HRT; SERM, PR and AR agonist, aromatase inhibitor, glucocorticoid and mineralocorticoid antagonist. (7α,17α)-17-Hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one Org-OD-14; Livial 5630-53-5 ≥98% 312.45 C21H28O2 CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O Ambient Ambient Soluble in ethanol, DMSO, and DMF. "Campisi R, Marengo FD. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovasc Drug Rev. 2007 Summer;25(2):132-45. PMID: 17614936.

 

Raobaikady B, Parsons MF, Reed MJ, et al. Tibolone and its delta-4, 7alpha-methyl norethisterone metabolite are reversible inhibitors of human aromatase. J Steroid Biochem Mol Biol. 2007 May;104(3-5):154-60. PMID: 17467267.

 

Vanhoecke BW, Bracke ME, Kloosterboer HJ, et al. Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro. Maturitas. 2006 Jun 20;54(3):229-37. PMID: 16581209.

 

Lund CO, Nilas L, Pedersen SH, et al. Tibolone and its metabolites acutely relax rabbit coronary arteries in vitro. Maturitas. 2004 Nov 15;49(3):179-88. PMID: 15488346.

 

Kloosterboer HJ. Tissue-selectivity: the mechanism of action of tibolone. Maturitas. 2004 Aug 30;48 Suppl 1:S30-40. PMID: 15337246.

" N Not dangerous goods.

LKT T3197 L-Thyroxine Sodium Pentahydrate 1 g 140.7 Endogenous thyroid hormone T4. Levothyroxine 6106-07-6 ≥97% 888.93 C15H10I4NNaO4 5H2O C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.O.O.O.O.O.[Na+] Ambient Ambient "Gullo D, Latina A, Frasca F, et al. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One. 2011;6(8):e22552. PMID: 21829633.

 

Svensson J, Ericsson UB, Nilsson P, et al. Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. J Clin Endocrinol Metab. 2006 May;91(5):1729-34. PMID: 16507633.

" None Not dangerous goods.

LKT T3197 L-Thyroxine Sodium Pentahydrate 5 g 534.5 Endogenous thyroid hormone T4. Levothyroxine 6106-07-6 ≥97% 888.93 C15H10I4NNaO4 5H2O C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.O.O.O.O.O.[Na+] Ambient Ambient "Gullo D, Latina A, Frasca F, et al. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One. 2011;6(8):e22552. PMID: 21829633.

 

Svensson J, Ericsson UB, Nilsson P, et al. Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. J Clin Endocrinol Metab. 2006 May;91(5):1729-34. PMID: 16507633.

" None Not dangerous goods.

LKT H8048 Human Follicular Gonadotropin Releasing Peptide 1 mg 235.5 Peptide, stimulates release of LH and FSH. hF-GRP ≥98% 1651.6 C68H94N22O27 Ambient -20°C Ramasharma K, Yamashiro D, Li CH. Human follicular gonadotropin releasing peptide analogs. Evaluation of biological (in vitro) and immunological activity. Int J Pept Protein Res. 1988 Dec;32(6):419-24. PMID: 3149951.

LKT H8162 (−)-Huperzine A 1 mg 92.5 Sesquiterpene alkaloid found in Huperzia serrata; AChE inhibitor, NMDA antagonist. 1-amino-13-ethylidene-11-methyl-6-aza-tricyclo- [7.3.1.02,7]trideca-2(7),3,10-trien-5-one HupA 102518-79-6 ≥97% 242.32 C15H18N2O CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3 Packaged under inert gas. Ambient 4°C Soluble in DMSO, ethanol, methanol, and aqueous acids. "Yu D, Thakor DK, Han I, et al. Alleviation of chronic pain following rat spinal cord compression injury with multimodal actions of huperzine A. Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):E746-55. PMID: 23386718.

 

Rafii MS, Walsh S, Little JT, et al. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. 2011 Apr 19;76(16):1389-94. doi: PMID: 21502597.

 

Park P, Schachter S, Yaksh T. Intrathecal huperzine A increases thermal escape latency and decreases flinching behavior in the formalin test in rats. Neurosci Lett. 2010 Feb 5;470(1):6-9. PMID: 20026382.

 

Zhang Z, Wang X, Chen Q, et al. Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial. Zhonghua Yi Xue Za Zhi. 2002 Jul 25;82(14):941-4. PMID: 12181083.

 

Gordon RK, Nigam SV, Weitz JA, et al. The NMDA receptor ion channel: a site for binding of Huperzine A. J Appl Toxicol. 2001 Dec;21 Suppl 1:S47-51. PMID: 11920920.

 

Camps P, El Achab R, Morral J, et al. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease. J Med Chem. 2000 Nov 30;43(24):4657-66. PMID: 11101357.

 

Lallement G, Veyret J, Masqueliez C, et al. Efficacy of huperzine in preventing soman-induced seizures, neuropathological changes and lethality. Fundam Clin Pharmacol. 1997;11(5):387-94. PMID: 9342591.

 

Xu SS, Gao ZX, Weng Z, et al. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease. Zhongguo Yao Li Xue Bao. 1995 Sep;16(5):391-5. PMID: 8701750.

" T+ "UN number: 1544     Class: 6.1     Packing Group: II

Proper shipping name: Alkaloids, solid, n.o.s. ((-)-Huperzine A)"

LKT H8162 (−)-Huperzine A 5 mg 407.7 Sesquiterpene alkaloid found in Huperzia serrata; AChE inhibitor, NMDA antagonist. 1-amino-13-ethylidene-11-methyl-6-aza-tricyclo- [7.3.1.02,7]trideca-2(7),3,10-trien-5-one HupA 102518-79-6 ≥97% 242.32 C15H18N2O CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3 Packaged under inert gas. Ambient 4°C Soluble in DMSO, ethanol, methanol, and aqueous acids. "Yu D, Thakor DK, Han I, et al. Alleviation of chronic pain following rat spinal cord compression injury with multimodal actions of huperzine A. Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):E746-55. PMID: 23386718.

 

Rafii MS, Walsh S, Little JT, et al. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. 2011 Apr 19;76(16):1389-94. doi: PMID: 21502597.

 

Park P, Schachter S, Yaksh T. Intrathecal huperzine A increases thermal escape latency and decreases flinching behavior in the formalin test in rats. Neurosci Lett. 2010 Feb 5;470(1):6-9. PMID: 20026382.

 

Zhang Z, Wang X, Chen Q, et al. Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial. Zhonghua Yi Xue Za Zhi. 2002 Jul 25;82(14):941-4. PMID: 12181083.

 

Gordon RK, Nigam SV, Weitz JA, et al. The NMDA receptor ion channel: a site for binding of Huperzine A. J Appl Toxicol. 2001 Dec;21 Suppl 1:S47-51. PMID: 11920920.

 

Camps P, El Achab R, Morral J, et al. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease. J Med Chem. 2000 Nov 30;43(24):4657-66. PMID: 11101357.

 

Lallement G, Veyret J, Masqueliez C, et al. Efficacy of huperzine in preventing soman-induced seizures, neuropathological changes and lethality. Fundam Clin Pharmacol. 1997;11(5):387-94. PMID: 9342591.

 

Xu SS, Gao ZX, Weng Z, et al. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease. Zhongguo Yao Li Xue Bao. 1995 Sep;16(5):391-5. PMID: 8701750.

" T+ "UN number: 1544     Class: 6.1     Packing Group: II

Proper shipping name: Alkaloids, solid, n.o.s. ((-)-Huperzine A)"

LKT H9611 Hydrocortisone 5 g 101.1 Endogenous steroid hormone involved in stress signaling; glucocorticoid agonist. (11β)-11,17,21-Trihydroxypregn-4-ene-3,20-dione Cortisol; Anflam; Dermacortal; Efcortelan; Ficortril; Hydracort; Medicort; Penecort; Texacort; Zenoxone 50-23-7 ≥98% 362.46 C21H30O5 CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O Ambient Ambient Soluble in ethanol (25 mg/mL), acetone (12 mg/mL), or propylene glycol. Very slightly soluble in ether and water. "Angelier F, Wingfield JC. Importance of the glucocorticoid stress response in a changing world: theory, hypotheses and perspectives. Gen Comp Endocrinol. 2013 Sep 1;190:118-28. PMID: 23770214.

 

Tarchalska-Kryńska B. Glucocorticosteroids: mechanism of action, pharmacological effects, pharmacokinetics and adverse effects. Otolaryngol Pol. 1994;48 Suppl 17:41-8. PMID: 8090502.

 

Sluyser M. Mechanism of steroid hormone action at the cellular level. Basic Life Sci. 1975;6:79-104. PMID:168860.

" Repr., Carc. Not dangerous goods.

LKT H9611 Hydrocortisone 10 g 173 Endogenous steroid hormone involved in stress signaling; glucocorticoid agonist. (11β)-11,17,21-Trihydroxypregn-4-ene-3,20-dione Cortisol; Anflam; Dermacortal; Efcortelan; Ficortril; Hydracort; Medicort; Penecort; Texacort; Zenoxone 50-23-7 ≥98% 362.46 C21H30O5 CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O Ambient Ambient Soluble in ethanol (25 mg/mL), acetone (12 mg/mL), or propylene glycol. Very slightly soluble in ether and water. "Angelier F, Wingfield JC. Importance of the glucocorticoid stress response in a changing world: theory, hypotheses and perspectives. Gen Comp Endocrinol. 2013 Sep 1;190:118-28. PMID: 23770214.

 

Tarchalska-Kryńska B. Glucocorticosteroids: mechanism of action, pharmacological effects, pharmacokinetics and adverse effects. Otolaryngol Pol. 1994;48 Suppl 17:41-8. PMID: 8090502.

 

Sluyser M. Mechanism of steroid hormone action at the cellular level. Basic Life Sci. 1975;6:79-104. PMID:168860.

" Repr., Carc. Not dangerous goods.

LKT H9611 Hydrocortisone 25 g 345.8 Endogenous steroid hormone involved in stress signaling; glucocorticoid agonist. (11β)-11,17,21-Trihydroxypregn-4-ene-3,20-dione Cortisol; Anflam; Dermacortal; Efcortelan; Ficortril; Hydracort; Medicort; Penecort; Texacort; Zenoxone 50-23-7 ≥98% 362.46 C21H30O5 CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O Ambient Ambient Soluble in ethanol (25 mg/mL), acetone (12 mg/mL), or propylene glycol. Very slightly soluble in ether and water. "Angelier F, Wingfield JC. Importance of the glucocorticoid stress response in a changing world: theory, hypotheses and perspectives. Gen Comp Endocrinol. 2013 Sep 1;190:118-28. PMID: 23770214.

 

Tarchalska-Kryńska B. Glucocorticosteroids: mechanism of action, pharmacological effects, pharmacokinetics and adverse effects. Otolaryngol Pol. 1994;48 Suppl 17:41-8. PMID: 8090502.

 

Sluyser M. Mechanism of steroid hormone action at the cellular level. Basic Life Sci. 1975;6:79-104. PMID:168860.

" Repr., Carc. Not dangerous goods.

LKT H9612 Hydrocortisone 21-Acetate 1 g 46.4 Steroid hormone involved in stress signaling; glucocorticoid agonist. (11β)11,17,21-Trihydroxypregn-4-ene-3,20-dione 21-acetate Colifoam; Cortaid; Cortifoam; Hydrocal; Lanacort; Sigmacort; Velopural 50-03-3 ≥98% 404.5 C23H32O6 CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)O Hygroscopic. Ambient Ambient Soluble in DMF and dioxane. Slightly soluble in chloroform, ethanol (4 mg/mL), methanol. ether and water. "Angelier F, Wingfield JC. Importance of the glucocorticoid stress response in a changing world: theory, hypotheses and perspectives. Gen Comp Endocrinol. 2013 Sep 1;190:118-28. PMID: 23770214.

 

Tarchalska-Kryńska B. Glucocorticosteroids: mechanism of action, pharmacological effects, pharmacokinetics and adverse effects. Otolaryngol Pol. 1994;48 Suppl 17:41-8. PMID: 8090502.

 

Sluyser M. Mechanism of steroid hormone action at the cellular level. Basic Life Sci. 1975;6:79-104. PMID:168860.

" Xn Repr Not dangerous goods.

LKT H9612 Hydrocortisone 21-Acetate 5 g 155.3 Steroid hormone involved in stress signaling; glucocorticoid agonist. (11β)11,17,21-Trihydroxypregn-4-ene-3,20-dione 21-acetate Colifoam; Cortaid; Cortifoam; Hydrocal; Lanacort; Sigmacort; Velopural 50-03-3 ≥98% 404.5 C23H32O6 CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)O Hygroscopic. Ambient Ambient Soluble in DMF and dioxane. Slightly soluble in chloroform, ethanol (4 mg/mL), methanol. ether and water. "Angelier F, Wingfield JC. Importance of the glucocorticoid stress response in a changing world: theory, hypotheses and perspectives. Gen Comp Endocrinol. 2013 Sep 1;190:118-28. PMID: 23770214.

 

Tarchalska-Kryńska B. Glucocorticosteroids: mechanism of action, pharmacological effects, pharmacokinetics and adverse effects. Otolaryngol Pol. 1994;48 Suppl 17:41-8. PMID: 8090502.

 

Sluyser M. Mechanism of steroid hormone action at the cellular level. Basic Life Sci. 1975;6:79-104. PMID:168860.

" Xn Repr Not dangerous goods.

LKT H9612 Hydrocortisone 21-Acetate 10 g 271.7 Steroid hormone involved in stress signaling; glucocorticoid agonist. (11β)11,17,21-Trihydroxypregn-4-ene-3,20-dione 21-acetate Colifoam; Cortaid; Cortifoam; Hydrocal; Lanacort; Sigmacort; Velopural 50-03-3 ≥98% 404.5 C23H32O6 CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)O Hygroscopic. Ambient Ambient Soluble in DMF and dioxane. Slightly soluble in chloroform, ethanol (4 mg/mL), methanol. ether and water. "Angelier F, Wingfield JC. Importance of the glucocorticoid stress response in a changing world: theory, hypotheses and perspectives. Gen Comp Endocrinol. 2013 Sep 1;190:118-28. PMID: 23770214.

 

Tarchalska-Kryńska B. Glucocorticosteroids: mechanism of action, pharmacological effects, pharmacokinetics and adverse effects. Otolaryngol Pol. 1994;48 Suppl 17:41-8. PMID: 8090502.

 

Sluyser M. Mechanism of steroid hormone action at the cellular level. Basic Life Sci. 1975;6:79-104. PMID:168860.

" Xn Repr Not dangerous goods.

LKT T3101 Thyrotropin-releasing Hormone, Free Acid 5 mg 60 Endogenous tripeptide, involved in HPA signaling; TRHR agonist. TRH, thyrotropin-releasing factor, TRF ≥95% 362.4 C16H21N5O5 C1CC(N(C1)C(=O)C(CC2C=NC=N2)NC(=O)C3CCC(=O)N3)C(=O)O Ambient -20°C "Fekete C, Lechan RM. Central Regulation of Pituitary-Thyroid Axis Under Physiological and Pathophysiological Conditions. Endocr Rev. 2013 Dec 4:er20131087. [Epub ahead of print]. PMID: 24423980.

 

Pekary AE, Sattin A. Increased TRH and TRH-like peptide release in rat brain and peripheral tissues during proestrus/estrus. Peptides. 2013 Dec 1;52C:1-10. PMID: 24296042.

 

Daimon CM, Chirdon P, Maudsley S, et al. The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases. Am J Alzheimers Dis (Columbia). 2013;1(1). PMID: 24199031.

 

Meier NT, Haslam IS, Pattwell DM, et al. Thyrotropin-releasing hormone (TRH) promotes wound re-epithelialisation in frog and human skin. PLoS One. 2013 Sep 2;8(9):e73596. PMID: 24023889.

" Not dangerous goods.

LKT T3101 Thyrotropin-releasing Hormone, Free Acid 10 mg 101.9 Endogenous tripeptide, involved in HPA signaling; TRHR agonist. TRH, thyrotropin-releasing factor, TRF ≥95% 362.4 C16H21N5O5 C1CC(N(C1)C(=O)C(CC2C=NC=N2)NC(=O)C3CCC(=O)N3)C(=O)O Ambient -20°C "Fekete C, Lechan RM. Central Regulation of Pituitary-Thyroid Axis Under Physiological and Pathophysiological Conditions. Endocr Rev. 2013 Dec 4:er20131087. [Epub ahead of print]. PMID: 24423980.

 

Pekary AE, Sattin A. Increased TRH and TRH-like peptide release in rat brain and peripheral tissues during proestrus/estrus. Peptides. 2013 Dec 1;52C:1-10. PMID: 24296042.

 

Daimon CM, Chirdon P, Maudsley S, et al. The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases. Am J Alzheimers Dis (Columbia). 2013;1(1). PMID: 24199031.

 

Meier NT, Haslam IS, Pattwell DM, et al. Thyrotropin-releasing hormone (TRH) promotes wound re-epithelialisation in frog and human skin. PLoS One. 2013 Sep 2;8(9):e73596. PMID: 24023889.

" Not dangerous goods.

LKT T3101 Thyrotropin-releasing Hormone, Free Acid 25 mg 180 Endogenous tripeptide, involved in HPA signaling; TRHR agonist. TRH, thyrotropin-releasing factor, TRF ≥95% 362.4 C16H21N5O5 C1CC(N(C1)C(=O)C(CC2C=NC=N2)NC(=O)C3CCC(=O)N3)C(=O)O Ambient -20°C "Fekete C, Lechan RM. Central Regulation of Pituitary-Thyroid Axis Under Physiological and Pathophysiological Conditions. Endocr Rev. 2013 Dec 4:er20131087. [Epub ahead of print]. PMID: 24423980.

 

Pekary AE, Sattin A. Increased TRH and TRH-like peptide release in rat brain and peripheral tissues during proestrus/estrus. Peptides. 2013 Dec 1;52C:1-10. PMID: 24296042.

 

Daimon CM, Chirdon P, Maudsley S, et al. The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases. Am J Alzheimers Dis (Columbia). 2013;1(1). PMID: 24199031.

 

Meier NT, Haslam IS, Pattwell DM, et al. Thyrotropin-releasing hormone (TRH) promotes wound re-epithelialisation in frog and human skin. PLoS One. 2013 Sep 2;8(9):e73596. PMID: 24023889.

" Not dangerous goods.

LKT H9613 N-(4-Hydroxyphenyl)retinamide 1 mg 47.6 Retinol (vitamin A) analog, binds RBP4; Des1 inhibitor. Fenretinide; 4-HPR, Retinoic acid p-hydroxyanilide 65646-68-6 ≥98% 391.55 C26H33NO2 CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C Ambient -20°C Soluble in DMSO (25mg/mL) or ethanol (25mg/mL). "Durante S, Orienti I, Teti G, et al. Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model. Oncotarget. 2014 May 28. [Epub ahead of print]. PMID: 25015569.

 

Bikman BT, Guan Y, Shui G, et al. Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis. J Biol Chem. 2012 May 18;287(21):17426-37. PMID: 22474281.

 

Koh IU, Jun HS, Choi JS, et al. Fenretinide ameliorates insulin resistance and fatty liver in obese mice. Biol Pharm Bull. 2012;35(3):369-75. PMID: 22382323.

 

Guilbault C, De Sanctis JB, Wojewodka G, et al. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis. Am J Respir Cell Mol Biol. 2008 Jan;38(1):47-56. PMID: 17656682.

 

Wu JM, DiPietrantonio AM, Hsieh TC. Mechanism of fenretinide (4-HPR)-induced cell death. Apoptosis. 2001 Oct;6(5):377-88. PMID: 11483862.

" Xn Xi Repr Not dangerous goods.

LKT H9613 N-(4-Hydroxyphenyl)retinamide 5 mg 122.3 Retinol (vitamin A) analog, binds RBP4; Des1 inhibitor. Fenretinide; 4-HPR, Retinoic acid p-hydroxyanilide 65646-68-6 ≥98% 391.55 C26H33NO2 CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C Ambient -20°C Soluble in DMSO (25mg/mL) or ethanol (25mg/mL). "Durante S, Orienti I, Teti G, et al. Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model. Oncotarget. 2014 May 28. [Epub ahead of print]. PMID: 25015569.

 

Bikman BT, Guan Y, Shui G, et al. Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis. J Biol Chem. 2012 May 18;287(21):17426-37. PMID: 22474281.

 

Koh IU, Jun HS, Choi JS, et al. Fenretinide ameliorates insulin resistance and fatty liver in obese mice. Biol Pharm Bull. 2012;35(3):369-75. PMID: 22382323.

 

Guilbault C, De Sanctis JB, Wojewodka G, et al. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis. Am J Respir Cell Mol Biol. 2008 Jan;38(1):47-56. PMID: 17656682.

 

Wu JM, DiPietrantonio AM, Hsieh TC. Mechanism of fenretinide (4-HPR)-induced cell death. Apoptosis. 2001 Oct;6(5):377-88. PMID: 11483862.

" Xn Xi Repr Not dangerous goods.

LKT H9613 N-(4-Hydroxyphenyl)retinamide 10 mg 224.3 Retinol (vitamin A) analog, binds RBP4; Des1 inhibitor. Fenretinide; 4-HPR, Retinoic acid p-hydroxyanilide 65646-68-6 ≥98% 391.55 C26H33NO2 CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C Ambient -20°C Soluble in DMSO (25mg/mL) or ethanol (25mg/mL). "Durante S, Orienti I, Teti G, et al. Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model. Oncotarget. 2014 May 28. [Epub ahead of print]. PMID: 25015569.

 

Bikman BT, Guan Y, Shui G, et al. Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis. J Biol Chem. 2012 May 18;287(21):17426-37. PMID: 22474281.

 

Koh IU, Jun HS, Choi JS, et al. Fenretinide ameliorates insulin resistance and fatty liver in obese mice. Biol Pharm Bull. 2012;35(3):369-75. PMID: 22382323.

 

Guilbault C, De Sanctis JB, Wojewodka G, et al. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis. Am J Respir Cell Mol Biol. 2008 Jan;38(1):47-56. PMID: 17656682.

 

Wu JM, DiPietrantonio AM, Hsieh TC. Mechanism of fenretinide (4-HPR)-induced cell death. Apoptosis. 2001 Oct;6(5):377-88. PMID: 11483862.

" Xn Xi Repr Not dangerous goods.

LKT T3100 Thyrotropin-releasing Hormone 5 mg 60 Endogenous tripeptide, involved in HPA signaling; TRHR agonist. TRH, thyrotropin-releasing factor, TRF ≥95% 362.4 C16H23N6O Ambient -20°C "Fekete C, Lechan RM. Central Regulation of Pituitary-Thyroid Axis Under Physiological and Pathophysiological Conditions. Endocr Rev. 2013 Dec 4:er20131087. [Epub ahead of print]. PMID: 24423980.

 

Pekary AE, Sattin A. Increased TRH and TRH-like peptide release in rat brain and peripheral tissues during proestrus/estrus. Peptides. 2013 Dec 1;52C:1-10. PMID: 24296042.

 

Daimon CM, Chirdon P, Maudsley S, et al. The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases. Am J Alzheimers Dis (Columbia). 2013;1(1). PMID: 24199031.

 

Meier NT, Haslam IS, Pattwell DM, et al. Thyrotropin-releasing hormone (TRH) promotes wound re-epithelialisation in frog and human skin. PLoS One. 2013 Sep 2;8(9):e73596. PMID: 24023889.

" Not dangerous goods.

LKT T3100 Thyrotropin-releasing Hormone 10 mg 101.9 Endogenous tripeptide, involved in HPA signaling; TRHR agonist. TRH, thyrotropin-releasing factor, TRF ≥95% 362.4 C16H23N6O Ambient -20°C "Fekete C, Lechan RM. Central Regulation of Pituitary-Thyroid Axis Under Physiological and Pathophysiological Conditions. Endocr Rev. 2013 Dec 4:er20131087. [Epub ahead of print]. PMID: 24423980.

 

Pekary AE, Sattin A. Increased TRH and TRH-like peptide release in rat brain and peripheral tissues during proestrus/estrus. Peptides. 2013 Dec 1;52C:1-10. PMID: 24296042.

 

Daimon CM, Chirdon P, Maudsley S, et al. The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases. Am J Alzheimers Dis (Columbia). 2013;1(1). PMID: 24199031.

 

Meier NT, Haslam IS, Pattwell DM, et al. Thyrotropin-releasing hormone (TRH) promotes wound re-epithelialisation in frog and human skin. PLoS One. 2013 Sep 2;8(9):e73596. PMID: 24023889.

" Not dangerous goods.

LKT T3100 Thyrotropin-releasing Hormone 25 mg 180 Endogenous tripeptide, involved in HPA signaling; TRHR agonist. TRH, thyrotropin-releasing factor, TRF ≥95% 362.4 C16H23N6O Ambient -20°C "Fekete C, Lechan RM. Central Regulation of Pituitary-Thyroid Axis Under Physiological and Pathophysiological Conditions. Endocr Rev. 2013 Dec 4:er20131087. [Epub ahead of print]. PMID: 24423980.

 

Pekary AE, Sattin A. Increased TRH and TRH-like peptide release in rat brain and peripheral tissues during proestrus/estrus. Peptides. 2013 Dec 1;52C:1-10. PMID: 24296042.

 

Daimon CM, Chirdon P, Maudsley S, et al. The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases. Am J Alzheimers Dis (Columbia). 2013;1(1). PMID: 24199031.

 

Meier NT, Haslam IS, Pattwell DM, et al. Thyrotropin-releasing hormone (TRH) promotes wound re-epithelialisation in frog and human skin. PLoS One. 2013 Sep 2;8(9):e73596. PMID: 24023889.

" Not dangerous goods.

LKT T3099 Thymus Factor 1 mg 60 Endogenous peptide, involved in immune signaling. Thymulin, Thymic factor, FTS ≥95% 875.9 C33H57N13O15 Ambient -20°C "Martines EV, Reggiani PC, Camihort G, et al. The thymulin-lactotropic axis in rodents: thymectomy, immunoneutralization and gene transfer studies. Neuroimmunomodulation. 2013;20(5):256-63. PMID: 23941809.

 

Lunin SM, Glushkova OV, Khrenov MO, et al. Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis. Immunobiology. 2013 Mar;218(3):402-7. PMID: 22727332.

 

Reggiani PC, Martines EV, Camihort GA, et al. Role of thymulin on the somatotropic axis in vivo. Life Sci. 2012 Sep 4;91(5-6):166-71. PMID: 22781709.

 

Santos M, Henriques-Coelho T, Leite-Moreira A. Immunomodulatory role of thymulin in lung diseases. Expert Opin Ther Targets. 2010 Feb;14(2):131-41. PMID: 20055713.

 

Goya RG, Bolognani F. Homeostasis, thymic hormones and aging. Gerontology. 1999 May-Jun;45(3):174-8. PMID: 10202264.

"

LKT T3099 Thymus Factor 2 mg 101.9 Endogenous peptide, involved in immune signaling. Thymulin, Thymic factor, FTS ≥95% 875.9 C33H57N13O15 Ambient -20°C "Martines EV, Reggiani PC, Camihort G, et al. The thymulin-lactotropic axis in rodents: thymectomy, immunoneutralization and gene transfer studies. Neuroimmunomodulation. 2013;20(5):256-63. PMID: 23941809.

 

Lunin SM, Glushkova OV, Khrenov MO, et al. Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis. Immunobiology. 2013 Mar;218(3):402-7. PMID: 22727332.

 

Reggiani PC, Martines EV, Camihort GA, et al. Role of thymulin on the somatotropic axis in vivo. Life Sci. 2012 Sep 4;91(5-6):166-71. PMID: 22781709.

 

Santos M, Henriques-Coelho T, Leite-Moreira A. Immunomodulatory role of thymulin in lung diseases. Expert Opin Ther Targets. 2010 Feb;14(2):131-41. PMID: 20055713.

 

Goya RG, Bolognani F. Homeostasis, thymic hormones and aging. Gerontology. 1999 May-Jun;45(3):174-8. PMID: 10202264.

"

LKT T3099 Thymus Factor 5 mg 180 Endogenous peptide, involved in immune signaling. Thymulin, Thymic factor, FTS ≥95% 875.9 C33H57N13O15 Ambient -20°C "Martines EV, Reggiani PC, Camihort G, et al. The thymulin-lactotropic axis in rodents: thymectomy, immunoneutralization and gene transfer studies. Neuroimmunomodulation. 2013;20(5):256-63. PMID: 23941809.

 

Lunin SM, Glushkova OV, Khrenov MO, et al. Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis. Immunobiology. 2013 Mar;218(3):402-7. PMID: 22727332.

 

Reggiani PC, Martines EV, Camihort GA, et al. Role of thymulin on the somatotropic axis in vivo. Life Sci. 2012 Sep 4;91(5-6):166-71. PMID: 22781709.

 

Santos M, Henriques-Coelho T, Leite-Moreira A. Immunomodulatory role of thymulin in lung diseases. Expert Opin Ther Targets. 2010 Feb;14(2):131-41. PMID: 20055713.

 

Goya RG, Bolognani F. Homeostasis, thymic hormones and aging. Gerontology. 1999 May-Jun;45(3):174-8. PMID: 10202264.

"

LKT H9615 17α-Hydroxyprogesterone Caproate 1 g 32.1 Synthetic steroid hormone; ER antagonist. 630-56-8 ≥98% 428.6 C27H40O4 CCCCCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)C Ambient 4°C "Briery CM, Klauser CK, Martin RW, et al. The use of 17-hydroxy progesterone in women with arrested preterm labor: a randomized clinical trial. J Matern Fetal Neonatal Med. 2014 Mar 10. [Epub ahead of print]. PMID: 24512252.

 

Yemini M, Borenstein R, Dreazen E, et al. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol. 1985 Mar 1;151(5):574-7. PMID: 3976757.

" T Not dangerous goods.

LKT H9615 17α-Hydroxyprogesterone Caproate 5 g 101.1 Synthetic steroid hormone; ER antagonist. 630-56-8 ≥98% 428.6 C27H40O4 CCCCCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)C Ambient 4°C "Briery CM, Klauser CK, Martin RW, et al. The use of 17-hydroxy progesterone in women with arrested preterm labor: a randomized clinical trial. J Matern Fetal Neonatal Med. 2014 Mar 10. [Epub ahead of print]. PMID: 24512252.

 

Yemini M, Borenstein R, Dreazen E, et al. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol. 1985 Mar 1;151(5):574-7. PMID: 3976757.

" T Not dangerous goods.

LKT H9615 17α-Hydroxyprogesterone Caproate 10 g 173 Synthetic steroid hormone; ER antagonist. 630-56-8 ≥98% 428.6 C27H40O4 CCCCCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)C Ambient 4°C "Briery CM, Klauser CK, Martin RW, et al. The use of 17-hydroxy progesterone in women with arrested preterm labor: a randomized clinical trial. J Matern Fetal Neonatal Med. 2014 Mar 10. [Epub ahead of print]. PMID: 24512252.

 

Yemini M, Borenstein R, Dreazen E, et al. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol. 1985 Mar 1;151(5):574-7. PMID: 3976757.

" T Not dangerous goods.

LKT H9618 Hydroquinone 50 g 39 Basic phenol skeleton structure found in various natural sources, oxidoreductant; potential topoisomerase II inhibitor. 1,4-Benzenediol Aida; Eldoquin; Eldopaque; Tecquinol 123-31-9 ≥96% 110.11 C6H6O2 C1=CC(=CC=C1O)O Oxidizes rapidly. Ambient 4°C Soluble in alcohol or ether. Slightly soluble in benzene. "Mondrala S, Eastmond DA. Topoisomerase II inhibition by the bioactivated benzene metabolite hydroquinone involves multiple mechanisms. Chem Biol Interact. 2010 Mar 19;184(1-2):259-68. PMID: 20034485.

 

Ji Z, Zhang L, Guo W, et al. The benzene metabolite, hydroquinone and etoposide both induce endoreduplication in human lymphoblastoid TK6 cells. Mutagenesis. 2009 Jul;24(4):367-72. PMID: 19491217.

" N, Muta., Carc., Xn, Xi "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Hydroquinone)"

LKT H9620 7-Hydroxyaristolochic Acid A 1 mg 169.9 Derivative of aristolochic acid found in Asarum; carcinogen. ≥95% 357.27 C17H11NO8 C1OC2=C(O1)C3=C(C(=C2)C(=O)O)C(=CC4=CC=CC=C43)[N+](=O)[O-] Ambient -20°C Soluble in water. Xie BB, Shang MY, Wang X, et al. A new aristolochic acid derivative from Asarum himalaicum. Yao Xue Xue Bao. 2011 Feb;46(2):188-92. PMID: 21542290. Not dangerous goods.

LKT H9620 7-Hydroxyaristolochic Acid A 5 mg 475.7 Derivative of aristolochic acid found in Asarum; carcinogen. ≥95% 357.27 C17H11NO8 C1OC2=C(O1)C3=C(C(=C2)C(=O)O)C(=CC4=CC=CC=C43)[N+](=O)[O-] Ambient -20°C Soluble in water. Xie BB, Shang MY, Wang X, et al. A new aristolochic acid derivative from Asarum himalaicum. Yao Xue Xue Bao. 2011 Feb;46(2):188-92. PMID: 21542290. Not dangerous goods.

LKT H9620 7-Hydroxyaristolochic Acid A 10 mg 679.5 Derivative of aristolochic acid found in Asarum; carcinogen. ≥95% 357.27 C17H11NO8 C1OC2=C(O1)C3=C(C(=C2)C(=O)O)C(=CC4=CC=CC=C43)[N+](=O)[O-] Ambient -20°C Soluble in water. Xie BB, Shang MY, Wang X, et al. A new aristolochic acid derivative from Asarum himalaicum. Yao Xue Xue Bao. 2011 Feb;46(2):188-92. PMID: 21542290. Not dangerous goods.

LKT T3096 Thymosin α-1 10 mg 750.1 Endogenous peptide fragment, immunostimulant;  indoleamine 2,3-dioxygenase activator. Thymalfasin; Zadaxin 62304-98-7 ≥95% 3108.3 C129H215N33O55 CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C Ambient -20°C "Tuthill C, Rios I, De Rosa A, et al. Thymosin α1 continues to show promise as an enhancer for vaccine response. Ann N Y Acad Sci. 2012 Oct;1270:21-7. PMID: 23050813.

 

Romani L, Moretti S, Fallarino F, et al. Jack of all trades: thymosin α1 and its pleiotropy. Ann N Y Acad Sci. 2012 Oct;1269:1-6. PMID: 23045964.

 

Yang X, Qian F, He HY, et al. Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro. Braz J Med Biol Res. 2012 Jan;45(1):25-32. PMID: 22245858.

 

Wan J, Shan Y, Shan H, et al. Thymosin-alpha1 promotes the apoptosis of regulatory T cells and survival rate in septic mice. Front Biosci (Landmark Ed). 2011 Jun 1;16:3004-13. PMID: 21622217.

" Not dangerous goods.

LKT T3096 Thymosin α-1 50 mg 2400.1 Endogenous peptide fragment, immunostimulant;  indoleamine 2,3-dioxygenase activator. Thymalfasin; Zadaxin 62304-98-7 ≥95% 3108.3 C129H215N33O55 CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C Ambient -20°C "Tuthill C, Rios I, De Rosa A, et al. Thymosin α1 continues to show promise as an enhancer for vaccine response. Ann N Y Acad Sci. 2012 Oct;1270:21-7. PMID: 23050813.

 

Romani L, Moretti S, Fallarino F, et al. Jack of all trades: thymosin α1 and its pleiotropy. Ann N Y Acad Sci. 2012 Oct;1269:1-6. PMID: 23045964.

 

Yang X, Qian F, He HY, et al. Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro. Braz J Med Biol Res. 2012 Jan;45(1):25-32. PMID: 22245858.

 

Wan J, Shan Y, Shan H, et al. Thymosin-alpha1 promotes the apoptosis of regulatory T cells and survival rate in septic mice. Front Biosci (Landmark Ed). 2011 Jun 1;16:3004-13. PMID: 21622217.

" Not dangerous goods.

LKT T3096 Thymosin α-1 1 g 9000.8 Endogenous peptide fragment, immunostimulant;  indoleamine 2,3-dioxygenase activator. Thymalfasin; Zadaxin 62304-98-7 ≥95% 3108.3 C129H215N33O55 CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C Ambient -20°C "Tuthill C, Rios I, De Rosa A, et al. Thymosin α1 continues to show promise as an enhancer for vaccine response. Ann N Y Acad Sci. 2012 Oct;1270:21-7. PMID: 23050813.

 

Romani L, Moretti S, Fallarino F, et al. Jack of all trades: thymosin α1 and its pleiotropy. Ann N Y Acad Sci. 2012 Oct;1269:1-6. PMID: 23045964.

 

Yang X, Qian F, He HY, et al. Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro. Braz J Med Biol Res. 2012 Jan;45(1):25-32. PMID: 22245858.

 

Wan J, Shan Y, Shan H, et al. Thymosin-alpha1 promotes the apoptosis of regulatory T cells and survival rate in septic mice. Front Biosci (Landmark Ed). 2011 Jun 1;16:3004-13. PMID: 21622217.

" Not dangerous goods.

LKT T3094 Thymopentin Acetate 10 mg 101 Peptide fragment of thymopoietin, immunostimulant. TP-5 Acetate 69558-55-0 ≥95% 679.8 C30H49N9O9 CH3COOH CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N Ambient -20°C Freely sol in water "Patruno A, Tosco P, Borretto E, et al. Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients. Nitric Oxide. 2012 Oct 15;27(3):143-9. PMID: 22721692.

 

Lunin SM, Glushkova OV, Khrenov MO, et al. Thymus peptides regulate activity of RAW 264.7 macrophage cells: inhibitory analysis and a role of signal cascades. Expert Opin Ther Targets. 2011 Dec;15(12):1337-46. PMID: 22148922.

 

Fan YZ, Chang H, Yu Y, et al. Thymopentin (TP5), an immunomodulatory peptide, suppresses proliferation and induces differentiation in HL-60 cells. Biochim Biophys Acta. 2006 Oct;1763(10):1059-66. PMID: 16952408.

 

Fabrizi F, Dixit V, Martin P. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1559-66. PMID: 16696803.

" Not dangerous goods.

LKT T3094 Thymopentin Acetate 50 mg 436.9 Peptide fragment of thymopoietin, immunostimulant. TP-5 Acetate 69558-55-0 ≥95% 679.8 C30H49N9O9 CH3COOH CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N Ambient -20°C Freely sol in water "Patruno A, Tosco P, Borretto E, et al. Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients. Nitric Oxide. 2012 Oct 15;27(3):143-9. PMID: 22721692.

 

Lunin SM, Glushkova OV, Khrenov MO, et al. Thymus peptides regulate activity of RAW 264.7 macrophage cells: inhibitory analysis and a role of signal cascades. Expert Opin Ther Targets. 2011 Dec;15(12):1337-46. PMID: 22148922.

 

Fan YZ, Chang H, Yu Y, et al. Thymopentin (TP5), an immunomodulatory peptide, suppresses proliferation and induces differentiation in HL-60 cells. Biochim Biophys Acta. 2006 Oct;1763(10):1059-66. PMID: 16952408.

 

Fabrizi F, Dixit V, Martin P. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1559-66. PMID: 16696803.

" Not dangerous goods.

LKT T3094 Thymopentin Acetate 1 g 1612.9 Peptide fragment of thymopoietin, immunostimulant. TP-5 Acetate 69558-55-0 ≥95% 679.8 C30H49N9O9 CH3COOH CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N Ambient -20°C Freely sol in water "Patruno A, Tosco P, Borretto E, et al. Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients. Nitric Oxide. 2012 Oct 15;27(3):143-9. PMID: 22721692.

 

Lunin SM, Glushkova OV, Khrenov MO, et al. Thymus peptides regulate activity of RAW 264.7 macrophage cells: inhibitory analysis and a role of signal cascades. Expert Opin Ther Targets. 2011 Dec;15(12):1337-46. PMID: 22148922.

 

Fan YZ, Chang H, Yu Y, et al. Thymopentin (TP5), an immunomodulatory peptide, suppresses proliferation and induces differentiation in HL-60 cells. Biochim Biophys Acta. 2006 Oct;1763(10):1059-66. PMID: 16952408.

 

Fabrizi F, Dixit V, Martin P. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1559-66. PMID: 16696803.

" Not dangerous goods.

LKT H9661 Hypocrellin A 10 mg 339.8 Prevents MHC II antigen presentation. Contains ~16% B Hypocrellin 77029-83-5 ≥77%, contains ~16% B 546.52 C30H26O10 CC(=O)C1C2=C(C(=C3C(=O)C=C(C4=C5C(=CC(=O)C6=C(C(=C(CC1(C)O)C(=C56)C2=C43)OC)O)OC)OC)O)OC Ambient 4°C Soluble in heptane. "Du W, Sun C, Liang Z, et al. Antibacterial activity of hypocrellin A against Staphylococcus aureus. World J Microbiol Biotechnol. 2012 Nov;28(11):3151-7. PMID: 22864599.

 

Park S, Im SA, Kim KH, et al. Immunomodulatory Effects of Hypocrellin A on MHC-restricted Antigen Processing. Immune Netw. 2011 Dec;11(6):412-5. PMID: 22346783.

 

Su Y, Sun J, Rao S, et al. Photodynamic antimicrobial activity of hypocrellin A. J Photochem Photobiol B. 2011 Apr 4;103(1):29-34. PMID: 21300554.

 

Xu Y, Zhang Z, Zhang H. Raman spectroscopic study of DNA after photosensitive damage caused by hypocrellins A and B. Sci China C Life Sci. 1998 Aug;41(4):360-6. PMID: 18726251.

 

" Not dangerous goods.

LKT H9661 Hypocrellin A 25 mg 611.5 Prevents MHC II antigen presentation. Contains ~16% B Hypocrellin 77029-83-5 ≥77%, contains ~16% B 546.52 C30H26O10 CC(=O)C1C2=C(C(=C3C(=O)C=C(C4=C5C(=CC(=O)C6=C(C(=C(CC1(C)O)C(=C56)C2=C43)OC)O)OC)OC)O)OC Ambient 4°C Soluble in heptane. "Du W, Sun C, Liang Z, et al. Antibacterial activity of hypocrellin A against Staphylococcus aureus. World J Microbiol Biotechnol. 2012 Nov;28(11):3151-7. PMID: 22864599.

 

Park S, Im SA, Kim KH, et al. Immunomodulatory Effects of Hypocrellin A on MHC-restricted Antigen Processing. Immune Netw. 2011 Dec;11(6):412-5. PMID: 22346783.

 

Su Y, Sun J, Rao S, et al. Photodynamic antimicrobial activity of hypocrellin A. J Photochem Photobiol B. 2011 Apr 4;103(1):29-34. PMID: 21300554.

 

Xu Y, Zhang Z, Zhang H. Raman spectroscopic study of DNA after photosensitive damage caused by hypocrellins A and B. Sci China C Life Sci. 1998 Aug;41(4):360-6. PMID: 18726251.

 

" Not dangerous goods.

LKT H9661 Hypocrellin A 100 mg 1910 Prevents MHC II antigen presentation. Contains ~16% B Hypocrellin 77029-83-5 ≥77%, contains ~16% B 546.52 C30H26O10 CC(=O)C1C2=C(C(=C3C(=O)C=C(C4=C5C(=CC(=O)C6=C(C(=C(CC1(C)O)C(=C56)C2=C43)OC)O)OC)OC)O)OC Ambient 4°C Soluble in heptane. "Du W, Sun C, Liang Z, et al. Antibacterial activity of hypocrellin A against Staphylococcus aureus. World J Microbiol Biotechnol. 2012 Nov;28(11):3151-7. PMID: 22864599.

 

Park S, Im SA, Kim KH, et al. Immunomodulatory Effects of Hypocrellin A on MHC-restricted Antigen Processing. Immune Netw. 2011 Dec;11(6):412-5. PMID: 22346783.

 

Su Y, Sun J, Rao S, et al. Photodynamic antimicrobial activity of hypocrellin A. J Photochem Photobiol B. 2011 Apr 4;103(1):29-34. PMID: 21300554.

 

Xu Y, Zhang Z, Zhang H. Raman spectroscopic study of DNA after photosensitive damage caused by hypocrellins A and B. Sci China C Life Sci. 1998 Aug;41(4):360-6. PMID: 18726251.

 

" Not dangerous goods.

LKT H9662 Hypocrellin B 10 mg 320.3 Induces DNA strand breakage. 123940-54-5 ≥90% 528.51 C30H24O9 CC1=C2C3=C4C(=C(C(=O)C(=O)C5=CC(=C6C(=CC(=C(C6=C54)C3=C(C(=C2C(=O)C)OC)O)O)OC)OC)OC)C1 Ambient 4°C Soluble in DMSO. "Jiang Y, Leung AW, Wang X, et al. Effect of photodynamic therapy with hypocrellin B on apoptosis, adhesion, and migration of cancer cells. Int J Radiat Biol. 2014 Jul;90(7):575-9. PMID: 24661233.

 

Jiang Y, Leung AW, Wang X, et al. Inactivation of Staphylococcus aureus by photodynamic action of hypocrellin B. Photodiagnosis Photodyn Ther. 2013 Dec;10(4):600-6. PMID: 24284117.

 

Babu A, Jeyasubramanian K, Gunasekaran P, et al. Gelatin nanocarrier enables efficient delivery and phototoxicity of hypocrellin B against a mice tumour model. J Biomed Nanotechnol. 2012 Feb;8(1):43-56. PMID: 22515093.

 

Xu Y, Zhang Z, Zhang H. Raman spectroscopic study of DNA after photosensitive damage caused by hypocrellins A and B. Sci China C Life Sci. 1998 Aug;41(4):360-6. PMID: 18726251.

 

" Not dangerous goods.

LKT H9662 Hypocrellin B 25 mg 566.3 Induces DNA strand breakage. 123940-54-5 ≥90% 528.51 C30H24O9 CC1=C2C3=C4C(=C(C(=O)C(=O)C5=CC(=C6C(=CC(=C(C6=C54)C3=C(C(=C2C(=O)C)OC)O)O)OC)OC)OC)C1 Ambient 4°C Soluble in DMSO. "Jiang Y, Leung AW, Wang X, et al. Effect of photodynamic therapy with hypocrellin B on apoptosis, adhesion, and migration of cancer cells. Int J Radiat Biol. 2014 Jul;90(7):575-9. PMID: 24661233.

 

Jiang Y, Leung AW, Wang X, et al. Inactivation of Staphylococcus aureus by photodynamic action of hypocrellin B. Photodiagnosis Photodyn Ther. 2013 Dec;10(4):600-6. PMID: 24284117.

 

Babu A, Jeyasubramanian K, Gunasekaran P, et al. Gelatin nanocarrier enables efficient delivery and phototoxicity of hypocrellin B against a mice tumour model. J Biomed Nanotechnol. 2012 Feb;8(1):43-56. PMID: 22515093.

 

Xu Y, Zhang Z, Zhang H. Raman spectroscopic study of DNA after photosensitive damage caused by hypocrellins A and B. Sci China C Life Sci. 1998 Aug;41(4):360-6. PMID: 18726251.

 

" Not dangerous goods.

LKT H9662 Hypocrellin B 100 mg 1910 Induces DNA strand breakage. 123940-54-5 ≥90% 528.51 C30H24O9 CC1=C2C3=C4C(=C(C(=O)C(=O)C5=CC(=C6C(=CC(=C(C6=C54)C3=C(C(=C2C(=O)C)OC)O)O)OC)OC)OC)C1 Ambient 4°C Soluble in DMSO. "Jiang Y, Leung AW, Wang X, et al. Effect of photodynamic therapy with hypocrellin B on apoptosis, adhesion, and migration of cancer cells. Int J Radiat Biol. 2014 Jul;90(7):575-9. PMID: 24661233.

 

Jiang Y, Leung AW, Wang X, et al. Inactivation of Staphylococcus aureus by photodynamic action of hypocrellin B. Photodiagnosis Photodyn Ther. 2013 Dec;10(4):600-6. PMID: 24284117.

 

Babu A, Jeyasubramanian K, Gunasekaran P, et al. Gelatin nanocarrier enables efficient delivery and phototoxicity of hypocrellin B against a mice tumour model. J Biomed Nanotechnol. 2012 Feb;8(1):43-56. PMID: 22515093.

 

Xu Y, Zhang Z, Zhang H. Raman spectroscopic study of DNA after photosensitive damage caused by hypocrellins A and B. Sci China C Life Sci. 1998 Aug;41(4):360-6. PMID: 18726251.

 

" Not dangerous goods.

LKT T3093 Thymopentin 5 mg 180 Synthetic peptide, thymopoietin analog. TP-5, RKDVY ≥95% 679.8 C30H49N9O9 CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N Ambient -20°C "Lunin SM, Glushkova OV, Khrenov MO, et al. Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis. Immunobiology. 2013 Mar;218(3):402-7. PMID: 22727332.

 

Patruno A, Tosco P, Borretto E, et al. Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients. Nitric Oxide. 2012 Oct 15;27(3):143-9. PMID: 22721692.

 

Lunin SM, Glushkova OV, Khrenov MO, et al. Thymus peptides regulate activity of RAW 264.7 macrophage cells: inhibitory analysis and a role of signal cascades. Expert Opin Ther Targets. 2011 Dec;15(12):1337-46. PMID: 22148922.

 

Liu Z, Zheng X, Wang J, et al. Molecular analysis of thymopentin binding to HLA-DR molecules. PLoS One. 2007 Dec 26;2(12):e1348. PMID: 18159232.

" Not dangerous goods.

LKT T3093 Thymopentin 10 mg 306.1 Synthetic peptide, thymopoietin analog. TP-5, RKDVY ≥95% 679.8 C30H49N9O9 CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N Ambient -20°C "Lunin SM, Glushkova OV, Khrenov MO, et al. Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis. Immunobiology. 2013 Mar;218(3):402-7. PMID: 22727332.

 

Patruno A, Tosco P, Borretto E, et al. Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients. Nitric Oxide. 2012 Oct 15;27(3):143-9. PMID: 22721692.

 

Lunin SM, Glushkova OV, Khrenov MO, et al. Thymus peptides regulate activity of RAW 264.7 macrophage cells: inhibitory analysis and a role of signal cascades. Expert Opin Ther Targets. 2011 Dec;15(12):1337-46. PMID: 22148922.

 

Liu Z, Zheng X, Wang J, et al. Molecular analysis of thymopentin binding to HLA-DR molecules. PLoS One. 2007 Dec 26;2(12):e1348. PMID: 18159232.

" Not dangerous goods.

LKT T3093 Thymopentin 25 mg 540 Synthetic peptide, thymopoietin analog. TP-5, RKDVY ≥95% 679.8 C30H49N9O9 CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N Ambient -20°C "Lunin SM, Glushkova OV, Khrenov MO, et al. Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis. Immunobiology. 2013 Mar;218(3):402-7. PMID: 22727332.

 

Patruno A, Tosco P, Borretto E, et al. Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients. Nitric Oxide. 2012 Oct 15;27(3):143-9. PMID: 22721692.

 

Lunin SM, Glushkova OV, Khrenov MO, et al. Thymus peptides regulate activity of RAW 264.7 macrophage cells: inhibitory analysis and a role of signal cascades. Expert Opin Ther Targets. 2011 Dec;15(12):1337-46. PMID: 22148922.

 

Liu Z, Zheng X, Wang J, et al. Molecular analysis of thymopentin binding to HLA-DR molecules. PLoS One. 2007 Dec 26;2(12):e1348. PMID: 18159232.

" Not dangerous goods.

LKT T3041 Thienylpropyl Isothiocyanate 25 mg 203.7 Thienylbutyl ITC analog. ≥98% 183.3 C8H9NS2 Ambient 4°C "Lam LKT, Kenney P, Bergstrom CP, et al.  Chem Biol Interact. 1999;127:163-80.

 

Hecht SS. Chemoprevention by isothiocyanates. J Cell Biochem Suppl. 1995;22:195-209. PMID: 8538199." Not dangerous goods.

LKT H9711 (Z)-4-Hydroxytamoxifen 5 mg 115.4 SERM. 68047-06-3 ≥98% 387.51 C26H29NO2 CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3 Ambient -20°C Soluble in DMSO, ethanol (20mg/ml) or methanol (10mg/ml); insoluble water. "Asp ML, Martindale JJ, Metzger JM. Direct, differential effects of tamoxifen, 4-hydroxytamoxifen, and raloxifene on cardiac myocyte contractility and calcium handling. PLoS One. 2013 Oct 24;8(10):e78768. PMID: 24205315.

 

Kohli L, Kaza N, Coric T, et al. 4-Hydroxytamoxifen induces autophagic death through K-Ras degradation. Cancer Res. 2013 Jul 15;73(14):4395-405. PMID: 23722551.

 

Schwartz JA, Zhong L, Deighton-Collins S, et al. Mutations targeted to a predicted helix in the extreme carboxyl-terminal region of the human estrogen receptor-alpha alter its response to estradiol and 4-hydroxytamoxifen. J Biol Chem. 2002 Apr 12;277(15):13202-9. Erratum in: J Biol Chem 2002 Jul 5;277(27):24842.  PMID: 11823467.

" Xn, Repr. Cat. 3 Not dangerous goods.

LKT H9711 (Z)-4-Hydroxytamoxifen 10 mg 192.4 SERM. 68047-06-3 ≥98% 387.51 C26H29NO2 CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3 Ambient -20°C Soluble in DMSO, ethanol (20mg/ml) or methanol (10mg/ml); insoluble water. "Asp ML, Martindale JJ, Metzger JM. Direct, differential effects of tamoxifen, 4-hydroxytamoxifen, and raloxifene on cardiac myocyte contractility and calcium handling. PLoS One. 2013 Oct 24;8(10):e78768. PMID: 24205315.

 

Kohli L, Kaza N, Coric T, et al. 4-Hydroxytamoxifen induces autophagic death through K-Ras degradation. Cancer Res. 2013 Jul 15;73(14):4395-405. PMID: 23722551.

 

Schwartz JA, Zhong L, Deighton-Collins S, et al. Mutations targeted to a predicted helix in the extreme carboxyl-terminal region of the human estrogen receptor-alpha alter its response to estradiol and 4-hydroxytamoxifen. J Biol Chem. 2002 Apr 12;277(15):13202-9. Erratum in: J Biol Chem 2002 Jul 5;277(27):24842.  PMID: 11823467.

" Xn, Repr. Cat. 3 Not dangerous goods.

LKT H9711 (Z)-4-Hydroxytamoxifen 25 mg 399.9 SERM. 68047-06-3 ≥98% 387.51 C26H29NO2 CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3 Ambient -20°C Soluble in DMSO, ethanol (20mg/ml) or methanol (10mg/ml); insoluble water. "Asp ML, Martindale JJ, Metzger JM. Direct, differential effects of tamoxifen, 4-hydroxytamoxifen, and raloxifene on cardiac myocyte contractility and calcium handling. PLoS One. 2013 Oct 24;8(10):e78768. PMID: 24205315.

 

Kohli L, Kaza N, Coric T, et al. 4-Hydroxytamoxifen induces autophagic death through K-Ras degradation. Cancer Res. 2013 Jul 15;73(14):4395-405. PMID: 23722551.

 

Schwartz JA, Zhong L, Deighton-Collins S, et al. Mutations targeted to a predicted helix in the extreme carboxyl-terminal region of the human estrogen receptor-alpha alter its response to estradiol and 4-hydroxytamoxifen. J Biol Chem. 2002 Apr 12;277(15):13202-9. Erratum in: J Biol Chem 2002 Jul 5;277(27):24842.  PMID: 11823467.

" Xn, Repr. Cat. 3 Not dangerous goods.

LKT T3041 Thienylpropyl Isothiocyanate 50 mg 342.2 Thienylbutyl ITC analog. ≥98% 183.3 C8H9NS2 Ambient 4°C "Lam LKT, Kenney P, Bergstrom CP, et al.  Chem Biol Interact. 1999;127:163-80.

 

Hecht SS. Chemoprevention by isothiocyanates. J Cell Biochem Suppl. 1995;22:195-209. PMID: 8538199." Not dangerous goods.

LKT T3041 Thienylpropyl Isothiocyanate 100 mg 554.8 Thienylbutyl ITC analog. ≥98% 183.3 C8H9NS2 Ambient 4°C "Lam LKT, Kenney P, Bergstrom CP, et al.  Chem Biol Interact. 1999;127:163-80.

 

Hecht SS. Chemoprevention by isothiocyanates. J Cell Biochem Suppl. 1995;22:195-209. PMID: 8538199." Not dangerous goods.

LKT T3041 Thienylpropyl Isothiocyanate 500 mg 2182.2 Thienylbutyl ITC analog. ≥98% 183.3 C8H9NS2 Ambient 4°C "Lam LKT, Kenney P, Bergstrom CP, et al.  Chem Biol Interact. 1999;127:163-80.

 

Hecht SS. Chemoprevention by isothiocyanates. J Cell Biochem Suppl. 1995;22:195-209. PMID: 8538199." Not dangerous goods.

LKT T3040 Thienylpentyl Isothiocyanate 25 mg 203.7 Thienylbutyl ITC analog. ≥98% 211.35 C10H13NS2 Ambient 4°C "Lam LKT, Kenney P, Bergstrom CP, et al.  Chem Biol Interact. 1999;127:163-80.

 

Hecht SS. Chemoprevention by isothiocyanates. J Cell Biochem Suppl. 1995;22:195-209. PMID: 8538199." Not dangerous goods.

LKT T3040 Thienylpentyl Isothiocyanate 50 mg 342.2 Thienylbutyl ITC analog. ≥98% 211.35 C10H13NS2 Ambient 4°C "Lam LKT, Kenney P, Bergstrom CP, et al.  Chem Biol Interact. 1999;127:163-80.

 

Hecht SS. Chemoprevention by isothiocyanates. J Cell Biochem Suppl. 1995;22:195-209. PMID: 8538199." Not dangerous goods.

LKT T3040 Thienylpentyl Isothiocyanate 100 mg 554.8 Thienylbutyl ITC analog. ≥98% 211.35 C10H13NS2 Ambient 4°C "Lam LKT, Kenney P, Bergstrom CP, et al.  Chem Biol Interact. 1999;127:163-80.

 

Hecht SS. Chemoprevention by isothiocyanates. J Cell Biochem Suppl. 1995;22:195-209. PMID: 8538199." Not dangerous goods.

LKT T3040 Thienylpentyl Isothiocyanate 500 mg 2182.2 Thienylbutyl ITC analog. ≥98% 211.35 C10H13NS2 Ambient 4°C "Lam LKT, Kenney P, Bergstrom CP, et al.  Chem Biol Interact. 1999;127:163-80.

 

Hecht SS. Chemoprevention by isothiocyanates. J Cell Biochem Suppl. 1995;22:195-209. PMID: 8538199." Not dangerous goods.

留言框

  • 产品:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

  • 省份:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
网站首页 公司简介 产品中心 招聘中心 技术支持 企业动态 联系我们 管理登陆
上海易汇生物科技有限公司主营:Eaivelly封板膜|Eaivelly八联管|Eaivelly针式过滤器|Eaivelly光学平盖|Eaivelly荧光定量|代理GE
GoogleSitemap ICP备案号:沪ICP备16010708号-3 技术支持:化工仪器网
张经理
  • 电话

    021-62962298

在线客服
扫一扫访问手机站扫一扫访问手机站
访问手机站